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Abstract	
Liver	 epithelial	 cells	 –hepatocytes	 and	 bile	 duct	 cells–	 intermingle	 with	 a	microenvironment	of	endothelial	cells,	macrophages	and	mesenchymal	cells	to	form	the	functional	unit	of	 the	tissue.	 In	chronic	or	severe	 liver	 injury,	when	hepatocyte	proliferation	 is	 compromised,	 ductal	 cells	 become	 activated	 into	 bipotential	progenitors	to	replace	lost	epithelium.	This	process	can	be	recapitulated	in	vitro	by	growing	hepatic	ductal	cells	under	defined	extracellular	matrix	and	growth	factors,	which	generates	3D	epithelial	 'liver	organoids'	 that	 resemble	adult	 tissue,	 yet	 lack	stromal	cell	 components	(Huch	et	al.,	2013).	 In	 this	dissertation,	we	compared	 the	capacity	 of	 two	 broad	 hepatic	 stromal	 cell	 populations,	 hematopoietic/endothelial	(H/E)	and	mesenchymal	 (Msc)	 cells,	 to	behave	as	 a	nurturing	 ‘niche’	of	 the	ductal	epithelium.	In	the	absence	of	exogenous	growth	factors,	primary	Msc	but	not	H/E	cells	support	ductal	cell	proliferation	and	organoid	formation	in	vitro.	A	cell	surface	marker	screen	of	the	Msc	fraction	showed	labelling	of	up	to	20%	of	the	cells	by	the	stem	cell	antigen	 1	 (SCA1).	 In	 vivo,	 SCA1+PDGFRα+	mesenchymal	 cells	 localise	 periportally,	closely	surrounding	biliary	duct	cells,	and	co-expanding	with	them	during	damage-induced	 regeneration.	 Isolated	 SCA1+	 mesenchymal	 cells	 express	 key	 pro-regenerative	 factors	 (Hgf,	 Rspo1/3,	 Fgf7),	 and	 support	 liver	 organoid	 formation	independently	 of	 cell-to-cell	 contact.	 Mesenchyme-sustained	 organoids	 resemble	those	grown	in	standard	medium,	although	they	are	biased	towards	a	more	mature	ductal	cell	lineage.	Liver	organoids	can	in	turn	support	the	expansion	of	SCA1+	Msc	cells	in	vitro,	suggesting	a	positive	feedback	loop	of	growth.	However,	physical	contact	from	the	SCA1+	Msc	cells	can	be	cytostatic	for	the	ductal	cells	depending	on	the	ratio	between	 the	 two	 cell	 populations.	 Interestingly,	 the	mesenchymal-to-ductal	 ratios	that	permit	and	inhibit	ductal	proliferation	in	vitro	recapitulate	the	ratios	observed	between	the	two	populations	in	vivo,	during	the	different	phases	of	liver	regeneration.	Our	findings	underscore	how	the	relationship	between	the	ductal	epithelium	and	its	mesenchymal	microenvironment	regulates	tissue	regeneration,	and	provide	avenues	for	the	development	of	organotypic	liver	cultures	to	model	epithelial/mesenchymal	interactions	in	vitro.	
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1.1 Liver	anatomy	and	physiology		
Akin	to	its	size	–ranking	as	the	largest	internal	organ	of	the	body	and	second	largest	after	the	skin–	the	liver	performs	a	prominent	role	in	regulating	whole-body	homeostasis.	 Liver	 functions	 include	 metabolism	 of	 dietary	 compounds,	 defence	against	 xenobiotics,	 regulation	 of	 blood	 glucose	 levels	 by	 glycogen	 storage,	 and	secretion	of	bile,	serum	proteins	and	blood	clotting	factors.	Such	versatile	physiology	is	 the	 product	 of	 well-designed	 histoarchitecture	 and	 multicellular	 cooperation	within	the	tissue.	
Figure	 1.1.	 The	 liver	 lobule.	 	 The	 liver	histoarchitecture	 can	 be	 sub-divided	 into	 hexagon-shaped	units	known	as	lobules,	which	contain	triads	of	portal	veins	(PV),	hepatic	arteries	(HA)	and	biliary	ducts	(BD)	 at	 the	 periphery	 and	 a	 central	 vein	 (CV)	 at	 the	centre.	
At	a	simple	glance,	the	landscape	of	the	adult	liver	tissue	is	remarkably	simple	compared	 to	 other	 endoderm-derived	 organs,	 containing	 only	 a	 few	 anatomical	landmarks	to	orientate	the	observer.	Almost	regardless	of	the	angle	of	sectioning,	the	tissue	can	be	subdivided	into	multiple	“lobule”	units	centred	around	a	hepatic	venule	(also	aptly	named	central	vein)	and	surrounded	by	 triads	of	portal	arteries,	portal	veins	 and	 bile	 ducts	 (Matsumoto	 et	 al.,	 1979);	 a	 tissue-uniformity	 referred	 to	 as	“isotropic	parenchyma”	(Matsumoto	and	Kawakami,	1982)	(Figure	1.1).		Hepatocytes	and	cholangiocytes	 (or	bile	duct	 cells)	constitute	 the	 two	main	epithelial	cell	types	of	the	lobule,	which	intermingle	with	a	great	variety	of	stromal	cells	 to	ensure	correct	 liver	physiology.	Hepatocytes	are	by	 far	 the	most	abundant	parenchymal	cell,	accounting	for	approximately	60%	of	the	liver’s	total	cell	number	(Gebhardt,	1992)	and	80%	of	its	volume	(Blouin,	Bolender	and	Weibel,	1977),	thus	fuelling	at	times	the	erroneous	perception	of	cellular	homogeneity	within	the	tissue.	Hepatocytes	are	arranged	in	one-cell	thick	anastomosing	plates	or	laminae	of	cords	
1.1	Liver	anatomy	and	physiology	
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that	span	the	portovenous	distance	of	the	lobule	and	face	sinusoidal	cells	from	their	basolateral	surface	(MacSween,	Anthony	and	Scheuer,	1987).	Being	the	workhorse	of	the	tissue,	these	cells	are	endowed	with	customised	machinery	–e.g.	specific	organelle	content	and	expression	of	metabolic/cytochrome	enzymes–	to	perform	a	wide	range	of	functions.	Their	workload	is	nonetheless	distributed;	hepatocytes	across	the	lobule	have	 evolved	 remarkable	 location-based	 heterogeneity	 concerning	 the	 uptake,	storage	and	 transformation	of	biological	molecules	 (Figure	1.2).	 First	proposed	by	Jungerman	and	Sasse	in	1978	upon	studying	carbohydrate	metabolism	(Jungermann	and	 Sasse,	 1978),	 liver	 zonation	 refers	 to	 the	 allocation	 of	 opposing	 metabolic	pathways	across	the	portovenous	axis	of	the	tissue	(Gebhardt,	1992).		
Figure	 1.2.	 Metabolic	 zonation	 of	 the	 liver.	Hepatocytes	 (pink)	 make	 up	 the	 bulk	 of	 the	 liver	parenchyma	and	are	 functionally	specialised	along	the	 porto-venous	 axis	 of	 the	 lobule	 due	 to	 the	concentration	 gradient	 of	 oxygen	 and	 nutrients	arriving	 from	 the	 portal	 circulation.	 Zone	 1	hepatocytes	are	closest	to	the	portal	vein	and	carry	out	 oxidative	 phosphorylation,	 gluconeogenesis,	 b	oxidation	 and	 urea	 synthesis;	 whilst	 zone	 3	hepatocytes	 are	 nearer	 to	 the	 central	 vein	 and	specialise	 in	 glycolysis,	 lipogenesis,	 ketogenesis,	glutamine	 synthesis	 and	 bile	 secretion.	 Zone	 2	hepatocytes	present	intermediate	phenotypes.	
	At	 the	 portal	 area,	 oxidative	 phosphorylation,	 glycogen	 synthesis	 (from	lactate),	gluconeogenesis,	b-oxidation,	cholesterol	biosynthesis	and	urea	production	occur;	whereas	closer	to	the	central	vein	there	is	glycogen	synthesis	(from	glucose),	glycolysis,	 lipogenesis,	 ketogenesis,	 bile	 acid	 synthesis	 and	 glutamine	 synthesis.	Various	 enzymes	 of	 the	 cytochrome	P450	 family	 also	 localise	 perivenously,	which	may	account	for	tissue-restricted	toxicity	to	certain	xenobiotics	(Baron	et	al.,	1986).	A	classic	example	is	that	of	carbon	tetrachloride	(CCl4),	which	is	metabolised	to	the	highly	 reactive	 trichloromethyl	 radical	 (CCl3*)	 species	 by	 cytochrome	 P450	 2E1	(CYP2E1).	 Given	 that	 CYP2E1	 is	 only	 expressed	 by	 pericentral	 hepatocytes,	 CCl3*-induced	necrosis	is	restricted	to	these	cells	(Manibusan,	Odin	and	Eastmond,	2007).	
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One	of	the	main	functions	of	hepatocytes	is	to	produce	bile,	a	yellowish	green	lipid	surfactant	that	aids	in	fat	digestion,	and	which	is	secreted	into	minute	tubular	spaces	 known	 as	 bile	 canaliculi	 between	 the	 tight	 junctions	 of	 neighbouring	hepatocytes	 (Rogers	 and	 Dintzis,	 2012)	 (Figure	 1.3).	 At	 the	 hepatocyte-ductular	interface	lies	the	canal	of	Hering,	a	channel	in	which	hepatocyte-lined	canaliculi	drain	into	the	terminal	cholangioles	(Figure	1.3).		
	
Figure	1.3.	Bile	canaliculi	and	the	biliary	duct	network.	Hepatocytes	secrete	bile	into	minute	tubular	spaces	termed	bile	canaliculi	(green	shading),	which	drain	into	ductal	cell-lined	terminal	cholangioles.	A	vast	network	of	ductal	conduits	expands	throughout	the	liver	to	transport	the	bile	to	the	gall	bladder.	The	Canal	of	Hering	is	a	zone	at	the	interface	between	the	hepatocyte	cords	and	the	terminal	cholangioles	from	where	facultative	progenitors	are	thought	to	arise	
Extending	from	here,	a	complex	tree	of	conduits	lined	by	biliary	epithelial	cells	form	interlobular,	septal,	and	major	ducts	that	run	in	parallel	with	branches	of	the	portal	 vein	 and	 hepatic	 artery	 –the	 previously	 alluded	 portal	 triads	 (Figure	 1.1).	Intrahepatic	 ducts	 eventually	 coalesce	 into	 extrahepatic	 ones	 that	 lead	 to	 the	 gall	bladder,	 where	 bile	 is	 stored	 and	 concentrated,	 ready	 to	 be	 funnelled	 into	 the	duodenum	 after	 food	 ingestion	 (Strazzabosco	 and	 Fabris,	 2008).	 The	 ductal	epithelium	is	also	responsible	for	bile	production,	accounting	for	40%	of	total	bile	in	humans	(Strazzabosco	and	Fabris,	2008)	despite	themselves	only	constituting	3%	of	the	hepatic	cell	numbers.	Ductal	cells	fluidise	and	alkalinise	bile	through	a	battery	of	secretory	and	absorptive	processes	(e.g.	using	osmolytes	like	Cl-	/	HCO3-)	in	order	to	meet	physiological	requirements	(Prall	and	LaRusso,	2000).	There	is	morphological	–and	 likely	 functional–	heterogeneity	amongst	ductal	cells:	columnar	bile-modifying	cells	with	 a	 low	 nucleus/cytoplasmic	 ratio	 constitute	 the	 enlarged	 sections	 of	 the	biliary	 tree	 (Benedetti	 et	 al.,	 1996);	 whereas	 the	 smaller,	 almost	 cuboidal,	 cells	nearest	to	the	canal	of	Hering	have	been	attributed	with	inflammatory	reactivity	and	cell-fate	plasticity	under	specific	stimuli	(Sell,	1990).	
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The	liver	is	a	richly	perfused	organ,	invariably	receiving	~25%	of	the	cardiac	output	through	two	main	vascular	systems:	the	hepatic	artery	(HA)	and	the	portal	vein	(PV),	 the	 latter	of	which	drains	 from	the	mesenteric,	gastric,	 splenic,	and	pancreatic	veins	(Lautt,	2009).	The	high	pressure,	well-oxygenated	arterial	blood	mixes	with	the	partially	 de-oxygenated,	 but	 nutrient	 rich,	 portal	 blood	 as	 they	 enter	 the	 sinusoidal	network	 that	 irrigates	 the	 liver	 parenchyma.	Blood-borne	nutrients	 and	oxygen	 are	thus	 progressively	 used	 up	 by	 cells	 across	 the	 perivenous	 distance,	 until	 the	 blood	drains	out	into	the	central	vein.	This	nutritional	gradient	accounts,	at	least	in	part,	for	the	streamlined	metabolic	zonation	of	the	lobule	(Gebhardt,	1992)	(Figure	1.2).	Considering	the	well	vascularised	nature	of	the	liver,	it	is	not	surprising	that	arterial,	 venous	 and	 sinusoidal	 endothelial	 cells	 (LSECs)	 make	 up	 a	 sizeable	percentage	 of	 the	 total	 hepatic	 population.	 LSECs	 line	 the	microvasculature	 of	 the	liver	and	comprise	up	to	20%	of	all	liver	cells	(Poisson	et	al.,	2017);	they	differ	from	other	capillaries	in	the	body	because	of	the	presence	of	small	openings	or	fenestrae	between	adjacent	cells	–	first	described	by	Wisse	in	1970–	which	endow	the	sinusoids	with	 high	 permeability	 and	 facilitate	 nutrient	 exchange	 with	 the	 surrounding	parenchyma	(Wisse,	1970;	Braet	and	Wisse,	2002)	(Figure	1.4).	Amongst	 the	 liver	 mesenchymal	 cell	 pool,	 hepatic	 stellate	 cells	 (HSCs)	 –formerly	known	as	 Ito	or	 fat-storing	cells–	are	 the	most	numerous	(5%)	and	most	extensively	studied	for	their	collagen-depositing	role	during	fibrogenesis	(Hasegawa,	Wallace	and	Friedman,	2015).	In	homeostasis,	they	have	star-shaped	cell	bodies	and	are	recognisable	for	their	high	intracellular	content	of	vitamin	A	droplets.	Stellate	cells	reside	within	 a	 perisinusoidal	 area	 known	 as	 the	 space	 of	Disse,	 from	which	 they	extend	 multiple	 processes	 to	 contact	 both	 LSECs	 and	 hepatocytes	 (Wake,	 1995).	Venous-	and	arterial-lining	smooth	muscle	cells	control	vascular	tone	(Burkel,	1970;	Dong,	 Ichimura	and	Sakai,	2010),	whereas	portal	 fibroblasts	are	 found	 in	 the	peri-biliary	 space	 and	 their	 role	 in	 homeostasis	 and	 injury-response	 remains	 poorly	understood	(Wells,	2014)	(Figure	1.4).		Liver-resident	 macrophages	 (Kupffer	 cells)	 localise	 intra-sinusoidally	 and	constitute	 15%	 of	 the	 total	 liver	 cell	 population	 (Bouwens	 et	 al.,	 1986).	 They	represent	 the	 first	 line	 of	 defence	 against	 foreign	 agents	 absorbed	 from	 the	
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gastrointestinal	 tract	 –detoxifying	 and/or	 eliminating	 them–,	 but	 are	 also	professional	scavengers	 for	 in	situ	degenerated	cells	and	mediate	 inflammation	(Ju	and	Tacke,	2016).	Other	cells	of	the	hematopoietic	lineage	that	are	either	anchored	in	or	 transiting	 the	 liver	 include	natural	killer	 (NK)	cells	–	 first	described	as	Pit	 cells	(Bouwens	et	al.,	1987)	–,	NK-T	lymphocytes	and	dendritic	cell	precursors	(Prickett,	McKenzie	and	Hart,	1988;	O’Connell	et	al.,	2000;	Crispe,	2003)	(Figure	1.4).	
	
Figure	1.4.	The	diversity	of	stromal	cells	in	the	liver.	The	epithelium	of	the	liver	is	surrounded	by	numerous	stromal	cells	that	aid	in	the	correct	functioning	of	the	tissue.	The	hepatic	artery	and	the	portal	and	central	veins	are	lined	by	endothelial	cells	and	a	smooth	muscle	cell	layer,	whereas	the	smaller	capillaries	irrigating	the	tissue	parenchyma	are	composed	of	fenestrated	liver	sinusoidal	endothelial	cells	(LSECs).	The	space	of	Disse,	found	between	 the	 sinusoids	 and	 the	hepatocyte	 cords,	 is	 inhabited	by	 a	mesenchymal	 population	 referred	 to	 as	hepatic	 stellate	 cells	 (HSCs).	Portal	 fibroblasts	on	 the	other	hand	 reside	 strictly	at	 the	portal	 tract,	 in	 close	proximity	 to	 the	 biliary	 ducts.	 Cells	 of	 the	 hematopoietic	 lineage	 including	 tissue-resident	 macrophages	(Kupffer	cells,	Mφ)	and	to	a	lesser	extent	T	and	NK	lymphocytes	can	also	be	found	patrolling	the	tissue.		
Despite	being	linked	to	hepatocyte	heterogeneity,	the	concept	of	liver	zonation	extends	to	cells	of	the	stroma	too.	Sinusoidal	wall	porosity,	as	determined	by	the	size	of	 the	 fenestrae,	 increases	 along	 the	 portovenous	 axis,	 coupled	 to	 a	 change	 in	endothelial	cell	ultrastructure	(Wisse	et	al.,	1985;	Horn,	Henriksen	and	Christoffersen,	1986).	 Kupffer	 cells	 are	 most	 numerous	 periportally	 (Bouwens	 et	 al.,	 1986),	 yet	pericentral	ones	are	more	phagocytic	(te	Koppele	and	Thurman,	1990),	likely	due	to	the	 pH	 gradient	 across	 the	 lobule.	 In	 contrast,	 HSCs	 show	 a	 discreet	 preferential	accumulation	towards	the	central	vein	(Horn	et	al.,	1988).	Although	much	of	this	work	has	 been	 based	 on	 descriptive	 electron	 microscopy,	 more	 recent	 studies	 are	beginning	to	elucidate	a	molecular	divergence	in	the	portal-to-venous	stroma.	As	an	example,	CV	but	not	PV	endothelium	is	a	key	source	of	the	WNT	agonist	RSPO3,	which	helps	to	sustain	GS+	hepatocytes	(Rocha	et	al.,	2015).	These	regional	differences	may	contribute	not	only	to	homeostatic	physiology	but	also	to	regeneration	and	disease	susceptibility.	Many	pathological	events	 in	 the	 liver	show	a	considerable	degree	of	zonal	preference	(McCuskey	and	Sipes,	2010).	
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1.2 Cellular	 turnover	 of	 the	 tissue:	 development,	
homeostasis	and	regeneration	
1.2.1 Development	
During	embryogenesis,	 the	anterior-posterior	patterning	of	naïve	endoderm	gives	rise	to	an	epithelium	with	foregut,	midgut	and	hindgut	 identities;	 the	ventral	segment	of	the	former	contains	precursors	for	the	commitment	towards	liver	tissue	and	its	hepatobiliary	system,	but	also	other	organs	including	the	pancreas,	lung	and	thyroid	(Zorn	and	Wells,	2009).	The	lineage	choice	of	these	precursors	–	which	occurs	from	~E8.0	to	E9.5	–	relies	on	a	gradient	of	fibroblast	growth	factor	(FGF)	and	bone	morphogenetic	protein	(BMP)	derived	from	the	closely	apposed	cardiac	mesoderm	and	septum	transversum	mesenchyme	(STM)	(Gualdi	et	al.,	1996;	Jung	et	al.,	1999;	Rossi	 et	 al.,	 2001)	 (Figure	 1.5).	 Based	 on	 differential	 cell	 proximity,	 these	 signals	induce	expression	of	lineage-specific	transcription	factors	to	determine	the	fate	of	one	endodermal	 tissue	 versus	 the	 other	 (Zaret,	 2008;	 Zorn	 and	Wells,	 2009).	 Nascent	hepatic	progenitors	–	collectively	referred	to	as	‘hepatoblasts’	–	have	the	potency	to	generate	 the	 two	 main	 epithelial	 cell	 types	 of	 the	 liver:	 hepatocytes	 and	cholangiocytes	(Miyajima,	Tanaka	and	Itoh,	2014),	and	become	identifiable	based	on	the	upregulation	of	key	liver-determining	transcription	factors	(Hepatocyte	nuclear	factor	4	alpha,	Hnf4a)	(Kyrmizi	et	al.,	2006)	and	proteins	such	as	a-fetoprotein	(AFP)	(Spear	et	al.,	2006)	and	albumin	(Cascio	and	Zaret,	1991).	 	Moderate	doses	of	FGF	favour	expression	of	the	albumin	gene	(Alb)	and	patterning	into	hepatic	fate,	whereas	too	 high	 and	 too	 low	 levels	 tilt	 the	 balance	 towards	 lung/thyroid	 and	 ventral	pancreas/duodenum	 progenitors,	 respectively	 (Deutsch	 et	 al.,	 2001;	 Serls	 et	 al.,	2005).	Whilst	the	cardiac	mesoderm	expresses	a	battery	of	FGF	factors	around	the	onset	of	hepatogenesis	(Fgf1,	Fgf2,	Fgf8,	and	Fgf10)	(Parlow	et	al.,	1991;	Crossley	and	Martin,	1995;	Zhu	et	al.,	1996;	Jung	et	al.,	1999;	Kelly,	Brown	and	Buckingham,	2001;	Cai	 et	 al.,	 2003),	 there	 is	 likely	 to	 be	 downstream	 redundancy	 amongst	 them	 via	activation	 of	 the	 MAPK	 pathway	 (Miller	 et	 al.,	 2000;	 Calmont	 et	 al.,	 2006).	 The	requirement	for	FGF	is	clear	nonetheless,	and	is	evolutionarily	conserved	in	zebrafish,	chick	and	Xenopus	(Chen	et	al.,	2003;	Zhang	et	al.,	2004;	Shin	et	al.,	2007).	
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As	if	to	make	hepatic	specification	fool-proof,	high	BMP	signalling	can	also	bias	precursor	fate	towards	the	hepatic	lineage	at	the	expense	of	pancreatic	development	(Rossi	 et	 al.,	 2001;	 Chung,	 Shin	 and	 Stainier,	 2008);	 this	 combinatorial	 effect	 of	FGF/BMP	signalling	is	peculiar,	but	has	precedent	in	other	developing	tissues	of	the	embryo	 like	 the	 tooth	 (Maas,	 1998).	 Bmp4	 null	 mouse	 embryos	 exhibit	 a	morphological	delay	 in	 liver	bud	 formation,	but	while	 loss	of	Bmp4	alone	does	not	prevent	 Alb	 induction	 in	 the	 endodermal	 progenitor	 pool,	 addition	 of	 the	 BMP	inhibitor,	 Noggin,	 does	 (Rossi	 et	 al.,	 2001).	 Lineage	 tracing	 experiments	 have	elegantly	shown	that	Bmp2	–	originating	 from	the	 lateral	plate	mesoderm	(LPM)	–	may	account	 for	 this,	as	 it	also	 favours	hepatic	over	pancreatic	specification	of	 the	endoderm	and	 therefore	 is	 redundant	with	Bmp4	 in	 this	 context	 (Chung,	 Shin	and	Stainier,	2008).		The	WNT	signalling	pathway	has	also	been	implicated	in	hepatic	patterning	of	the	embryo,	although	with	a	more	complex,	time-dependent,	role	than	FGF	and	BMP.	In	 early-somite	Xenopus	 embryos,	WNT	 signalling	 is	 antagonised	 (e.g.	 via	 secreted	frizzled-related	 protein	 5,	 Sfrp5)	 in	 the	 anterior	 endoderm	 to	 maintain	 foregut	identity	and	to	relieve	inhibition	of	the	hepatopancreatic-specifier	Hhex;	the	converse	situation	takes	place	on	the	posterior	endoderm,	where	high	WNT	signalling	drives	intestinal	differentiation	by	obstructing	foregut	fate	(McLin,	Rankin	and	Zorn,	2007;	Li	et	al.,	2008)	(Figure	1.5).	At	a	later	developmental	stage,	exogenous	activation	of	WNT	signalling	leads	to	enlargement	of	the	liver	bud	(McLin,	Rankin	and	Zorn,	2007);	despite	seeming	paradoxical,	 these	results	agree	with	studies	 in	zebrafish	wherein	WNT	 signalling	 (Wnt2bb	 of	 mesodermal	 origin)	 specifies	 liver	 fate	 and	 promotes	hepatoblast	proliferation	(Ober	et	al.,	2006;	Goessling	et	al.,	2008).	The	reiteration	of	WNT	signals,	with	distinct	cellular	outcomes	across	time,	is	a	noteworthy	feature	of	liver	organogenesis	(Nejak-Bowen	and	Monga,	2008).	The	development	of	the	liver	diverticulum	(or	liver	bud)	begins	at	E9.5	in	the	mouse	when	hepatoblasts	delaminate	 and	migrate	 as	 cords	 into	 the	 adjacent	 STM	(Zaret,	2002);	this	is	an	epithelial-to-mesenchymal	transition	(EMT)-like	process	that	relies	 on	 close-range	 interactions	 with	 the	 mesenchyme	 (Le	 Douarin,	 1975;	Houssaint,	1980),	expression	of	matrix	metalloproteinases	(MMPs)	(Margagliotti	et	
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al.,	2008)	–	by	both	the	epithelium	and	the	STM	–	as	well	as	the	presence	of	endothelial	cells	despite	the	absence	of	blood	flow	(Matsumoto	et	al.,	2001)	(Figure	1.5).	At	later	stages,	immature	‘mesothelial’	cells	surrounding	the	liver	parenchyma	secrete	mitogens	such	as	hepatocyte	growth	factor	(HGF),	midkine,	and	pleiotrophin	(Onitsuka,	 Tanaka	 and	 Miyajima,	 2010),	 which	 induce hepatoblast	 expansion,	whereas	mature	 Thy1+	mesenchymal	 cells	 drive	 hepatoblast	maturation	 by	 direct	cell-to-cell	 contact	 as	 shown	 in	 a	 co-culture	 system	 (Hoppo	et	 al.,	 2004).	Embryos	lacking	 H2.0-like	 homeobox	 (Hlx),	 a	 transcription	 factor	 enriched	 in	 visceral	mesenchyme,	exhibit	impaired	liver	expansion	–	with	only	3%	of	the	normal	cell	count	by	 E12.5	 –	 despite	 successful	 generation	 of	 the	 liver	 diverticulum	 (Hentsch	 et	 al.,	1996).	There	is	thus	strong	evidence	supporting	the	requirement	of	mesenchymal-to-epithelial	interactions	during	liver	ontogeny,	as	is	the	case	for	many	other	embryonic	tissues	(Ribatti	and	Santoiemma,	2014).	During	mid-gestation	the	liver	serves	transiently	as	a	site	of	haematopoiesis,	a	period	in	which	hepatic	epithelium	and	blood	cells	interact	closely.	Blood-cell	(CD45+)	derived	Oncostatin	M	(OSM),	a	member	of	the	interleukin-6	(IL-6)	family,	is	required	for	hepatocyte	maturation	in	vivo	(Kamiya	et	al.,	1999)	and	is	commonly	used	for	in	
vitro	differentiation	protocols	from	primary-isolated	or	induced	pluripotent	stem	cell	(iPSC)-derived	hepatoblasts	(Suzuki	et	al.,	2003;	Si-Tayeb	et	al.,	2010).	Interestingly,	immature	hepatic	progenitors	sustain	haematopoiesis	via	secretion	of	granulocyte-macrophage	colony	stimulating	factor	(GM-CSF)	and	macrophage	colony	stimulating	factor	(M-CSF)	(Hata	et	al.,	1993),	but	stop	doing	so	as	they	differentiate	–	shown	by	
in	vitro	co-cultures	(Kinoshita	et	al.,	1999).	This	highlights	a	feed-back	loop	of	cell-to-cell	communication	that	ensures	epithelial	differentiation	but	also	the	timely	arrest	of	haematopoiesis.	Hepatocytes	undergo	a	further	round	of	maturation	at	the	peri-	and	postnatal	 stages	of	development,	when	anatomical	 (vasculature)-based	zonation	 is	established;	a	notable	case	is	that	of	glutamine	synthetase,	which	becomes	restricted	to	perivenous	hepatocytes	(1	to	3	cell	layers)	in	the	last	days	before	birth	(Gaasbeek	Janzen	et	al.,	1987),	while	the	heterogeneity	in	enzymes	of	the	carbohydrate	pathway	stabilises	 1	week	 postnatally	 (Burch	 et	 al.,	 1963).	 The	 precise	 signals	 driving	 this	process	are	still	largely	uncharacterised.	
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In	mice,	the	specification	of	bile	duct	cells	from	hepatoblasts	occurs	at	~E15	in	the	immediate	vicinity	of	the	portal	vein,	on	cue	from	periportal	mesenchymal	cells.	Nascent	ductal	cells	can	be	identified	by	osteopontin	(OPN)	and	the	SRY-related	HMG	box	transcription	 factor	9	 (SOX9),	 the	 latter	of	which	 controls	 the	 timing	of	biliary	tubulogenesis	(Antoniou	et	al.,	2009).	Activation	of	Notch	signalling	via	the	Jagged1	(mesenchymal)	–	Notch2	(epithelial)	axis	 is	essential	 for	ductal	maturation	(Figure	1.5);	this	is	evident	in	Alagille	syndrome	patients	carrying	mutations	in	the	JAG1	and	
NOTCH2	genes	who	suffer	from	intrahepatic	biliary	defects	(Alagille	et	al.,	1987;	Li	et	
al.,	1997;	McDaniell	et	al.,	2006),	as	well	as	in	multiple	loss-of-	and	gain-of-function	studies	in	mice	(McCright,	Lozier	and	Gridley,	2002;	Hofmann	et	al.,	2010).	Besides	directing	progenitor	commitment	towards	the	ductal	fate,	Notch	signalling	regulates	bile	 duct	 morphogenesis;	 constitutive	 Notch	 activation	 in	 hepatoblasts	 (AFP-Cre,	
RosaNCID)	leads	to	more	numerous	but	also	ectopic	(mid-lobular)	formation	of	tubules	(Zong	et	al.,	2009).	Juxtaposed	to	this,	constitutive	deletion	of	the	Notch	effector,	hes	family	bHLH	transcription	factor	1	(Hes1),	completely	abrogates	tubular	formation	of	intrahepatic	biliary	ducts	(Kodama	et	al.,	2004).	
	Signalling	 via	 transforming	 growth	 factor	 beta	 (TGFb)	 has	 also	 been	implicated	 in	 ductal-fate	 specification.	 Using	 a	 transgenic	 mice	 harbouring	 an	activin/TGFb	reporter	(CAGA12/GFP),	Clotman	and	colleagues	showed	the	presence	of	a	TGFb	gradient	emanating	from	the	portal	tract	of	the	developing	liver	(Clotman	
et	al.,	2005).	At	E15.5,	there	is	widespread	TGFb1	expression	in	the	liver,	while	Activin	A,	 TGFb2	 and	 TGFb3	 are	 specifically	 enriched	 in	 the	 periportal	 mesenchyme	(Antoniou	et	al.,	2009).	High	periportal	TGFb	signalling	drives	ductal	commitment	of	the	hepatoblasts;	whereas	towards	the	parenchyma,	the	Hepatocyte	Nuclear	Factor-6	(HNF-6)	and	One-cut-2	(OC-2)	transcription	factors	counteract	TGFb	signalling	to	allow	commitment	into	the	hepatocyte	lineage	(Clotman	et	al.,	2005;	Antoniou	et	al.,	2009)	(Figure	1.5).	In	addition,	Sox9-deficient	livers	exhibit	delayed	ductal	maturity	and	are	characterised	by	abnormal	expression	of	the	TGFb	receptor	type	II	(Antoniou	
et	al.,	2009).		
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Figure	 1.5.	 Liver	 organogenesis	 is	 modulated	 by	 the	 microenvironment.	 Around	 E8.5,	 the	 foregut	endoderm	becomes	specified	 into	hepatic	epithelium	by	a	gradient	of	FGF	and	BMP	signals	secreted	by	the	apposed	cardiac	mesoderm	and	septum	transversum	mesenchyme	(STM).	Foregut	identity	itself	is	maintained	through	blockade	of	WNT	signaling	(e.g.	via	the	WNT	inhibitor	Sfrp5).	At	E9.5,	liver	progenitors	(hepatoblasts)	delaminate	from	the	liver	bud	structure	in	a	process	that	requires	matrix	metalloproteinases	(MMPs)	and	the	presence	of	both	mesenchymal	and	endothelial	cells.	At	E15,	commitment	of	hepatoblasts	towards	the	biliary	fate	(SOX9+)	is	regulated	by	Notch2-Jagged1	interactions	with	the	portal	mesenchyme	and	by	a	portal-derived	gradient	of	TGFb.	TGFb	signalling	is	blocked	in	parenchymal	hepatocytes	through	the	transcription	factors	HNF-6	and	OC-2.		
1.2.2 Homeostasis	
The	wear	and	tear	of	tissues	across	time	invariably	entails	loss	and/or	aging	of	cells	 that	 the	 organism	 must	 replace	 in	 order	 to	 preserve	 histoarchitecture	 and	function	 –	 a	 process	 referred	 to	 as	 tissue	 homeostasis.	 The	 timeframe	 and	mechanisms	through	which	this	renewal	occurs	do	vary	considerably	from	cell	to	cell	and	across	development.	In	contrast	to	the	rapid	events	of	its	organogenesis,	the	healthy	adult	liver	is	a	slow	cycling	tissue	in	which	no	more	than	0.5%	of	cells	are	dividing	at	any	given	time	point		(MacDonald,	1961).	This	paucity	of	cell	proliferation	differs	significantly	from	endodermal	 organs	 like	 the	 small	 intestine	 and	 the	 stomach	 (Barker,	Bartfeld	 and	Clevers,	2010),	and	resembles	 that	of	 the	pancreas	(Finegood,	Scaglia	and	Bonner-Weir,	1995).	Despite	being	bonafide	progenitors	during	development,	hepatoblasts	are	not	believed	to	persist	postnatally,	and	the	homeostatic	turnover	of	liver	cells	does	not	rely,	or	does	so	minimally,	on	a	dedicated	pool	of	adult	stem	cells;	instead,	the	liver	epithelium	 is	 maintained	 by	 the	 rare	 self-replication	 of	 existing	 hepatocytes	 and	ductal	cells	(Miyajima,	Tanaka	and	Itoh,	2014),	without	any	mixing	of	 the	 lineages.	Still,	this	paradigm	has	been	speckled	with	decade-long	controversies,	likely	due	to	
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the	well-established	ability	of	the	liver	to	regenerate	via	mechanisms	that	may	include	facultative	stem	cell	activation	and	reprogramming	(see	section	1.2.3).	Dating	back	to	1985,	one	of	 the	most	contested	theories	concerning	hepatic	homeostasis	is	that	of	the	‘streaming	liver’,	which	suggests	that	hepatocytes	become	replenished	 from	 a	 periportal	 source	 within	 less	 than	 a	 year	 –as	 determined	 by	tritiated	thymidine	tracing,	much	 like	a	stream	would	flow	across	the	portovenous	distance	of	the	lobule	(Zajicek,	Oren	and	Weinreb,	1985).	Furuyama’s	lineage	tracing	from	the	Sox9	locus	–which	claimed	to	be	ductal-specific–	exacerbated	the	debate,	as	it	supported	a	streaming-like	model	of	homeostasis	but	with	the	duct	epithelium	at	the	 top	 of	 the	 hierarchy	 (Furuyama	et	 al.,	 2011).	 Recent	 studies	 have	nonetheless	shown	that	periportal	SOX9+	hybrid	hepatocytes,	not	ductal	cells,	expand	dramatically	and	repopulate	the	liver,	although	only	in	the	context	of	damage	(Font-Burgada	et	al.,	2015);	 whilst	 Sox9-based	 tracing	 of	 embryogenic	 progenitors,	 marking	 both	interlobular	bile	ducts	and	periportal	hepatocytes	in	adulthood,	showed	no	evidence	of	 a	 continuous	 hepatic	 cell	 supply	 under	 steady-state	 (Carpentier	 et	 al.,	 2011).	Further	 support	 against	 ductal-derived	 hepatocytes	 in	 homeostasis	 was	 obtained	using	 an	 OPN-CreER	 mouse	 line	 (Español-Suñer	 et	 al.,	 2012).	 	 In	 the	 converse	approach,	Malato	and	colleagues	have	marked	almost	the	entirety	of	the	hepatocyte	compartment	 (>99%)	 and	 found	no	dilution	 of	 the	 labelling	 index	 over	 time,	 thus	concluding	 that	hepatocytes	are	 renewed	 from	pre-existing	ones	 in	 the	absence	of	damage	(Malato	et	al.,	2011).	Could	a	unipotent	hepatocyte	progenitor	exist	 in	homeostasis	then?	At	 least	not	periportally.	Work	from	the	Nusse	lab	points	towards	a	pericentral,	and	diploid,	self-renewing	Axin2+	hepatocyte	population	capable	of	robust	liver	repopulation	and	exhibiting	a	high	proliferative	index	(Wang	et	al.,	2015).	This	is	at	odds	with	in	vitro	experiments	 in	 which	 GS+	 pericentral	 hepatocytes	 proliferate	 less	 than	 their	 GS-	counterpart,	irrespective	of	a	wide	range	of	mitogenic	stimuli	(Gebhardt	et	al.,	1986).	The	answer	could	lie	in	the	in	vivo	microenvironment,	as	Axin2+	hepatocytes	rely	on	WNT	 secretion	 (Wnt2	 and	Wnt9b)	 from	 the	 central	 vein	 endothelium	 to	maintain	their	high	rates	of	proliferation	(Wang	et	al.,	2015).	
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Still,	 the	dynamics	of	 this	 cell	 expansion	 come	across	as	 rather	exceptional,	considering	 that	 ‘neutral’	 tracing	experiments	 in	 the	 liver	have	demonstrated	slow	and	location-blind	homeostatic	cell	replacement.	For	instance,	Bralet	and	colleagues	marked	 hepatocytes	 at	 near-to-clonal	 level	 using	 retroviral-delivered	 b-galatactosidase	after	partial	hepatectomy	 (so	as	 to	 allow	viral	 infection).	One	year	after	 the	 procedure,	 the	 pattern	 of	 positive	 cell	 distribution–	which	 encompassed	periportal,	midlobular	and	pericentral	zones	–	was	unmodified	compared	to	day	3	and	day	15	post-labelling,	while	 the	non-dilution	of	 the	positive	 clusters	bespeaks	of	 a	slow	rate	of	cell	replacement	in	the	tissue	(Bralet	et	al.,	1994).	A	recent	study	by	Lin	et	al.,	has	rekindled	the	idea	of	a	stem	cell/progenitor	population	in	the	homeostatic	liver	(Lin	et	al.,	2018).	The	group	found	rare,	but	whole-lobule	interspersed	hepatocytes	with	elevated	expression	and	activity	of	telomerase	reverse	 transcriptase	 (Tert),	 a	 key	 trait	 of	 stem	 cell	 populations	 in	 other	 tissues	(Montgomery	 et	 al.,	 2011;	 Schepers	 et	 al.,	 2011;	 Itzkovitz	 et	 al.,	 2012;	 Pech	 et	 al.,	2015).	In	the	absence	of	damage,	TertCreERT2	reporter	mice	showed	a	gradual	increase	in	 labelled	 hepatocytes	 (from	 ~3%	 to	 ~30%)	 after	 a	 year	 of	 tracing;	 with	 cell	replenishment	in	all	zones	of	the	lobule,	and	potency	towards	GS-	and	GS+	hepatocytes	according	to	clonal	analyses.	Expression	of	Tert	on	traced	hepatocytes	–	assessed	by	single	molecule	RNA	fluorescence	in	situ	hybridization	–	was	comparable	between	3	days	and	1	month,	but	decreased	after	a	year,	which	could	be	indicative	of	a	switch	from	self-renewal	 to	 asymmetric	 cell	 division.	This	 finding	 comes	 after	decades	of	evidence	disproving	the	existence	of	homeostatic	liver	stem	cells,	and	thus	calls	for	further	scrutiny.		
1.2.3 Regeneration	
Contrary	 to	 the	 customary	 turnover	 of	 cells	 that	 accompanies	 tissue	functioning,	 acute	 and/or	 chronic	 injuries	may	 disturb	 a	 tissue’s	 steady-state	 and	awaken	 diverse	 wound	 healing	 mechanisms.	 The	 latter	 are	 shaped	 according	 to	evolutionary	pressure;	and	there	is	perhaps	no	better	example	than	that	of	the	liver:	a	metabolic	hub	under	constant	exposure	to	both	foreign	and	endogenous	damaging	agents.	
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Figure	1.6.	Coping	with	injury:	mechanisms	of	wound	healing.	A)	Lower	vertebrates,	such	as	axolotls,	are	able	 to	regenerate	severed	 limbs	 through	a	process	 that	reconstitutes	original	 tissue	anatomy	and	 function	without	 leaving	 a	 scar	 of	 extracellular	matrix	 (ECM).	 	Mammals	may	 similarly	 regenerate	 complex	 tissues	during	 embryogenesis,	 but	 lose	 most	 of	 this	 capacity	 in	 adulthood.	 B)	 The	 liver	 is	 one	 of	 the	 few	 adult	mammalian	organs	that	retains	a	remarkable	ability	to	regenerate.	Resection	of	up	to	70%	of	the	liver	mass	via	partial	hepatectomy	(PHx)	leads	to	compensatory	growth	from	the	intact	tissue	to	restore	organ	size	in	a	matter	of	days,	similarly	to	axolotl	limb	regrowth.	However,	the	hepatectomised	liver	is	not	considered	“damaged”	as	there	 is	 no	 epithelial	 necrosis.	 C)	 The	 liver	 may	 also	 regenerate	 following	 injury	 by	 exogenous	 and/or	endogenous	agents	(e.g.,	alcohol,	hepatitis	B/C	viruses,	fatty	acids)	that	cause	hepatocyte	death.	However,	if	the	damaging	 insult	persists,	 the	 tissue	will	be	 repaired	 instead	of	 regenerated,	 resulting	 in	excessive	 scarring,	known	as	fibrosis.	Adapted	from	(Cordero-Espinoza	and	Huch,	2018).	
Bona	fide	regeneration	is	the	ability	to	recreate	original	tissue	architecture	and	function	after	damage	without	leaving	a	scar	(Gurtner	et	al.,	2008)	(Figure	1.6).	Far	from	 mythological	 contrivance,	 this	 mechanism	 is	 present	 in	 nature	 yet	 varies	dramatically	 across	 metazoan	 species	 (Sánchez	 Alvarado,	 2000)	 and	 with	 age	(Timchenko,	2009).	Lower	vertebrates	like	axolotls	and	salamanders	can	seamlessly	regrow	 limbs	 after	 amputation;	 mammals	 share	 a	 similar	 ability	 during	 prenatal	development	but	lose	most	of	 it	 in	adulthood.	Adult	 injuries	tend	to	be	repaired	as	opposed	to	regenerated,	replacing	functional	tissue	parenchyma	with	a	meshwork	of	extracellular	matrix	(ECM).	The	liver	is	one	of	the	few	organs	in	the	mammalian	body	that	defies	this	paradigm,	as	it	can	regenerate	efficiently	from	a	wide	range	of	physical	and	toxic	injuries	(Michalopoulos,	2007),	although	not	indefinitely	(Figure	1.6).	The	process	 of	 regeneration	 following	 an	 acute	 insult	 is	 characterised	 by	 a	 dynamic	multicellular	 response	 involving	 pro-inflammatory	 cell	 recruitment,	 in	 situ	mesenchymal	 cell	 activation,	 ECM	 remodelling	 and	 epithelial	 cell	 expansion	 to	replenish	lost	numbers	(Taub,	2004).	This	is	however	a	transient	reaction;	switching-off	mechanisms	are	embedded	within	the	process	of	wound	healing	because	the	same	
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pathways	 that	 promote	 regeneration,	 when	 overstimulated	 (as	 in	 chronic	 injury),	progressively	drive	 scarring	and	degeneration	of	 the	 tissue	 in	a	process	known	as	fibrosis	(Cordero-Espinoza	and	Huch,	2018)	(see	section	1.2.4).	
1.2.3.1 The	epithelial	perspective	
The	 relative	 mitotic	 quiescence	 of	 the	 liver	 epithelium	 is	 deceiving:	 if	challenged,	the	hepatic	tissue	displays	a	remarkable	capacity	for	regeneration	and	can	reinstall	homeostasis	via	several	mechanisms.		1.2.3.1.1 The	mighty	hepatocyte:	regeneration	from	surgical	injury	
Reminiscent	of	 limb	regrowth	 in	amphibians,	up	 to	70%	of	 the	 liver	can	be	surgically	resected	–a	process	known	as	partial	hepatectomy	(PHx)–	and	the	organ	will	 grow	 back	 to	 its	 original	 size	 through	 compensatory	 hypertrophy	 and	proliferation	of	both	the	epithelium	and	the	stroma	(Michalopoulos	and	DeFrances,	1997;	Miyaoka	et	al.,	2012)	(Figure	1.6B).	Much	like	in	homeostasis,	the	contribution	of	liver	stem/progenitor	cells	to	this	process	appears	to	be	negligible	(Michalopoulos	and	DeFrances,	1997).	Reinstating	70%	of	 lost	hepatic	 tissue	entails,	 in	 large	part,	generating	a	substantial	new	amount	of	hepatocyte	mass;	this	has	fuelled	a	fascination	in	 the	 field	 concerning	 the	 remarkable,	 almost	 unlimited,	 expansion	 potential	 of	hepatocytes:	 serial	 PHx	 and	 transplantation	 studies	 estimate	 that	 hepatocytes	 can	repopulate	5-6	times	the	liver	while	undergoing	at	least	69	cell	doublings	or	a	7.3	×	1020–fold	expansion	(Simpson	and	Finckh,	1963;	Overturf	et	al.,	1997).	As	one	of	the	earliest	 described	 models	 of	 liver	 injury	 (Higgins	 and	 Anderson,	 1931),	 PHx	 has	sculpted	much	of	our	understanding	of	wound	healing	in	this	organ	(Michalopoulos,	2007);	 however,	 the	 hepatectomised	 liver	 should	 not	 be	 considered	 injured	 nor	“damaged”,	regeneration	occurs	from	the	unscathed	lobe(s)	as	a	result	of	the	organ’s	ability	to	sense	insufficient	size.	At	no	point	do	necrosis	and	inflammation	contribute	to	the	process	(Luedde,	Kaplowitz	and	Schwabe,	2014).	The	PHx	procedure	is	thus	non-physiological	–	exposure	to	a	surgeon’s	scalpel	is	extremely	rare	for	the	average	person;	 clinical	 relevance	 can	 be	 argued	 for	 live-donor	 transplants	 and	 tumour	resections,	but	 is	of	 less	consequence	to	high	burden	chronic	 liver	pathologies	 like	non-alcoholic	 fatty	 liver	 disease	 and	 cirrhosis	 (Lim	 and	 Kim,	 2008).	 Still,	
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inadvertently,	PHx	 studies	are	believed	 to	have	 contributed	 to	 the	 commonly	held	prejudice	that	stem/progenitor	cells	are	dispensable	for	liver	regeneration.		1.2.3.1.2 ‘Oval	cells’:	a	damage-associated	hepatic	population	
Many	adult	tissues	rely	on	facultative	epithelial	progenitors	to	compensate	for	tissue	 damage,	 in	 what	 has	 been	 hypothesized	 as	 a	 reiteration	 of	 developmental	mechanisms	(Jensen	et	al.,	2005;	Fancy	et	al.,	2011).	As	proposed	by	Zipori,	“stemness	might	be	a	transient	and	reversible	trait	 that	almost	any	cell	can	assume	given	the	correct	trigger	(niche)”	(Zipori,	2004).	Pioneering	work	dating	back	to	the	1950s	first	described	the	appearance	of	small,	proliferative,	oval-shaped	cells	in	adult	rat	livers	with	early	stage	carcinomas	induced	 by	 ethionine	 or	 2-acetylaminofluorene	 (2-AAF)	 (Farber,	 1956).	 This	observation,	 referred	 commonly	 as	 ductular	 reaction,	 held	 true	 for	 various	 other	chemical/carcinogen-based	models	of	liver	damage,	particularly	those	that	inhibited	hepatocyte	 proliferation	 (Petersen,	 Zajac	 and	 Michalopoulos,	 1998).	 Oval	 cells	sparked	interest	due	to	their	mixed	cell-state	features:	expressing	a	combination	of	biliary,	 hepatocyte	 and	developmental	markers	 (e.g.	keratin	 19	 (krt19),	 g-glutamyl	transpeptidase,	 AFP)	 (Bird,	 Lorenzini	 and	 Forbes,	 2008),	 and	 showing	 capacity	 to	pulse-chase	 into	 the	 hepatocyte	 lineage	 (Evarts	 et	 al.,	 1987,	 1989)	 –with	 some	contradictory	 reports	 (Tatematsu	 et	 al.,	 1984;	 Gerlyng	 et	 al.,	 1994)–	 despite	 their	suspected	biliary	cell	ancestry.	 	Evidence	 for	 the	 latter	stems	 from	their	periportal	location,	 branching	 from	 the	 Canals	 of	 Hering	 as	 ductular	 structures	 (Paku	 et	 al.,	2001),	as	well	as	from	their	impaired	proliferation	after	destruction	of	the	biliary	tree	by	 4,4′-methylenedianiline	 (Petersen	 et	 al.,	 1997).	 A	 different	model,	 perhaps	 just	semantically	(Zipori,	2004),	posits	that	oval	cells	represent	a	transiently	amplifying	compartment	derived	 from	 the	activation	of	periductular	progenitor	 cells	 (Dabeva	and	 Shafritz,	 1993).	 This	 was	 exciting,	 considering	 that	 ductular	 reactions	characterise	virtually	all	chronic	liver	pathologies	and	correlate	with	disease	severity	(Roskams	 and	Desmet,	 1998;	 Lowes	et	 al.,	 1999;	Roskams,	 Libbrecht	 and	Desmet,	2003).	
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A	better	understanding	of	the	oval	cell-of-origin	was	assumed	to	come	with	the	power	of	mouse	genetics.	Morphologically	 comparable	 cells	have	been	detected	 in	mice	 livers	 using	 alternative	 hepatotoxic	 regimens	 such	 as	 the	 choline-deficient	ethionine-supplemented	 (CDE)	 diet	 and	 administration	 of	 the	 carcinogens	 3,5-diethoxycarbonyl-1,4-dihydrocollidine	(DDC)	or	carbon	tetrachloride	(CCl4)	(Akhurst	et	al.,	2001;	Preisegger	et	al.,	1999;	Pritchard	and	Nagy,	2010).	Unfortunately,	these	murine	regimes	do	not	block	hepatocyte	proliferation	as	effectively	as	the	rat	models	(Wang,	Foster,	et	al.,	2003);	2-AAF	in	particular	cannot	be	used	in	mice	because	they	are	 unable	 to	 biotransform	 this	 compound	 into	 its	 damaging	 form	 (DeBaun	 et	 al.,	1968).	This	is	far	from	trivial,	and	may	account	for	much	of	the	difficulty	in	proving	the	existence	of	bipotential	ductal	progenitors	in	the	mouse.		1.2.3.1.3 Probing	the	existence	and	potency	of	liver	progenitors		
The	experimental	precedent	of	the	rat,	as	well	as	the	expression	of	biliary	duct	markers	 in	 ‘oval	 cell’	 equivalents	 of	 mice	 and	 humans	 (Conigliaro,	 Brenner	 and	Kisseleva,	 2010)	 suggested,	 but	 not	 proved,	 ductal	 ancestry	 of	 these	 putative	progenitors.	 	 More	 recently,	 this	 knowledge	 has	 been	 harnessed	 to	 isolate	 ductal	marker–enriched	 (e.g.	 EpCAM+	MIC1-1C3+,	 CD133+)	 primary	 cells	 or	whole	 ductal	tree	fragments	from	the	liver,	which	can	be	expanded	in	vitro	as	2D	monolayers	or	3D	organoid	cultures	that	self-renew	and/or	maintain	potency	towards	the	ductal	and	hepatocyte	 lineage	(Schmelzer	et	al.,	2007;	Kamiya	et	al.,	2009;	Okabe	et	al.,	2009;	Dorrell	et	al.,	2011;	Huch	et	al.,	2013)	(see	section	1.3).	In	conjunction,	studies	of	in	
vitro	clonogenicity	and	differentiation	potential	have	built	the	strongest	case	in	favour	of	 a	 ductal-derived	 bipotential	 stem/progenitor	 cell	 in	 the	 liver,	 but	 have	 been	criticised	 by	 some	 since	 ex	 vivo	 culturing	 can	 induce	 artefactual	 cellular	 plasticity	(Raff,	2003).	Accordingly,	efforts	have	shifted	slightly	towards	classical	in	vivo	assays	of	 ‘stemness’,	 including	 repopulation	 capacity	upon	 transplantation,	 as	well	 as	 the	more	rigorous	genetic-based	lineage	tracing.		Wang	 and	 colleagues	 performed	 a	 chimeric	 liver	 study	 wherein	 wild-type	hepatocytes	were	 transplanted	 into	 fumarylacetoacetate	 hydrolase	 (Fah)-deficient	mice	 (with	 >90%	 repopulation	 efficiency),	 thus	 generating	 genetically	 distinct	fractions	of	hepatocytes	and	all	other	hepatic	cells;	subsequent	damage	of	these	livers	
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resulted	in	the	expansion	of	progenitor	cells	of	apparent	non-hepatocyte	origin	(Fah-/-).	 In	 addition,	 they	 demonstrated	 that	 isolated	 progenitors	 were	 competent	 to	differentiate	 into	 large	 hepatocyte	 nodules	 following	 competitive	 transplantation	(Wang,	Foster,	et	al.,	2003).	Notwithstanding,	issues	such	as	purity	of	the	transplanted	cells	and	cell	fusion	may	confound	the	interpretation	of	repopulation	studies	like	this	one,	as	was	demonstrated	in	transplantations	of	bone	marrow	cells	once	purported	to	give	rise	to	hepatocytes	(Wang,	Willenbring,	et	al.,	2003).		Owing	to	lineage-specific	CreER	mouse	lines	generated	in	the	last	10	years,	it	is	almost	irrefutable	now	that	cholangiocyte-derived	cells	can	expand	in	the	context	of	 regeneration,	 as	 shown	 by	 tracing	 from	 the	 Sox9,	 Opn,	 Hnf1b	 and	 Krt19	 loci	(Furuyama	et	al.,	2011;	Español-Suñer	et	al.,	2012;	Rodrigo-Torres	et	al.,	2014;	Schaub	
et	al.,	2014).	Far	more	controversial	has	been	the	potency	of	these	cells	to	replenish	the	 hepatocyte	 parenchyma,	 which	 may	 in	 turn	 depend	 on	 the	 damaging	 model.	Through	a	nearly	 exhaustive	 labelling	of	 the	hepatocyte	 compartment,	Malato	 and	colleagues	 found	1-2%	newly	born	hepatocytes	of	non-hepatocyte	ancestry	 in	CCl4	damaged	 livers	 (Malato	 et	 al.,	 2011)	 –whilst	 ruling	 out	 such	 phenomenon	 in	homeostasis.	 In	contrast,	Furuyama	and	colleagues	demonstrated	extensive	tracing	throughout	 the	 hepatocyte	 parenchyma	 using	 the	 presumed	 biliary-specific	 Sox9-
CreER	allele	across	a	range	of	injury	models	(Furuyama	et	al.,	2011)	(Figure	1.7);	this	argued	for	a	much	more	prominent	role	of	ductal-sustained	regeneration	that	did	not	fit	the	estimates	of	Malato	et	al.,	2011.	But	the	strategy	of	Furuyama	et	al.	may	have	unintentionally	picked	up	on	a	hybrid	hepatocyte	population,	found	also	periportally,	which	expresses	low	levels	of	Sox9	and	excels	at	regenerating	the	injured	liver	(Font-Burgada	et	al.,	2015).	Using	a	different	Sox9-CreER	line	and	clonal-density	labelling,	Tarlow	et	al.	found	a	much	more	conservative	(<1%)	ductal	contribution	towards	the	regeneration	of	hepatocytes	(Tarlow,	Finegold	and	Grompe,	2014).	Fittingly,	2.45%	biliary-derived	hepatocytes	were	 reported	 in	Opn-CreER	 transgenic	mice	damaged	chronically	with	the	CDE	diet,	but	not	with	DDC	nor	CCl4	(Español-Suñer	et	al.,	2012);	whilst	 Rodrigo-Torres	 et	 al.,	 argued	 for	 a	 contribution	 of	 just	 under	 2%	 when	damaging	Hnf1b-CreER	mice	also	with	CDE	but	not	DDC	(Rodrigo-Torres	et	al.,	2014)	(Figure	1.7).	
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In	parallel,	there	have	been	genetic	fate-tracing	studies	from	loci	believed	to	be	progenitor-specific,	as	is	the	case	of	forkhead	box	L1	(Foxl1)	and	leucine	rich	repeat	containing	G	protein	coupled	receptor	5	(Lgr5)	(Figure	1.7).	The	notion	of	progenitor	specificity	relies	on	the	lack	of,	or	minimal,	expression	of	these	markers	in	the	healthy	liver	 epithelium	 (both	 in	 cholangiocytes	 and	 hepatocytes),	 juxtaposed	 to	 a	 clear	expression	within	the	damage-induced	progenitor	cells.	Both	Foxl1+	and	Lgr5+	cells	expand	following	liver	damage	and	exhibit	bipotentiality	in	vivo	and	in	vitro	(Sackett	
et	 al.,	 2009;	 Shin	 et	 al.,	 2011;	 Huch	 et	 al.,	 2013).	 Instead	 of	 cellular	 identity,	‘progenitor-specific’	 genes	may	 reflect	 the	molecular	 changes	 that	 accompany	 the	process	of	de-differentiation	and/or	activation	of	stem-like	features	(Huch	and	Dollé,	2016).	Lgr5	is	a	WNT	target	gene	and	common	marker	of	adult	stem	cells	which	rely	on	 high	WNT	 signalling	 for	 their	 self-renewal	 (Barker,	 Tan	 and	 Clevers,	 2013).	 In	agreement	with	this,	ductal	fragments	from	healthy	liver	–	expanded	under	defined	growth	medium	including	WNT	agonists–	self-renew	in	vitro	as	liver	organoids	with	high	Lgr5	expression	(Huch	et	al.,	2013).		
	
Figure	1.7	The	contested	existence	of	ductal	liver	progenitors.	Multiple	CreloxP	methods	of	lineage	tracing	have	been	used	to	probe	the	existence	of	ductal	progenitors	in	the	adult	damaged	liver.	The	most	remarkable,	but	controversial,	proof	of	ductal-driven	regeneration	has	come	from	the	Sox9-CreER	model	by	Furuyama	et	al.,	wherein	significant	hepatocyte	replenishment	was	detected.	This	has	since	been	contested	using	several	ductal-specific	alleles	including	a	different	Sox9-CreER	as	well	as	Opn-CreER	and	Hnf1b-CreER.	These	methods	reported	a	small	percentage	(1-3%)	of	ductal-derived	hepatocytes,	which	fitted	with	the	~2%	of	non-hepatocyte	tracing	observed	 in	 AAV8-Ttr-Cre	 labelled	 livers.	 Tracing	 from	 the	 Lgr5-CreER	 and	 Folx1-CreER	 loci,	 which	 label	proliferating	progenitors	after	damage,	 also	 supports	potency	 towards	 the	hepatocyte	 lineage	but	does	not	prove	 ductal	 ancestry.	 No	 tracing	 was	 detected	 with	 mesenchymal	 alleles	 (Pdgfrb,	 Sm22).	 In	 contrast,	hepatocytes	display	a	remarkable	ability	to	regenerate	themselves,	as	shown	using	Sox9CreER,	AAV8-Ttr-Cre	and	AAV8-TGB-Cre.	Grey	arrows	and	 text:	negligible	or	non-detected	 tracing	 into	hepatocytes.	Thickness	of	arrows	reflects	the	amount	of	tracing	into	hepatocytes.	Brown	hepatocytes:	damaged/necrotic.	
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The	liver	field	is	no	stranger	to	controversy.	The	existence	of	ductal-derived	progenitors	was	questioned	anew	with	a	couple	of	studies	from	the	Willenbring	and	Stanger	labs	in	2014.	After	refining	their	formerly	published	strategy	of	hepatocyte	labelling	(by	coupling	AAV8-Ttr-Cre	with	the	more	sensitive	reporter	R26-RFP,	instead	of	 R26-YFP)	 (Malato	 et	 al.,	 2011),	 the	 Willenbring	 group	 detected	 only	 0.4%	hepatocytes	 of	 non-hepatocyte	 origin	 and	 found	 negligible	 (<0.1%)	 hepatocyte	regeneration	using	mouse	 lines	of	ductal	(Krt19-CreER)	and	mesenchymal	(Pdgfrb-
CreER	and	Sm22-CreER)	specificity	exposed	to	the	same	chronic	damage	regime	as	in	Español-Suñer	 et	 al.	 2012	 (Schaub	 et	 al.,	 2014).	 On	 that	 same	 year,	 Yanger	 and	colleagues	used	a	comprehensive	list	of	pulse-chasing	protocols	–encompassing	the	labelling	of	cholangiocytes	(Krt19-CreER),	ductal	progenitors	(DDC	or	CDE	followed	by	Krt19-CreER	tracing),	hepatocytes	(AAV8-TBG-Cre)	and	rapidly	proliferating	cells	(CDE	 or	 DDC	 followed	 by	 labelling	 with	 thymidine	 analogues)–,	 to	 convincingly	demonstrate	that	regenerated	hepatocytes	arise	from	self-duplication	(Yanger	et	al.,	2014)	(Figure	1.7).	Almost	 foretelling	 the	 controversy	 of	 the	 ensuing	 years,	 ‘true	 oval	 cell	responses’	had	already	been	reported	to	arise	only	when	hepatocyte	proliferation	is	inhibited	 (Petersen,	 Zajac	 and	 Michalopoulos,	 1998).	 Comparably,	 in	 the	 clinic,	ductular	 responses	 are	 observed	 in	 patients	 with	 chronic	 liver	 disease	 when	hepatocytes	are	mostly	senescent	and	cease	to	proliferate	(Wiemann	et	al.,	2002).	It	is	 thus	emerging	that	ductal	progenitor	potency	should	be	reassessed	with	models	that	 stringently	block	 regeneration	 from	 the	hepatocyte	 compartment.	Conditional	deletion	of	 transformed	mouse	3T3	 cell	 double	minute	2	 (Mdm2)	 in	up	 to	98%	of	hepatocytes,	which	 causes	 them	 to	 senesce,	 activates	 a	 vigorous	ductal	progenitor	response	 that	 correlates	with	 the	 full	 recovery	 of	 liver	 function	 in	mice	 (Lu	 et	 al.,	2015)	 (Figure	 1.8).	 Similar	 results	 have	 been	 observed	 in	 zebrafish	 livers	 after	extreme	 hepatocyte	 loss	 (Choi	 et	 al.,	 2014;	 He	 et	 al.,	 2014),	 which	 may	 reflect	environmentally	forced	plasticity	to	cope	with	damage	(see	below)	(Figure	1.8).	On	the	other	hand,	mature	hepatocytes	have	been	shown	to	undergo	reversible	ductular	metaplasia	 in	chronically	damaged	 livers,	 regenerating	up	 to	60%	of	 their	 lost	cell	numbers,	which	suggests	that	part	of	the	progenitor	pool	could	originate	from	a	small	number	 of	 hepatocytes	 as	 an	 injury	 escape	mechanism	 (Tarlow	 et	 al.,	 2014).	 The	
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phenomenon	of	hepatocyte-to-ductal	 reprogramming	occurs	 spontaneously	during	liver	damage	but	can	be	enhanced	through	modulation	of	the	Notch,	Hippo	and	TGFb	signalling	pathways	(Jeliazkova	et	al.,	2013;	Yanger	et	al.,	2013;	Yimlamai	et	al.,	2014;	Schaub	et	al.,	2018).	Recently,	 using	 lineage	 tracing	 approaches,	 Raven	 and	 colleagues	 have	unequivocally	 shown	 that	ductal	progenitors	 contribute	 to	 the	 regeneration	of	 the	hepatocyte	lineage	in	murine	livers	with	impaired	hepatocyte	proliferation,	caused	by	both	p21	overexpression	and	loss	of	integrin	β1	(Itgb1)	(Raven	et	al.,	2017)	(Figure	1.8).	Remarkably,	when	there	is	severe	chronic	damage,	biliary	cells	may	bypass	the	‘intermediate’	 progenitor	 state	 and	 directly	 convert	 into	 hepatocytes	 within	 the	ductule	 structure	 in	 the	 absence	 of	 proliferation	 (Deng	 et	 al.,	 2018).	 This	transdifferentiation	 process	 is	 not	 due	 to	 blockage	 of	 hepatocyte	 cycling	 as	 in	 the	models	of	Lu	et	al.	2015	and	Raven	et	al.	2017,	and	no	‘oval’	cell	marker	expression	is	detected	(Figure	1.8).		
	
Figure	1.8.	Biliary	duct	cells	regenerate	the	liver	when	hepatocytes	cannot.	The	contribution	of	ductal	cells	towards	hepatocyte	regeneration	has	been	re-assessed	using	models	in	which	there	is	significant	hepatocyte	loss	or	hepatocyte	proliferation	is	impaired.	The	former	has	been	done	in	zebrafish	coupled	to	fate-tracing	from	the	Tp1CreER	 locus,	 a	Notch	 responsive	element	enriched	 in	ductal	 cells.	 In	mice,	 transplantation	of	ductal	progenitors	 into	 livers	 with	 senescent	 hepatocytes	 (induced	 via	 knock-out	 of	 Mdm2)	 repopulated	 the	hepatocyte	parenchyma.	25%	of	non-hepatocyte	tracing	was	also	observed	in	damaged	livers	with	hepatocyte-specific	loss	of	Itgb1,	which	impairs	cell	proliferation.	Tracing	from	the	Krt19-CreER	locus	demonstrated	that	ductal-derived	hepatocytes	amount	to	15%	in	livers	where	p21	overexpression	causes	hepatocyte	senescence.	Ductal	 cells	 can	 also	 transdifferentiate	 into	 hepatocytes	 after	 severe	 chronic	 damage	 without	 the	 need	 to	genetically	impair	hepatocyte	proliferation.		
One	 concept	which	 is	 able	 to	 reconcile	much	of	 the	 recent	data	 in	 the	 liver	regeneration	 field	 is	 that	 of	 cellular	 plasticity,	 whereby	 the	 epithelial	 cell	compartments	of	the	liver	may	altruistically	interconvert	onto	one	another	to	repair	damage	 as	 needed	 	 –	 either	 through	 a	 facultative	 progenitor	 state	 or	 via	 direct	
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transdifferentiation	 (Kopp,	 Grompe	 and	 Sander,	 2016;	 Michalopoulos,	 2018).	 The	concept	 of	 cellular	 plasticity	 has	 not	 been	 ascribed	 exclusively	 to	 the	 hepatic	epithelium,	yet	 it	 is	possible	 that	 the	evolutionary	pressure	applied	by	 continuous	metabolism	of	toxic	waste	has	made	it	a	more	frequent	and	obvious	necessity	in	this	organ.	This	subject	is	comprehensively	reviewed	elsewhere	(Aloia,	Mckie	and	Huch,	2016;	Kopp,	Grompe	and	Sander,	2016).	
1.2.3.2 The	stromal	perspective		
Re-epithelization	is	the	ultimate	goal	of	the	regenerative	response;	however,	no	epithelial	cell,	mighty	as	it	be,	can	re-establish	homeostasis	unaided.	The	recovery	from	epithelial-specific	injuries	relies	on	auxiliary	responses	by	nondamaged	stromal	cells	 that	 become	 activated	 in	 situ	 and/or	 get	 recruited	 from	 the	 bloodstream	(Gurtner	 et	 al.,	 2008)	 (Figure	 1.9).	 Borrowing	 from	 the	 stem	 cell	 field,	 this	 is	 an	extension	 of	 the	 concept	 of	 ‘niches’:	 specialised	 micro-environments	 capable	 of	influencing	stem	cell	 fate	decisions	 like	self-renewal	and	differentiation.	But	unlike	other	 epithelial	 tissues	 with	 well-defined	 stem-niche	 duos	 (Mesa,	 Rompolas	 and	Greco,	 2015),	 the	 liver	 has	 lagged	 considerably	 in	 this	 respect,	 likely	 due	 to	 the	relentless	questioning	of	the	stem	cell	itself.		Genetic	mouse	models	and	in	vitro	culturing	efforts	at	the	heart	of	the	cell-of-origin	 debate	 have	 incidentally	 uncovered	 a	 multitude	 of	 paracrine	 molecules	essential	for	liver	regeneration	(Erker	and	Grompe,	2008).	The	majority	of	these	are	thought	 to	 be	 of	 stromal	 origin	—for	 instance	WNT/Rspondin	 (Ding	 et	 al.,	 2010;	Boulter	et	al.,	2012;	Rocha	et	al.,	2015),	HGF	(Matsumoto	and	Nakamura,	1991;	Ding	
et	al.,	2010;	Chen	et	al.,	2012)	and	fibroblast	growth	factor	(FGF)	(Takase	et	al.,	2013);	highlighting	 the	 absolute	 necessity	 of	 studying	 hepatic	 wound	 healing	 as	 a	 joint	endeavour	between	stromal	and	epithelial	cells.	It	is	fascinating	that	many	aspects	of	the	regenerative	microenvironment	—both	the	cells	and	their	paracrine	signals—	are	conserved	 across	 various	 models	 of	 liver	 injury	 despite	 the	 distinct	 sources	 of	epithelial	 replacement	 (e.g.	 hepatocytes,	 cholangiocytes,	 ‘oval’/ductal	 progenitors)	(Michalopoulos,	2007;	Duncan,	Dorrell	and	Grompe,	2009).	This	hints	at	evolutionary	adapted,	 and	 possibly	 redundant,	 pathways	 to	 ensure	 tissue	 regeneration	 by	whatever	means	necessary:	cell	cycle	entry,	transdifferentiation	and/or	activation	of	
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facultative	 stem	 cells.	 Notwithstanding,	 our	 knowledge	 in	 this	 field	 remains	convoluted;	the	spatiotemporal	dynamics	and	the	cell	source/recipient	combinations	of	many	regenerative	pathways	have	been	poorly	defined.	1.2.3.2.1 Mesenchymal	cell	activation	
The	 multicellular	 events	 that	 drive	 wound	 healing	 are	 notoriously	 well	understood	in	the	epidermis,	particularly	concerning	the	role	of	mesenchymal	cells.	In	this	tissue,	soon	after	inflammation,	resident	fibroblasts	adjacent	to	the	wound	or	recruited	 from	 the	 bone	 marrow	 are	 induced	 to	 secrete	 ECM	 to	 generate	 a	 scar	(Gurtner	et	al.,	2008).	This	mesenchymal	activation	entails	a	phenotypic	switch	of	the	fibroblasts	 into	 myofibroblasts,	 highly	 contractile	 cells	 that	 lay	 down	 matrix	(predominantly	collagen)	and	deform	it	to	progressively	bring	the	edges	of	the	wound	together	(Tomasek	et	al.,	2002).	In	the	latter	phases	of	healing,	auxiliary	stromal	cells	including	the	myofibroblasts	themselves	retract	or	become	apoptotic	(Desmoulière	et	
al.,	1995),	but	epithelial–mesenchymal	interactions	are	thought	to	continue	to	ensure	tissue	stability	(Szabowski	et	al.,	2000).	Taking	lessons	from	the	skin,	mesenchymal	cell	activity	has	also	been	assessed	in	 the	 context	 of	 hepatic	 regeneration,	 but	 even	 more	 so	 during	 pathological	fibrogenesis	(see	section	1.2.4).	 Injury-induced	myofibroblasts	are	 thought	 to	have	diverse	 origins	 in	 the	 liver,	 the	most	 prominent	 being	HSCs	 and	portal	 fibroblasts	(Figure	 1.9).	 Bone	marrow–recruited	monocytes	may	 also	 differentiate	 into	 ECM-producing	 “fibrocytes”	 as	 part	 of	 the	 inflammatory	 response,	 but	 transplantation	studies	 suggest	 that	 their	 contribution	 to	 the	 development	 of	 hepatic	 fibrosis	 is	minimal	compared	to	that	of	tissue-resident	mesenchymal	cells,	for	which	they	have	been	given	less	attention	(Kisseleva	et	al.,	2006;	Brenner	et	al.,	2012).	The	 transition	 from	 quiescent	 “cell	 X”	 (be	 it	 HSC,	 portal	 fibroblast,	 or	monocyte)	to	active	myofibroblast-like	phenotype	is	a	malleable	process	wherein	the	chronicity	of	the	damage	stimuli	may	generate	a	mixed	spectrum	of	mesenchymal	cell	signatures	(Schmitt-Gräff	et	al.,	1994).	While	HSC-derived	myofibroblasts	have	been	reported	to	revert	to	quiescence	readily		(Kisseleva	et	al.,	2012;	Troeger	et	al.,	2012),	myofibroblasts	 originating	 from	 portal	 fibroblasts	 are	 locked	 in	 a	 more	
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mature/committed	state	and	seem	to	die	by	apoptosis	instead	of	transitioning	back	(Guyot	 et	 al.,	 2007,	 2010).	 Myofibroblast	 heterogeneity	 may	 thus	 be	 crucial	 for	understanding	the	balance	between	regeneration	and	fibrosis.		
i. Hepatic	stellate	cells	
Almost	expectedly,	the	question	of	mesenchymal	aid	in	the	liver	has	swivelled	attention	to	the	HSC	lineage,	the	most	abundant	mesenchymal	cell	of	the	tissue.	Their	widespread	perisinusoidal	location	may	indeed	endow	these	cells	with	a	competitive	advantage	–	acting	swiftly	at	multiple	sites	of	injury	–	as	they	consistently	respond	to	diverse	 types	of	 damage	 such	 as	DDC,	CCl4,	and	 acetaminophen	 (Shen	et	 al.,	 2011;	Mederacke	 et	 al.,	 2013).	 Seminal	 observations	 established	 a	 spatiotemporal	 link	between	perisinusoidal	‘lipocytes’,	now	recognised	to	be	HSCs,	and	collagen	fibres	in	injured	livers	(McGee	and	Patrick,	1972;	Kent	et	al.,	1984).		Following	tissue	damage,	the	vitamin	A-rich	quiescent	HSCs	indeed	transition	into	proliferative,	contractile	cells	that	 meet	 all	 the	 criteria	 of	 the	 myofibroblast-like	 phenotype.	 Their	 cytoskeleton	bears	 witness	 to	 this:	 microfilament	 bundles	 –including	 a	 smooth	 muscle	 actin	(aSMA),	 a	 marker	 for	 activated	 myofibroblasts–	 accumulate	 intracellularly,	suggesting	competence	for	contraction	(Schmitt-Gräff,	Chakroun	and	Gabbiani,	1993;	Enzan	 et	 al.,	 1999)	 (Figure	 1.9).	 In	 addition,	 these	 cells	 become	 equipped	 with	 a	repertoire	of	fibrillar	collagens	including	type	I	and	III	(Maher	and	McGuire,	1990),	and	express	a	number	of	mitogenic	factors	for	epithelial	cells,	including	HGF	(Maher,	1993;	Chen	et	al.,	2012)	(Figure	1.9).	Still,	much	of	this	mechanistic	evidence	remains	circumstantial,	and	the	modes	through	which	HSC-derived	myofibroblasts	contribute	to	regeneration,	not	fibrosis,	are	not	well	understood.		Non-genetic	methods	to	inhibit	HSC	activation	in	vivo	–including	gliotoxin	and	l-cysteine–	 prevent	 normal	 regenerative	 responses	 of	 both	 hepatocytes	 and	 ‘oval’	cells	in	injured	livers	(Pintilie	et	al.,	2010;	Shen	et	al.,	2011),	although	these	have	been	criticised	for	their	lack	of	cell	specificity.		A	study	by	Kalinichenko	et	al.	showed	that	haploinsufficiency	of	forkhead	box	f1	(Foxf1)	–a	transcription	factor	enriched	in	the	septum	 transversum	 and	 HSCs	 throughout	 ontogeny–	 diminishes	 aSMA+	 cell	expansion	 and	 collagen	 deposition	 following	 CCl4	 injury,	 concomitant	 with	 an	increase	 in	 pericentral	 hepatocyte	 apoptosis	 (Kalinichenko	et	 al.,	 2003).	 Chen	 and	
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colleagues	have	also	highlighted	the	dynamicity	of	the	HSC	‘niche’:	these	cells	switch	from	secreting	pro-proliferative	(HGF)	to	anti-proliferative	(TGFb)	factors	at	different	time	points	following	CCl4	administration	(Chen	et	al.,	2012),	a	biological	rheostat	that	may	ensure	the	timely	progression	and	arrest	of	regeneration.			A	 big	 caveat	 of	 many	 HSC	 focused	 studies	 is	 the	 difficulty	 in	 proving	 the	identity	of	these	cells	unequivocally.	Even	some	of	the	most	commonly	used,	markers	like	glial	fibrillary	acidic	protein	(GFAP)	and	Collagen-a1,	are	not	exclusive	to	the	HSC	lineage	and	 label	other	mesenchymal	and	even	non-mesenchymal	 cell	 types	of	 the	liver	(Mederacke	et	al.,	2013;	Lua	et	al.,	2016);	likewise,	HSC	ancestry	should	not	be	assumed	for	myofibroblasts	based	on	co-expression	of	these	markers,	and	the	field	would	benefit	from	cell-specific	CreloxP	tools	for	fate	tracing	and	ablation.	Mederacke	and	colleagues	have	recently	made	advances	on	this	respect	by	generating	a	CreloxP	mouse	 in	which	99%	of	HSCs	are	 labelled	 from	the	 lecithin-retinol	acyltransferase	(Lrat)	 locus	 (Mederacke	et	al.,	 2013).	 Similarly,	both	quiescent	and	 injury-induced	HSCs	are	labelled	efficiently	with	a	Pdgfrb-Cre	line	(Henderson	et	al.,	2013).		
ii. Portal	fibroblasts	
The	 portal	 fibroblast	 population	 sparked	 interest	 rather	 recently	 following	reports	 from	diseased	 livers	 in	which	peribiliary	matrix-embedded	myofibroblasts	presented	a	signature	inconsistent	with	HSC	ancestry	(Knittel	et	al.,	1999;	Cassiman	
et	al.,	2002).	Although	the	ontogeny	of	portal	fibroblasts	and	HSCs	is	thought	to	be	shared	–tracing	back	to	STM-derived	mesothelial	cells	(Asahina	et	al.,	2011)–	portal	fibroblasts	 exclusively	 localise	 to	 the	 portal	 tract	 of	 the	 liver	 lobule,	 and	 their	activation	is	seemingly	biased	to	‘injuries’	of	the	biliary	epithelium.	This	may	include	malignancies	 like	 cholangiocarcinoma,	 which	 differs	 histologically	 from	hepatocellular	carcinoma	with	respect	 to	 the	presence	of	abundant	 fibrous	stroma	(Tadashi	et	al.,	1996).	Tuchweber	et	al.	compared	the	kinetics	of	mesenchymal	cell	expansion	 in	 rats	 following	 bile	 duct	 ligation	 (BDL),	 an	 obstructive	 model	 of	cholestasis	 (Rodríguez-Garay,	 2003);	 soon	 after	 injury,	 portal	 fibroblasts	 nearly	doubled	 the	 proliferative	 index	 of	 HSCs	 (31%	 vs	 18%	 at	 72h	 post	 injury)	 and	detection	of	aSMA-expression	was	restricted	to	the	stroma	adjacent	to	proliferating	ductal	cells,	not	the	HSCs	of	the	lobule	(Tuchweber	et	al.,	1996).	A	similar	abundance	
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of	suspected	non-HSC-derived	myofibroblasts	(based	on	lack	of	Desmin	expression)	was	 confirmed	 by	 ischemic	 injury	 of	 the	 bile	 ducts,	 although	 no	 positive	 lineage	tracing	 was	 performed	 (Beaussier	 et	 al.,	 2007).	 The	 specificity	 and	 sensitivity	 of	reported	portal	fibroblast	markers	like	fibulin	2,	elastin,	IL-6	and	NTPDase	2	need	to	be	thoroughly	validated	(Wells,	2014);	at	present,	studies	remain	ambiguous	in	their	cell-lineage	definition	and	instead	appeal	to	the	positional	bias	of	the	portal	fibroblast	compared	to	HSCs	(Figure	1.9).	Consistent	with	the	myofibroblast	phenotype,	periportal	fibroblasts	in	the	BDL	model	 do	 synthesise	 ECM	 proteins	 like	 collagen	 I,	 IV,	 procollagen	 III,	 elastin	 and	tenascin,	 as	well	 as	 tissue	 inhibitor	 of	metalloproteinase	 1	(Timp1);	 although	 they	appear	 to	 do	 so	 prior	 to	 myofibroblastic	 differentiation	 (as	 assessed	 via	 aSMA	staining)	(Desmoulière	et	al.,	1997).	Several	of	these	matrix	proteins	–	tenascin	and	collagen	 IV	 in	 particular–	 have	 been	 implicated	 in	 bile	 duct	 development	 and	 in	intrahepatic	 cholangiocarcinoma	 in	 humans	 (Terada	 and	 Nakanuma,	 1994).	Moreover,	collagen	IV	is	one	of	the	major	constituents	of	Matrigel,	the	matrix	required	for	 the	 in	 vitro	 expansion	 of	 ductal	 progenitors	 into	 organoids,	 as	 discussed	 in	section1.3.1.	Selected	publications	suggest	that,	beyond	their	injury-induced	expansion	and	matrix	 deposition,	 portal	 mesenchymal	 cells	 engage	 with	 the	 biliary	 epithelium	through	paracrine	signalling.	Takase	and	colleagues	showed	 that,	 in	DDC-damaged	livers,	 periportal	 thymus	 cell	 antigen	1	 (Thy1)+	mesenchymal	 cells	 (encompassing	portal	 fibroblasts	but	also	HSCs)	 induce	 the	activation	and	proliferation	of	murine	liver	progenitors	through	FGF7	secretion	(Figure	1.9);	and	forced	overexpression	of	this	 factor	 alone	 is	 sufficient	 to	 stimulate	 progenitor	 emergence	 in	 healthy	 livers	(Takase	et	al.,	2013).	Years	before,	Sackett	and	colleagues	had	alluded	 to	a	similar	niche	 of	 portal	 fibroblasts	 for	 Foxl1+	 labelled	 ductal	 progenitors,	 although	 no	molecular	link	had	been	established	then	(Sackett	et	al.,	2009).	In	chronic	models	of	liver	 damage,	 periportal	 Jagged1+	 myofibroblasts	 direct	 progenitor	 differentiation	towards	 the	 ductal	 lineage	 (Boulter	 et	 al.,	 2012)	 (Figure	 1.9),	 a	 process	 that	recapitulates	 the	 Notch-mediated	 interaction	 between	 hepatoblasts	 and	 portal	mesenchyme	 in	 embryogenesis	 (see	 section	 1.2.1).	 The	 model	 of	 Boulter	 and	colleagues	 is	 appealing	 because	 it	 proposes	 that	 progenitor	 fate-decisions	 in	
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adulthood	are	modulated	according	to	the	local	microenvironment	(Boulter,	Lu	and	Forbes,	2013).	 If	 that	 is	the	case,	peribiliary	mesenchymal	cells	should	be	carefully	studied	as	the	putative	‘niche’	of	ductal-derived	progenitors.		
	
Figure	1.9.	Hepatic	regeneration	involves	activation	of	mesenchymal	cells.	The	process	of	hepatic	wound	healing	 involves	 an	 early	 inflammatory	 response,	 wherein	 tissue-resident	 macrophages	 and	 recruited	monocytes	detect	epithelial	necrosis	and	secrete	pro-inflammatory	cytokines.	Mesenchymal	cells	(orange)	in	the	tissue,	mainly	HSCs	and	portal	fibroblasts	(PF),	become	activated	and	differentiate	into	myofibroblasts	(MF,	magnified	cell),	contractile	aSMA+	cells	that	deposit	and	remodel	ECM	to	aid	in	wound	closure.	Activated	HSCs	secrete	a	variety	of	mitogenic	growth	factors	(e.g.	HGF)	and	are	the	main	contributors	to	liver	fibrosis	regardless	of	 aetiology.	 Activated	 PF	 expand	 periportally	 in	 cholestasis	 and	 similar	 ductal-specific	 injury	 models.	Periportal	Thy1+	mesenchymal	cells	secrete	FGF7	to	activate	the	ductal	progenitors	(green	round	cells)	after	injury,	whilst	mesenchymal	Jagged1	promotes	biliary	fate	commitment	of	the	ductal	progenitors.	PF-MF:	portal	fibroblast-derived	myofibroblast,	HSC-MF:	HSC-derived	myofibroblast.	
iii. In	vitro	isolation	and	culture	of	primary	mesenchymal	cells		
Our	understanding	of	hepatic	mesenchymal	cells,	both	in	homeostasis	and	in	injury,	has	been	revolutionised	by	the	ability	to	culture	them	ex	vivo.	For	this,	livers	are	typically	perfused	in	situ	or	digested	after	harvest	with	tissue-disrupting	enzymes	like	collagenase,	as	is	customary	for	most	other	primary	hepatic	cell	isolations.		HSCs	can	 be	 efficiently	 sorted	 out	 via	 density	 gradient	 separation,	 a	method	 that	 takes	advantage	 of	 their	 buoyancy	 caused	 by	 high	 content	 of	 intracellular	 vitamin	 A	(Friedman	and	Roll,	1987);	the	caveat	is	a	bias	towards	isolation	of	quiescent	HSCs,	given	that	HSC-derived	myofibroblasts	lose	their	lipid	droplets	during	the	process	of	differentiation	 (Friedman,	Wei	 and	 Blaner,	 1993).	 Portal	 fibroblasts,	 on	 the	 other	hand,	 may	 be	 extracted	 through	 a	 modified	 protocol	 of	 cholangiocyte	 isolation	(Kruglov,	Jain	and	Dranoff,	2002)	and	by	outgrowth	from	dissected	biliary	fragments	(Uchio	et	al.,	2002;	Kinnman	et	al.,	2003).	At	the	expense	of	cellular	yields,	many	of	these	techniques	have	been	adapted	to	mice	livers	and	now	incorporate	fluorescence	
Chapter	1	Introduction	
38	
activated	cell	sorting	(FACS)	to	ensure	higher	cell	purity.	It	is	clear	that	for	both	HSCs	and	 portal	 fibroblasts,	 in	 vitro	 culture	 leads	 to	 the	 progressive	 acquisition	 of	myofibroblastic	morphology	 and	marker	 expression	 (e.g.	aSMA),	 a	 process	 that	 is	regulated	 by	 TGFb,	 platelet-derived	 growth	 factor	 (PDGF)	 and	 substrate	 stiffness	(Kinnman	et	al.,	2003;	Li	et	al.,	2007).	In	addition,	several	stable	cell	lines	of	hepatic	mesenchyme	have	also	been	developed	to	bypass	the	need	for	primary	cell	isolation	(Herrmann,	Gressner	and	Weiskirchen,	2007;	Fausther	et	al.,	2015),	but	demand	extra	caution	due	to	the	major	alterations	inherent	to	the	process	of	cell	immortalisation.		
1.2.4 Fibrosis	and	its	resolution	
Regeneration	and	fibrosis	share	a	common	cascade	of	cellular	and	molecular	interactions	 that	 bifurcates	 as	 a	 result	 of	 the	 chronicity	 of	 the	 damage	 (Cordero-Espinoza	and	Huch,	2018).	At	the	heart	of	this	lies	the	ability	to	deposit	matrix,	but	also	to	remodel	it	and	remove	it	in	order	to	ensure	recovery	of	the	tissue	(Issa	et	al.,	2003;	Kallis	et	al.,	2011).	Fibrosis	occurs	when	ECM	proteins	accumulate	in	excessive	amounts,	leading	to	scarring	that	distorts	the	normal	layout	and	stiffness	of	the	tissue.	As	the	injury	becomes	chronic,	the	once-functional	hepatic	parenchyma	is	overtaken	by	an	acellular	mesh	of	connective	tissue	–	mostly	collagen	and	elastin	fibers	–	whose	progressive	 cross-linking	 restrains	 access	 to	 degrading	 enzymes	 and	 makes	 scar	resolution	increasingly	difficult	(Ramachandran	and	Iredale,	2012).		An	important	mechanism	of	hepatic	fibrogenesis	is	the	accumulation	of	ECM-producing	myofibroblasts	in	the	tissue.	Given	that	both	portal	fibroblasts	and	HSCs	could	fulfil	the	criteria	of	bona	fide	pro-fibrotic	cells	in	the	context	of	hepatic	damage,	the	field	has	deliberated	extensively	about	the	pathogenic	contribution	of	each	cell-type.	 Mederacke	 and	 colleagues	 proposed	 HSCs	 as	 the	 dominant	 contributors	 of	matrix	 deposition	 in	 liver	 fibrosis,	 independent	 of	 its	 aetiology	 (Mederacke	 et	 al.,	2013),	which	is	currently	the	most	accepted	view;	there	is	however	growing	support	for	 the	 portal	 fibroblast	 as	 a	 ‘first	 responder’	 after	 injury,	 particularly	 that	 of	 the	biliary	epithelium	(Wells,	2014).	For	many	years	 tissue	 fibrosis	was	considered	 to	be	a	degenerative	disease	with	no	possibility	of	regression.	A	seminal	study	by	Okazaki	and	Maruyama	in	1974	
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was	the	first	to	show	collagenase	activity	in	fibrotic	livers,	hinting	at	the	feasibility	of	disease	resolution	under	certain	contexts	(Okazaki	and	Maruyama,	1974).	Since	then,	the	 liver	has	provided	exceptional	evidence	of	 the	plasticity	of	 this	process,	where	even	advanced	fibrotic	tissues	are	capable	of	reacquiring	homeostatic	traits	(Ellis	and	Mann,	 2012).	 The	 mechanisms	 for	 this	 are	 complex	 and	 out	 of	 the	 scope	 of	 this	dissertation	 (Henderson	 and	 Iredale,	 2007;	 Ramachandran	 and	 Iredale,	 2012);	however,	 they	 include	 pro-fibrotic	 cell	 clearance	 by	 immune	 cells	 (Radaeva	 et	 al.,	2006;	Glässner	et	al.,	2012;	Hammerich	et	al.,	2014),	reversal	to	quiescence	(Kisseleva	
et	 al.,	 2012;	 Troeger	 et	 al.,	 2012)	 or	 senescence	 of	 the	 myofibroblast	 population	(Krizhanovsky	et	al.,	2008).	
1.3 In	vitro	cultures	of	liver	progenitors	
Despite	 certain	 discrepancies	 in	 the	 methods	 of	 isolation,	 bipotential	hepatoblast	populations	can	be	extracted	from	the	developing	embryo	and	grown	in	
vitro	(reviewed	in	(Miyajima,	Tanaka	and	Itoh,	2014)).	Pluripotent	stem	cell	cultures	(ESC	 or	 iPSC)	 can	 also	 be	 directed	 to	 differentiate	 into	 hepatoblast-like	 cells	 by	recapitulating	 the	 soluble	 factors	of	 the	embryonic	microenvironment	 in	 vitro	 in	 a	timely	and	step-wise	manner	(Si-Tayeb	et	al.,	2010;	Touboul	et	al.,	2010;	Dianat	et	al.,	2014;	 Ogawa	 et	 al.,	 2015;	 Sampaziotis	 et	 al.,	 2015)	 (Figure	 1.10).	 Embryonic	progenitors	can	be	pushed	towards	a	committed	hepatocyte	or	cholangiocyte	fate,	but	they	typically	remain	immature	compared	to	the	adult	tissue,	particularly	concerning	the	great	degree	of	hepatocyte	specification	(i.e.	zone	specific	signatures)	that	occurs	postnatally	(Baxter	et	al.,	2015);	these	types	of	cultures	are	thus	ideal	 for	studying	hepatic	 patterning	 and	 morphogenesis	 during	 development,	 but	 are	 less	 useful	models	of	adult	hepatic	epithelium.	The	expansion	of	adult	hepatic	cells	has	historically	proven	more	challenging.	In	stark	contrast	to	their	robust	regenerative	capacity	in	vivo,	hepatocytes	fare	poorly	
in	vitro,	both	in	terms	of	survival	and	retention	of	key	metabolic	functions	(Shan	et	al.,	2013),	precluding	 their	use	 for	disease	modelling	and	cell-based	 therapies	 (Figure	1.10).	One	alternative	solution	has	been	the	holy	grail	of	the	adult	stem/progenitor	cell.		Whilst	elusive	in	vivo,	cells	fulfilling	the	requirements	of:	a)	clonogenic	with	high	expansion	potential,	 b)	 able	 to	differentiate	 into	 the	hepatocyte	 and	 cholangiocyte	
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lineages,	and	in	some	cases	c)	capable	of	repopulating	the	liver	after	transplantation;	do	exist	in	vitro	(Miyajima,	Tanaka	and	Itoh,	2014)	(Figure	1.10).	Interestingly,	most	of	such	cells	have	been	sorted	using	classical	ductal	markers	including	EpCAM	(Okabe	
et	al.,	2009),	CD133	(also	known	as	prominin	1)	(Kamiya	et	al.,	2009)	and	the	MIC1-1C3	antigen	(Dorrell	et	al.,	2011)	from	both	damaged	and	healthy	livers;	the	latter	of	which	suggests	that	the	extraction	of	cholangiocytes	from	their	local	niches	and/or	the	in	vitro	conditions	in	which	they	are	grown	induces	the	activation	of	facultative	progenitors.		
	
Figure	1.10.	 In	vitro	 systems	 to	 culture	hepatic	epithelium.	 	A)	 Cholangiocytes	 and	hepatocytes	 can	be	generated	 in	vitro	 from	hepatoblasts	extracted	 from	embryonic	 livers	or	 through	directed	differentiation	of	ESC-	or	iPSC-derived	endodermal	progenitors.	This	process	requires	a	step-wise	recapitulation	of	the	stromal	signals	 that	 drive	 hepatogenesis	 in	 the	 embryo.	 B)	 The	 expansion	 of	 mature	 adult	 cholangiocytes	 and	hepatocytes	in	vitro	has	historically	proven	difficult,	as	these	cells	quickly	lose	their	native	function	and	tissue	organisation.	C)	Putative	adult	progenitors	isolated	from	homeostatic	and	damaged	livers	using	ductal-specific	markers	 display	 clonogenic	 potential	 in	 vitro	 and	 can	 differentiate	 into	 the	 cholangiocyte	 and	 hepatocyte	lineages	on	2D	cultures.		During	embryogenesis,	the	puzzle	for	building	hepatic	epithelium	requires	two	key	pieces:	a	competent	endodermal	cell	source,	but	also	stromal-derived	signals	for	tissue	specification.	Having	the	ductal	lineage	as	a	common	epithelial	denominator	in	the	adult,	a	natural	leap	forward	was	to	attempt	to	faithfully	recapitulate	in	vitro	the	signals	 that	promote	physiological	 tissue	 function	and	histo-architecture	 in	 vivo.	A	history	of	culturing	hepatocytes	as	spheroids	and	via	gel	entrapment	already	hinted	
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at	the	relevance	of	three-dimensional	organisation	for	correct	liver-specific	function	(Meng,	 2010).	 Huch	 et	 al.	 made	 a	 significant	 advancement	 in	 this	 respect	 by	generating	adult-derived	self-organising	3D	hepatic	organoids	in	medium	conditions	that	recapitulate	in	vivo	regenerative	pathways	(Huch	et	al.,	2013)	(Figure	1.11).	
1.3.1 Liver	organoids	
Seminal	work	from	Sato	and	colleagues	in	2009	first	showed	the	isolation	of	single	Lgr5+	adult	stem	cells	from	the	small	intestine	and	their	expansion	into	near-physiological	 self-renewing	 3D	 epithelial	 structures	 –	 coined	 ‘organoids’;	 these	cultures	contained	a	mixture	of	progenitor	and	mature	functional	cell	types	and	were	maintained	in	virtue	of	the	faithful	recapitulation	of	key	signals	from	the	endogenous	stem	cell	niche	(Sato	et	al.,	2009).	The	simple	and	well-defined	nature	of	the	culture	technology,	juxtaposed	to	the	complexity	and	long-term	stability	of	the	3D	epithelial	structures,	 has	 quite	 literally	 revolutionised	 the	 field	 of	 in	 vitro	 adult	 stem	 cell	cultures.	Not	surprisingly,	this	technology	has	since	been	adapted	to	grow	epithelial	stem/progenitor	cell	populations,	both	murine	and	human,	from	diverse	endodermal-derived	organs	including	colon,	stomach,	pancreas	and	liver	(Barker	et	al.,	2010;	Sato	
et	al.,	2011;	Huch	et	al.,	2013,	2015;	Stange	et	al.,	2013;	Boj	et	al.,	2015),	as	well	as	non-endodermal	tissues	like	the	endometrium	(Turco	et	al.,	2017).	The	 signalling	 pathways	 that	 sustain	 endoderm-derived	 organoids	 are	astonishingly	conserved,	with	 the	Rspondin	1	 (RSPO1)-LGR5	axis	 (agonist	of	WNT	signalling)	at	the	core	of	it	all	(de	Lau	et	al.,	2014).	It	was	thus	the	recognition	of	WNT	signalling	 as	 a	 key	 driver	 of	 liver	 regeneration	 and	 the	 identification	 of	 damage-induced	bipotential	Lgr5+	cells	in	the	adult	mouse	liver	that	encouraged	the	idea	of	growing	these	cells	as	3D	organoids	(Apte	et	al.,	2007;	Huch	et	al.,	2013).	Single	Lgr5+	cells	can	be	isolated	and	expanded	in	Matrigel™	–	an	extracellular	matrix	containing	collagen	and	laminin-	with	the	support	of	a	medium	rich	in	mitogens	(FGF,	epidermal	growth	 factor,	 EGF;	 HGF)	 and	 the	 LGR5	 ligand	 RSPO1	 (Figure	 1.11).	 As	 the	 cells	proliferate,	 they	 self-organise	 into	 3D	 single-layer	 epithelial	 structures	 of	 cystic	morphology	that	express	a	mixture	of	progenitor	(Lgr5,	Tacstd2),	ductal	(Krt7,	Krt19)	and	hepatocyte	(Ttr,	Hnf4a)	markers.	Placing	healthy	biliary	ducts	under	 the	same	culture	conditions	leads	to	the	formation	of	identical	organoids	(Huch	et	al.,	2013);	
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whilst	 this	has	been	achieved	 for	single	EpCAM+	cells	–	but	not	hepatocytes–	 from	healthy	human	livers	simply	by	supplementing	the	medium	with	an	activator	of	cAMP	signalling	and	an	inhibitor	of	TGFβ	signalling	(Huch	et	al.,	2015).	This	reinforces	the	idea	 that,	 at	 least	 in	 vitro,	 it	 is	 the	 ductal	 compartment	 that	 contains	 facultative	progenitor	 potential;	 and	 highlights	 a	 conservation	 of	 progenitor	 biology	 across	species	in	the	liver.	In	support	of	this,	canine	and	rat	liver	organoids	have	also	been	generated	more	recently	(Nantasanti	et	al.,	2015;	Kuijk	et	al.,	2016).	As	 if	 retaining	 memory	 of	 their	 cell-of-origin,	 liver	 organoids	 exhibit	 a	molecular	 signature	 that	 is	 biased	 towards	 the	 biliary	 fate	 (Huch	 et	 al.,	 2013).	Hepatocyte	 maturation	 is	 possible	 but	 does	 not	 occur	 spontaneously;	 it	 requires	removal	 of	 proliferative	 stimuli	 (WNT	 agonists)	 and	modulation	 of	 key	 signalling	pathways	that	vary	slightly	according	to	species.	This	is	unlike	intestinal	organoids,	wherein	the	whole	spectrum	of	differentiated	cell	types	from	the	crypt-villus	unit	are	produced	 without	 exogenous	manipulation	 (Sato	 et	 al.,	 2009),	 but	 does	 resemble	other	organoid	systems,	even	those	of	rapidly	cycling	tissues	like	the	stomach	(Barker	
et	al.,	2010).	In	the	mouse	liver	organoids,	addition	of	dexamethasone	in	combination	with	 inhibition	of	Notch	 and	TGFβ	 signalling	 –both	of	 them	crucial	 for	 biliary	 fate	specification	 in	 the	 embryo–	drives	differentiation	 towards	 the	hepatocyte	 lineage	(Huch	 et	 al.,	 2013).	 The	 biliary	 fate	 may	 thus	 be	 the	 ‘default	 pathway’	 for	 these	bipotential	progenitors,	and	hepatocyte	commitment	requires	the	blockade	of	biliary-sustaining	 signals.	 Following	 differentiation,	 the	 organoids	 express	 mature	hepatocyte	markers	(Cyp3a11,	Fah,	G6pc	and	Alb)	but	also	function	as	such.	The	gross	majority	 of	 cells	 become	 competent	 for	 low-density	 lipoprotein	 (LDL)	 uptake	 and	accumulate	glycogen;	they	secrete	albumin	and	display	detoxifying	capacities	based	on	 cytochrome	 P450	 activity	 (Huch	 et	 al.,	 2013)	 (Figure	 1.11).	 Although	 these	functions	outcompete	hepatocyte	cell	lines	(HepG2),	they	are	still	subpar	compared	to	 freshly	 isolated	hepatocytes.	Organoid-derived	hepatocytes	can	also	prolong	the	life	 span	 of	 Fah-/-	mice	 despite	 poor	 engraftment	 in	 vivo	 (Huch	 et	 al.,	 2013)	 and	pathologies	 with	 hepatocyte	 specific-phenotypes	 may	 be	 modelled	 in	 human	organoids,	as	is	the	case	of	α1-antitrypsin	(A1AT)	deficiency	(Huch	et	al.,	2015),	which	manifests	clinically	as	protein	aggregates	of	A1AT	within	the	endoplasmic	reticulum	of	hepatocytes	(Lawless	et	al.,	2008).		
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A	 remarkable	 feature	 of	 all	 adult	 liver	 organoid	 cultures	 to	 date,	 especially	considering	the	historical	difficulties	of	primary	liver	cell	culture,	is	their	prolonged	capacity	 for	 self-renewal:	 a	 single	 cell	 can	 generate	 106	 cells	 in	 ~5-6	 weeks	 (a	population	doubling	rate	of	48–60h)	and	continue	to	expand	for	up	to	1	year	(Huch	et	
al.,	2013,	2015).	Despite	this	high	number	of	cell	divisions,	organoid	cells	do	not	show	signs	of	transformation	even	at	late	passage.	Sequencing	of	human	organoid	cells	soon	after	 isolation	 and	 following	 3	 months	 of	 clonal	 expansion	 detected	 only	 one	synonymous	base	substitution,	a	remarkable	level	of	genomic	stability	(Huch	et	al.,	2015).	 This	 contrasts	 greatly	 with	 iPSC-derived	 organoid	 cultures,	 which	 exhibit	aneuploidy,	 chromosomal	 alterations	 and	 up	 to	 1,058–1,808	 de	 novo	 base	substitutions	 that	 are	mostly	 remnants	 of	 the	 process	 of	 somatic	 reprogramming	(Cheng	et	al.,	2012).	
	
Figure	1.11.	Organoids	as	a	novel	3D	model	to	expand	liver	progenitors.	Healthy	biliary	duct	fragments	or	damage-induced	single	Lgr5+	progenitors	can	be	isolated	from	the	liver	and	expanded	in	a	3D	matrix	of	Matrigel	and	a	defined	growth	factor	medium	that	mimics	key	signalling	pathways	of	liver	regeneration	(WNT	agonist	Rspo1,	HGF,	EGF	and	FGF10).	The	cells	expand	and	self-organise	into	3D	single-layer	epithelial	structures	of	cystic	morphology	 called	 ‘organoids’,	which	express	 a	 combination	of	progenitor	 (Lgr5)	ductal	 (Krt19)	 and	hepatocyte	(Hnf4a)	markers.	Addition	of	dexamethasone	in	combination	with	inhibition	of	Notch	(DAPT)	and	TGFβ	signalling	(A3801)	commits	the	organoids	to	a	more	mature	hepatocyte	fate;	they	express	markers	like	
Alb,	Cyp3a11	and	Fah,	but	also	secrete	albumin,	uptake	LDL	and	store	glycogen.	
1.3.2 Co-culturing	of	liver	progenitors	and	stroma		
Adult-derived	 liver	 organoids	 are	 an	 excellent	 resource	 for	 modelling	normal/pathological	 liver	 physiology	 and,	 in	 particular,	 regenerative	 processes	inherent	to	the	epithelial	parenchyma	(Hindley,	Cordero-Espinoza	and	Huch,	2016).	Yet	 the	 term	 ‘organoid’	 is	 a	 bit	 of	 a	 misnomer,	 in	 that	 the	 adult	 liver	 is	 not	 only	composed	of	 epithelial	 cells	 but	 also	 a	wide	 variety	 of	 stromal	 cells	 that	 aid	 in	 its	
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architecture	 and	 function,	 both	 in	 homeostasis	 and	 after	 injury	 (refer	 to	 section	1.2.3.2).	 In	 vivo,	 complete	 epithelial	 cell	 maturation	 from	 progenitor	 cells	 is	 also	thought	 to	 require	 the	 support	 of	 non-parenchymal	 cells	 (Boulter,	 Lu	 and	 Forbes,	2013),	which	means	that	this	level	of	multicellular	complexity	cannot	be	studied	fully	using	the	liver	organoid	technology	as	it	stands	today.	The	 directed	 differentiation	 of	 ESC/iPSC	 into	 hepatic	 cells	 often	 does	encompass	 multicellular	 crosstalk	 because	 endodermal	 patterning	 is	 not	 100%	efficient,	 and	 thus,	 the	 emergence	 and/or	 maturation	 of	 bipotential	 hepatoblasts	benefits	from	the	presence	of	additional	cell	lineages	that	have	co-differentiated	from	the	 pluripotent	 stem	 cells	 of	 origin.	 As	 an	 example,	 the	 directed	 differentiation	 of	human	 ESCs-derived	 endodermal	 cells	 co-generates	 vascular	 endothelial	 growth	factor	receptor	2	(VEGFR2)+	hepatic	progenitors	and	VEGFR2-	mature	hepatic	cells,	where	the	former	population	supports	the	maturation	of	the	latter	(Goldman	et	al.,	2013).	Guye	and	colleagues	have	also	shown	that	through	heterogeneous	induction	of	the	visceral	endoderm	transcription	 factor,	Gata6,	 all	 three	germ	 layers	co-emerge	from	 a	 culture	 of	 human	 iPSCs	 and	 self-organise	 into	 a	 liver	 bud-like	 structure,	including	mesenchymal,	 endothelial	 and	 haematopoietic	 stromal	 cells	 (Guye	 et	 al.,	2015).		The	approach	of	Guye	et	 al.	 is	 elegant	 in	 terms	of	 the	minimal	 intervention	required	 for	multicellular	 co-emergence	 and	 self-organisation;	 however,	 these	 are	stochastic	 events	 that	 are	 difficult	 to	 reproduce	 consistently	 in	 vitro.	 Takebe	 and	colleagues	have	shown	that	iPSC-derived	hepatoblasts	can	also	be	co-cultured	with	exogenously	 added	human	mesenchymal	 stem	cells	 (hMSCs)	 and	human	umbilical	cord	endothelial	 cells	 (HUVECs)	 in	a	3D	culture	 system	(Takebe	et	al.,	 2013).	This	gives	 rise	 to	 multicellular	 embryonic	 liver	 bud	 structures	 that	 recapitulate	 some	aspects	 of	 hepatogenesis	 in	 vitro	 and	 that	 can	 further	 mature	 when	 ectopically	transplanted	 in	vivo	 (Takebe	et	al.,	2013).	 In	contrast,	 similar	organotypic	cultures	with	adult-derived	liver	epithelium	have	been	less	successful	thus	far,	 likely	due	to	the	 higher	 diversification	 of	 stromal	 cells	 in	 the	 adult	 organ	 (e.g.	 HSCs,	 portal	fibroblasts,	 LSECs,	 Kupffer	 cells	 and	 lymphocytes)	 and	 the	 difficulty	 of	 expanding	them	in	vitro.		
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1.4 Aims	
Tissue	 regeneration	 is	 a	 cooperative	 and	 timely	 process	 that	 relies	 on	epithelial	and	stromal	cell	responses.	Following	chronic	damage	or	when	hepatocyte	proliferation	is	inhibited,	biliary	duct	cells	expand	in	situ	as	progenitor-like	cells	and	replenish	 the	 lost	 epithelium,	 a	 process	 guided	 by	 stromal-derived	 signalling.	Nonetheless,	 stromal-to-epithelial	 interactions	 are	 inherently	 complex	 to	 study	 in	
vivo,	and	whilst	major	advances	have	been	made	to	culture	hepatic	epithelium	in	vitro	–	including	3D	liver	organoids–	current	models	have	not	been	exploited	to	assess	the	ability	 of	 hepatic	 stromal	 cells	 to	 regulate	 epithelial	 cell	 fate	 as	well	 as	 to	 pursue	organotypic	hepatic	cultures.	Specifically,	in	this	dissertation	I	aim	to:	
a) Identify	candidate	hepatic	stromal	populations	that	behave	as	a	supportive	ductal	cell	‘niche’	during	regeneration,	making	use	of	the	process	of	liver	organoid	formation	in	vitro	as	a	model	of	the	transition	that	ductal	cells	undergo	from	homeostasis	to	regeneration.	We	hypothesise	that	functional	‘niche’	cells	should	be	enriched	in	pro-regenerative	mitogens	and	support	robust	organoid	growth	in	vitro	when	co-cultured	with	homeostatic	ductal	cells	(Figure	1.12-a1).	Candidate	stromal	cells,	and	their	paracrine	signals,	will	then	be	validated	in	vivo	using	animal	models	of	liver	damage	(Figure	1.12-a2).	b) Generate	chimeric	liver	organoid	cultures	that	incorporate	not	only	hepatic	epithelium	but	also	stromal	cells	identified	in	a)	in	an	attempt	to	recreate	the	complexity	of	physical	cell-cell	interactions	in	vivo.		To	facilitate	this,	mouse	and	organoid	reporter	lines	will	be	established	to	keep	track	of	and	inducibly	ablate	the	different	cell	populations	in	vitro	(Figure	1.12-b).	
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Figure	1.12	Aims	of	the	dissertation.	a1)	To	screen	for	hepatic	stromal	cell	populations	that	support	ductal	cell	(DC)	expansion	in	vitro.	Hepatic	stromal	cell	fractions	will	be	sorted	from	healthy	mice	and	co-cultured	with	DC	to	assess	for	enhanced	3D	organoid	formation	in	vitro,	which	models	the	proliferative	transition	of	DC	during	the	regenerative	response.	a2)	To	validate	any	putative	niche	population	identified	in	a1)	using	an	experimental	mouse	model	of	 liver	damage.	b)	To	generate	chimeric	organoids	 that	 incorporate	both	DC	epithelium	and	stromal	cell	types	within	a	single	structure.	
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2.1 Mouse	line	generation	and	maintenance		
All	 mouse	 experiments	 were	 regulated	 under	 the	 Animals	 (Scientific	Procedures)	Act	1986	Amendment	Regulations	2012	following	ethical	review	by	the	University	 of	 Cambridge	Animal	Welfare	 and	Ethical	Review	Body	 (AWERB).	Mice	were	kept	under	standard	handling	procedures	in	a	pathogen-free	environment	with	a	12	h	day/night	cycle.	Sterile	food	and	water	were	given	to	the	animals	ad	libitum.	The	 mouse	 strains	 used	 in	 this	 study	 are	 summarised	 in	 Table	 2.1.	 Hybrid	 lines	containing	two	alleles	were	generated	by	breeding	two	different	stock	strains	with	each	 other	 and	 then	 crossing	 the	 f1	 generation	 to	 obtain	 homozygous	 pups	when	possible.	In	the	case	of	the	Sox2-Cre,	nGFP	and	Sox2-Cre,	mGFP	 lines,	the	respective	parental	 lines	 nTnG	 and	mTmG	 were	 bred	 with	 Sox2-Cre	 mice;	 resulting	 in	 Cre-mediated	excision	of	 the	 tdTomato	cassettes	and	 in-frame	expression	of	GFP	 since	early	on	 in	embryonic	development.	After	confirming	successful	recombination	via	GFP	fluorescence	in	tissue	biopsies,	the	f1	pups	were	bred	further	to	verify	germ	line	transmission.	
2.2 Genotyping	
Mouse	earclips	were	digested	overnight	with	DirectPCR	lysis	reagent	(VIAGEN,	102-T)	and	Proteinase	K	(NEB,	P8107S)	at	60°C.	Their	DNA	was	amplified	through	polymerase	 chain	 reaction	 (PCR)	 using	 the	 GoTaq	 G2	 Flexi	 DNA	 polymerase	(Promega,	 M780B)	 and	 allele-specific	 primers	 detailed	 in	 Table	 2.2	 to	 determine	zygosity	 at	 relevant	 gene	 loci.	 PCR	 products	 were	 analysed	 via	 DNA	 gel	electrophoresis.	
2.3 Liver	damage	by	DDC	administration	
8-12	week	old	mice	were	transferred	to	individual	wheat-free	cages	and	were	fed	 with	 diet	 pellets	 supplemented	 with	 0.1%	 DDC	 (3,5-diethoxycarbonyl-1,4-dihydrocollidine)	(Custom	Animal	diets,	LLC).	The	diet	was	provided	ad	libitum	 for	the	duration	of	the	experiment	(5	days),	after	which	the	mice	were	either	sacrificed	or	switched	back	to	normal	chow	diet	to	allow	recovery.	Weight	loss	was	monitored	throughout	the	course	of	the	diet	and	was	not	allowed	to	surpass	25%.	
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2.4 Lentiviral	production	and	administration	
PGK.GFP	 and	 PGK.GFP.142T	 lentiviral	 vectors	 (LVs)	 were	 produced	 by	transient	 transfection	 in	 293T	 cells	 and	 concentrated	 by	 ultracentrifugation	 as	previously	 described	 (Dull	 et	 al.,	 1998).	 The	 titre	 of	 the	 viruses	 –	 expressed	 as	transducing	units	 (TU)/ml–	was	 calculated	by	 infecting	a	defined	number	of	293T	cells	 with	 serial	 dilutions	 of	 each	 virus	 and	 analysing	 the	 percentage	 of	 GFP	fluorescent	cells	by	flow	cytometry.	Vector	administration	to	mice	was	performed	via	tail	vein	injections.	PGK-GFP	LVs	were	injected	into	pups	(2	days	old)	at	1	x	107	-	2.5	x	 108	 TU/pup,	 whereas	 adult	 mice	 (7	 to	 10	 weeks	 old)	 were	 injected	 with	PGK.GFP.142T	at	1	x	109	-	3	x	109	TU/mouse.	This	work	was	carried	out	by	Dr.	Alessio	Cantore	and	Michela	Milani	in	the	lab	of	Dr.	Luigi	Nadini,	Milan.	
2.5 Liver	 ductal	 tree	 isolation	 and	 fluorescence	 activated	
cell	sorting	(FACS)	
Livers	were	harvested	from	8-10	week	old	male	mice	and	washed	thoroughly	in	phosphate	buffer	saline	(PBS)	to	remove	non-resident	cell	populations.	The	tissue	was	placed	on	a	petri	dish	to	dissect	out	the	gall	bladder	and	to	mince	it	with	a	razor	blade	until	small	pieces	of	~1	mm3	were	obtained.	Enzymatic	digestion	was	carried	out	 for	 3-4	 hours	 at	 37°C	 and	 constant	 shaking	 with	 a	 solution	 (25	 ml/liver)	containing	0.0125%	(mg/ml)	collagenase	(SIGMA,	C9407),	0.0125%	(mg/ml)	dispase	II	 (GIBCO,	 17105-041)	 and	 1%	 foetal	 bovine	 serum	 (FBS)	 (GIBCO)	 in	DMEM/Glutamax	(GIBCO,	31966-021)	supplemented	with	Hepes	(Invitrogen,	15630-056)	 and	 Penicillin/Streptomycin	 (Invitrogen,	 15140-122).	 Halfway	 through	 the	incubation	period,	the	tissues	were	mechanically	disrupted	by	pipetting,	spun	down	at	100	g	for	5	min,	and	incubated	with	fresh	enzymatic	solution.	The	progress	of	the	digestion	was	monitored	regularly	by	aliquoting	small	volumes	of	 the	solution	and	inspecting	whether	ductal	tree	fragments	were	visible	under	the	microscope.	After	3-4	hours,	the	duct-enriched	tissue	was	digested	into	single	cells	by	incubating	with	5	ml	 of	 TrypLE	 5x	 (Gibco,	 A12177-01)	 for	 10	 min.	 The	 solution	 was	 filtered	 twice	through	a	40	μm	strainer	and	cells	were	quantified	using	a	haemocytometer.	Cells	were	collected	into	polypropylene	FACS	tubes	(Falcon,	352063),	blocked	with	2%	FBS	
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DMEM/Glutamax	 for	 10	 min	 at	 4°C	 and	 incubated	 with	 fluorophore-conjugated	antibodies	(Table	2.3)	for	30	min	at	4°C,	at	a	concentration	of	1	μl	of	antibody/1	x	106	cells	 in	 1	 ml	 of	 1%	 FBS	 DMEM/Glutamax.	 After	 two	 washes	 in	 1%	 FBS	DMEM/Glutamax,	cells	were	sorted	with	a	MoFlo	3	machine	(Beckman	Coulter)	and	collected	into	eppendorf	tubes	containing	AdDMEM/F12	(GIBCO,	12634-010)	with	10	μM	 ROCK	 inhibitor	 (Ri)	 (Y-27632,	 AbMole).	 Organoid-forming	 ductal	 cells	 were	sorted	 as	EpCAM+CD45-CD11b-CD31-,	whereas	 stromal	 fractions	were	EpCAM-	and	positive/negative	for	additional	markers	as	detailed	in	results.	
2.6 Organoid	and	mesenchymal	cell	maintenance	
All	 cells	 were	 maintained	 in	 a	 humidified	 incubator	 at	 37°C	 and	 5%	 CO2.	Organoids	were	 cultured	 in	AdDMEM/F12	 (Invitrogen)	medium	containing	Hepes,	Penicillin/Streptomycin,	 Glutamax	 (Invitrogen,	 35050-068),	 1%	 B27	 (Invitrogen,	17504-044),	1%	N2	(Invitrogen,	17502-048)	and	1.25	mM	N-acetylcysteine	(Sigma-Aldrich,	 A9165)	 –referred	 to	 as	 Basal	medium–,	which	was	 further	 supplemented	with	10	nM	gastrin	(Sigma-Aldrich,	G9145),	50	ng/ml	mEGF	(Invitrogen,	PMG8043),	5%	RSPO1	conditioned	medium	(homemade),	100	ng/ml	FGF10	(Peprotech,	100-26),	10	mM	nicotinamide	(Sigma-Aldrich,	N0636)	and	50	ng/ml	HGF	(Peprotech,	100-39)	–referred	 to	 as	 expansion	 medium	 (EM).	 Following	 isolation,	 EpCAM+	 cells	 were	cultured	 in	 EM	 supplemented	 with	 30%	 WNT	 conditioned	 medium	 (WNT	 CM)	(homemade)	and	25	ng/ml	Noggin	(Peprotech,	120-10C)	for	3	days	and	were	then	switched	 to	 standard	 EM.	 Other	medium	 compositions	were	 created	 by	 removing	specific	growth	factors	mentioned	above.	In	all	experiments	where	cells	were	seeded	as	single	cells	(e.g.	after	sorting),	10	μM	of	ROCK	inhibitor	(Ri)	was	included	in	the	medium	to	promote	cell	survival.	Organoids	were	passaged	at	a	1:3	ratio	once	a	week	or	 when	 fully	 grown	 through	 mechanical	 dissociation	 –repeated	 pipetting	 with	 a	narrowed	glass	Pasteur	pipette–	and	were	re-seeded	in	fresh	matrigel	bubbles.	SCA1+	and	SCA1-	mesenchymal	cells	were	cultured	in	Basal	+	WNT	CM	medium	and	were	passaged	at	1:3	and	1:2	ratios,	respectively,	through	enzymatic	digestion	with	TrypLE	Express	(Gibco,	12605-010)	for	5	min	at	37°C.	
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2.7 Co-cultures	and	conditioned	medium		
2.7.1 Within-matrigel	drop	co-culture	
Freshly	 sorted	 ductal	 (EpCAM+CD45-CD11b-CD31-)	 and	 stromal	 cell	populations	were	mixed	-unless	stated	otherwise-	in	a	1:5	ratio	(5000:	25000	cells),	spun	down	at	300	g	for	5	min	and	seeded	into	three-dimensional	droplets	(25	μl)	of	matrigel	on	48	well	plates	(Starlab,	CC7682-7548).	Cultures	were	maintained	in	Basal	+	WNT	CM	medium	and	analysed	at	d8-d10.	Of	note,	this	culture	method	resulted	in	limited	physical	contact	between	stromal	and	ductal	cells.	
2.7.2 Transwell	co-culture	
Freshly	sorted	mesenchymal	cells	were	seeded	on	the	bottom	of	24	transwell-fitting	plates	(Corning,	3470)	and	cultured	in	Basal	+	WNT	CM	medium	for	5-7	days	until	reaching	80-90%	confluency.	Freshly	sorted	EpCAM+	cells	were	then	seeded	on	top	on	cell-impermeable	transwell	inserts	within	a	25	μl	drop	of	matrigel.	Both	the	top	and	bottom	compartments	of	the	transwell	were	maintained	in	Basal	or	Basal	+	WNT	CM	medium	and	analysed	at	d8-d10	after	ductal	cell	seeding.		
2.7.3 Conditioned	medium	
Sorted	 mesenchymal	 cells	 were	 expanded	 (up	 to	 passage	 2	 or	 3)	 on	 cell	culture-treated	 plates	 in	 Basal	 +	 WNT	 CM	 medium.	 When	 reaching	 80-90%	confluency,	cells	were	washed	twice	with	PBS	and	fresh	Basal	+	WNT	CM	medium	was	added	for	conditioning.		After	48	h,	the	medium	was	collected,	spun	down	at	500	g	for	10	 min	 to	 remove	 any	 cell	 debris	 and	 stored	 at	 4°C	 as	 ready-to-use	 conditioned	medium.	
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2.8 Cell-cell	aggregation	
2.8.1 Encapsulation-based	cell	aggregation	
Ductal	 and	mesenchymal	 cells	were	 co-encapsulated	 into	microgels	 using	 a	microfluidic	 flow	 focusing	 device	 (FFD)	 previously	 described	 (Anna,	 Bontoux	 and	Stone,	2003)	(Figure	2.1).	Chips	were	designed	to	contain	two	separate	inlets	for	the	loading	 of	 two	 distinct	 cell	 populations	 (in	 aqueous	 phase),	 one	 inlet	 for	 the	continuous	phase	(fluorinated	oil	HFE-7500	containing	0.3%	PicoSurf	surfactant)	and	one	outlet.	To	maximize	cell-to-cell	proximity,	the	cross	geometry	of	the	chip	where	droplet	 formation	 occurs	was	 limited	 to	 a	width	 of	 70	μm	 and	 a	 height	 of	 75	μm.	EpCAM+	ductal	cells	and	SCA1+	mesenchymal	cells	were	isolated	from	nGFP	and	nTnG	mice,	respectively	or	viceversa,	and	were	expanded	in	vitro	as	detailed	in	Section	2.6.	Each	population	was	then	harvested	through	TrypLE	digestion	at	37°C	-10	min	for	the	organoids,	5	min	for	the	SCA1+	mesenchyme-,	passed	through	a	40	μm	cell	strainer	and	resuspended	as	0.75	x	106	cells/50	μl	of	Basal	+	WNT	CM	+	Ri	medium.	The	ductal	and	mesenchymal	cell	suspensions	were	mixed	with	3%	SeaPrep®	agarose	solution	in	a	volume	ratio	of	1:1	(both	at	37	°C)	and	were	loaded	onto	two	100	μl	glass	syringes	connected	to	tubings,	which	were	in	turn	affixed	to	the	two	aqueous	phase	inlets	of	the	FFD.	A	second	syringe	was	prepared	containing	the	continuous	phase.	The	flow	rates	for	the	production	of	mono-dispersed	micro	gels	were	controlled	using	syringe	pumps	(neMESYS).	A	flow	rate	of	3	μl/min	was	used	for	the	aqueous	phase	and	a	flow	rate	of	30	μl/min	for	the	continuous	phase.	The	resulting	microgel/cell	emulsion	was	collected	in	an	ice-cooled	test	tube	and	was	demulsified	into	200	µl	of	Basal	+	WNT	CM	medium.	For	 live	 imaging	of	 the	cells,	μ-slide	8	well	dishes	(ibidi,	80826)	were	layered	 with	 130	 μl	 of	 ice-cold	 matrigel/well	 and	 10-15	 μl	 of	 the	 microgel/cell	suspension	was	seeded	within	each	well.	The	cultures	were	maintained	 in	Basal	+	WNT	CM	medium.	This	work	was	carried	out	in	collaboration	with	Timo	Kohler	from	the	labs	of	Dr.	Florian	Hollfelder	and	Dr.	Kevin	Chalut,	University	of	Cambridge.	
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Figure	2.1.	Double	 inlet	microfluidic	 flow	 focusing	device	
(FFD)	 for	 controlled	 co-encapsulation	 of	 cells	 into	
monodisperse	microgels.	 The	 device	 contains	 two	 separate	inlets	for	the	 loading	of	two	distinct	cell	populations	(Input	A	and	 Input	 B,	 in	 aqueous	 phase),	 one	 inlet	 for	 the	 continuous	phase	 (oil)	 and	 one	 outlet.	Droplet	 formation	 occurs	 through	non-miscibility	 at	 a	 point	 (indicated	 by	 arrow)	 with	 a	 cross	geometry	 of	 70	μm	 width	 and	 75	μm	 height.	 Cells	 are	 thus	encapsulated	within	 small-sized	 droplets	 that	 are	 induced	 to	polymerise	 into	 microgels	 (in	 the	 case	 of	 agarose,	 via	 ice-cooling).	
2.8.2 2D	matrigel	cell	aggregation		
As	outlined	in	Section	2.5,	EpCAM+	ductal	cells	and	SCA1+	mesenchymal	cells	were	 isolated	 from	 fluorescently	 labelled	 mice	 and	 were	 either	 used	 directly	 for	aggregation	or	expanded	in	vitro	prior	to	being	aggregated	(stated	in	each	case).	Cells	were	 harvested	 via	 TrypLE	 digestion	 and	mixed	 in	 the	 following	mesenchyme-to-ductal	 cell	 ratios:	 0:1,	 0.1:1,	 0.5:1,	 1:1,	 5:1	 and	10:1.	After	mixing,	 cells	were	 spun	down	at	300	g	for	5	min	and	were	seeded	on	top	of	a	2D-layer	of	solidified	matrigel	covering	the	bottom	of	the	well.	Medium	of	choice	(EM	+	WNT	CM	or	Basal	+	WNT	CM)	was	then	added	on	top.	The	total	number	of	ductal	cells	used	was	5,000	or	10,000	and	the	matrigel	layer	50	μl	or	100	μl,	when	seeding	onto	96-well	or	48-well	plates,	respectively.	We	observed	that,	contrary	to	the	within-matrigel	drop	co-culture,	this	method	promotes	mesenchyme-to-ductal	cell	aggregation	very	efficiently.	
2.9 Colony	formation	and	organoid	size	quantification	
Organoid	formation	efficiency	was	quantified	by	counting	the	total	number	of	lumen-containing	organoid	structures	inside	the	matrigel	bubble	after	8-10	days	in	culture	 and	 normalising	 it	 by	 the	 total	 number	 of	 EpCAM+	 cells	 seeded	 (typically	
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5000).	Corrections	were	made	to	account	for	any	‘contaminant’	EpCAM+	cells	present	in	the	niche	fraction	(see	Results).	Organoid	size	was	quantified	with	a	custom-made	Fiji	macro	designed	by	Richard	Butler.	
2.10 Tissue	processing	and	cryostat	sectioning		
Tissues	 expressing	 fluorescent	 reporters	 were	 imaged	 with	 a	 stereoscope	prior	to	being	processed.	Livers	were	washed	in	PBS,	diced	with	a	razor	blade	and	fixed	overnight	in	10%	formalin	whilst	rolling	at	4°C.	Small	intestines	were	flushed	once	with	PBS	to	remove	their	faecal	content	and	then	with	formalin	10%;	overnight	fixation	was	 carried	out	 as	 for	 the	 livers.	 Tissues	were	washed	 thrice	with	PBS	 to	remove	any	traces	of	the	fixative	and	were	incubated	with	30%	sucrose	PBS	for	24-48	h	whilst	rolling	at	4°C.	Liver	pieces	(up	to	3	per	mould)	or	short	sections	of	the	small	 intestine	 were	 placed	 into	 cryomoulds	 (Sakura,	 4566),	 layered	 with	 OCT	compound	(VWR,	361603E)	and	frozen	on	dry	ice.	Tissue	blocks	were	either	stored	at	-80C	or	cut	with	a	Leica	CM-3050S	cryostat	into	8	μm	sections	that	were	mounted	onto	SuperFrost	Plus	slides	(VWR,	631-0108)	for	further	staining.	
2.11 Immunostaining,	confocal	imaging	and	cell	counting	
Cells	 were	 fixed	 with	 ice-cold	 4%	 paraformaldehyde	 (PFA)	 (Electron	Microscopy	 Sciences,	 15713-S)	 for	 30	min	 and	 blocked/permeabilised	 for	 2h	 in	 a	buffer	–	referred	to	as	PBSTD	-	containing	0-1%	Triton	X-100	(SIGMA,	T8787),	2%	dimethyl	sulfoxide	(SIGMA,	D8418),	1%	bovine	serum	albumin	(BSA,	A8806)	and	2%	donkey	serum	(SIGMA,	D9663)	diluted	in	PBS.	Triton	concentration	was	optimised	according	to	the	subcellular	localisation	of	the	protein	of	interest:	0%	for	membrane-bound,	 0.3%	 for	 cytoplasmic	 and	 1%	 for	 nuclear.	 Primary	 antibodies	were	 added	overnight	at	4°C	in	1:100-diluted	PBSTD	buffer	and	were	washed	three	times	prior	to	adding	secondary	antibodies	for	2h	at	room	temperature	in	PBS-0.05%	BSA.	Nuclei	were	 counterstained	 with	 Hoechst	 33342	 (Thermo	 Scientific,	 H3570)	 for	 10	min.	Frozen	tissue	sections	generated	as	in	Section	2.10	were	stained	similarly,	ignoring	the	 initial	 fixation	step.	For	 the	complete	 list	of	primary	and	secondary	antibodies	used	 refer	 to	 Table	 2.3	 and	Table	 2.4,	 respectively.	 Images	were	 acquired	 using	 a	confocal	 microscope	 (Leica	 SP5)	 and	 processed	 using	 Volocity	 software	
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(PerkinElmer)	or	ImageJ	software.	Cell	populations	were	quantified	using	the	ImageJ	plugin	‘cell	counter’.	
2.12 EdU	incorporation	
EdU	 incorporation	 experiments	 were	 performed	 using	 the	 Click-iT®	 EdU	Alexa	Fluor®	594	or	647	Imaging	Kit	(C10339,	Life	Technologies)	according	to	the	manufacturer’s	 protocol.	 Cells	 were	 incubated	 for	 16h	 with	 10	 μM	 EdU	 in	 their	respective	 culture	 medium,	 after	 which	 they	 were	 fixed	 in	 4%	 PFA	 for	 30	 min,	permeabilised	 with	 0.5%	 Triton	 X-100	 for	 20	 min	 and	 incubated	 with	 freshly	prepared	 1X	 Click-iT™	 EdU	 cocktail	 (Life	 Technologies)	 for	 30	 min	 at	 room	temperature.	Nuclei	were	stained	with	Hoechst	33342	(Life	Technologies)	for	15	min.	
2.13 qRT-PCR	
Total	RNA	was	extracted	from	cells	using	the	Arcturus	PicoPure	RNA	Isolation	Kit	 (Applied	 Biosystems,	 12204-01)	 according	 to	 the	 manufacturer’s	 protocol;	including	a	15	min	digestion	step	with	DNAse	to	remove	traces	of	genomic	DNA.	The	RNA	(50-250	ng)	was	reverse-transcribed	with	the	Moloney	Murine	Leukemia	Virus	reverse	 transcriptase	 (M-MLVRT)	 (Promega,	M368B)	 and	was	 amplified	 using	 the	iTaq™	Universal	SYBR®	Green	Supermix	(Bio-Rad)	on	the	CFX	Connect™	Real-Time	PCR	Detection	System	(Bio-Rad).	The	list	of	primers	used	for	qRT-PCR	is	summarised	in	Table	2.5.	Gene	expression	levels	were	normalised	to	the	housekeeping	gene	Hprt1.		
2.14 RNA	sequencing	and	bioinformatic	analysis	
Liver	 ductal	 tree	 isolations	 were	 performed	 as	 in	 Section	 2.5.	 For	 the	sequencing	 of	 duct-associated	 stroma,	 populations	 were	 sorted	 from	 the	 healthy	livers	 of	 two	 littermates	 as:	 ductal	 (EpCAM+	 CD45-	 CD11b-	 CD31-),	hematopoietic/endothelial	 (CD45+	 CD11b+	 CD31+	 EpCAM-)	 and	 mesenchymal-enriched	(CD45-	CD11b-	CD31-	EpCAM-),	all	of	which	were	further	sorted	based	on	SCA1	staining	(SCA1+	and	SCA1-).	For	the	sequencing	of	cells	in	culture,	mesenchymal	(SCA1+CD45-CD11b-CD31-EpCAM-)	 cells	 from	 two	 littermates	 were	 lysed	 as	 t=0	controls	 or	 were	 cultured	 on	 the	 bottom	 of	 24	 transwell-fitting	 plates	 (50000	
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cells/well)	 for	 7	 days	 in	 Basal	 +	WNT	 CM	medium;	 after	 which	 they	 were	 either	cultured	alone	or	together	with	freshly	sorted	ductal	(EpCAM+	CD45-	CD11b-	CD31-)	cells	from	two	additional	littermates	seeded	on	a	cell-impermeable	transwell	insert	(5000	cells/matrigel	bubble)	 	 (as	 in	Section	2.7.3)	 for	15	days	 in	Basal	+	WNT	CM	medium.	As	 controls,	 ductal	 cells	 from	 the	 same	preparation	were	 lysed	 at	 t=0	 or	seeded	in	EM	without	any	mesenchymal	cells	and	collected	at	day	15.	Total	RNA	was	extracted	 from	 all	 samples	 with	 the	 Picopure	 RNA	 Extraction	 Kit	 according	 to	manufacturer’s	instructions	(including	DNAse	digestion).		RNA	libraries	were	prepared	using	Smartseq2	(Picelli	et	al.,	2014)	and	were	sequenced	 on	 an	 Illumina	HiSeq	 4000	 instrument	 in	 single	 read	mode	 at	 50	 base	length.	FastQC	(version	0.11.4)	was	used	for	initial	quality	control	of	the	reads.	Sickle	(version	1.33)	and	Trim	Galore	(0.4.4)	were	used	for	quality	and	adapter	trimming	of	the	raw	reads	respectively.	Reads	were	 then	mapped	 to	 the	GRCm38/mm10	UCSC	reference	genome	using	STAR	aligner	(version	2.5.0a).	Raw	counts	were	generated	using	featureCounts	(version	1.6.0)	software	and	includes	all	exons	for	a	gene	from	the	mm10	UCSC	GTF	 file	 (http://genome.ucsc.edu/cgi-bin/hgTables).	RPKMs	were	generated	 with	 raw	 counts	 and	 gene	 lengths	 reported	 by	 featureCounts	 package.	RPKMs	were	used	for	clustering	and	PCA	analysis	using	‘hclust’	and	‘prcomp’	R	Core	Packages.	Heatmaps	were	prepared	based	on	scaled	RPKM	values	using	the	Clustvis	software	(https://biit.cs.ut.ee/clustvis/).	Genes	at	RPKM	<1.0	were	considered	non-expressed	and	were	excluded	from	the	analyses.		.	
2.15 Time-lapse	imaging	and	video	processing	
Time-lapse	 imaging	 of	 cells	 was	 carried	 out	 at	 37°C	 and	 5%	 CO2	 for	 24h-periods.	For	quantification	purposes,	we	used	a	20x	air	lens	on	a	confocal	spinning-disk	 microscope	 system	 (Intelligent	 Imaging	 Innovations,	 Inc.	 3i)	 comprising	 an	Observer	Z1	inverted	microscope	(Zeiss),	a	CSU	X1	spinning	disk	head	(Yokogawa),	and	 a	 QuantEM	 512SC	 camera	 (Photometrics).	 Imaging	was	 performed	 at	 15	min	intervals,	with	a	z-step	of	7	μm,	a	z-range	of	100	μm	and	laser	power	of	up	to	20%.	For	higher	image	resolution,	we	used	a	10x	air	lens	on	a	Zeiss	710	confocal	microscope	
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and	imaged	at	15	min	intervals,	with	a	z-step	of	9	μm,	a	z-range	of	100	μm	and	1024	x	1024	bidirectional	scanning.	Videos	were	generated	with	the	Slidebook6	software	and	were	analysed	with	the	ImageJ	software.		
2.16 Flow	cytometry	
Single	cell	suspensions	were	prepared	via	trypsinisation	(as	detailed	in	Section	2.8.1),	blocked	in	2%	FBS	DMEM/Glutamax	and	stained	with	fluorophore-conjugated	antibodies	(Table	1)	diluted	in	1%	FBS	DMEM/Glutamax	for	30	min	at	4°C.	Antibody	staining	was	omitted	in	cells	encoding	fluorescent	reporters.	Cells	were	washed	once	in	 1%	 FBS	 DMEM/Glutamax	 and	 were	 resuspended	 in	 1%	 FBS	 DMEM/Glutamax	containing	DNAse	at	0.1	mg/ml	(Sigma	Aldrich,	DN25)	for	analysis	with	a	BD	Fortessa	machine.	 	 Unstained	 or	 non-fluorescent	 cells	were	 used	 as	 controls	 for	 setting	 up	gating	parameters.		
2.17 Viability/cytotoxicity	assay		
Cell	viability	was	assessed	using	the	Viability/Cytotoxicity	Assay	Kit	for	Animal	Live	&	Dead	Cells	(30002-T,	Biotum).	Matrigel-embedded	cells	were	washed	twice	in	PBS	and	were	 incubated	with	2	μM	calcein	AM/4	μM	EthD-III	 for	30	min	at	 room	temperature	as	indicated	in	the	manufacturer’s	protocol.	The	staining	solution	was	then	 replaced	 with	 fresh	 medium	 and	 the	 cells	 were	 imaged	 using	 a	 confocal	microscope	(Leica,	Sp5).	The	calcein	and	EthD-III	dyes	were	excited	using	the	488	and	568	lasers	respectively.	The	percentage	of	live	and	dead	cells	was	quantified	using	the	ImageJ	software.		
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2.18 	Statistics	
Data	were	analysed	using	the	Mann–Whitney	non-parametric	test.	P<0.05	was	considered	statistically	significant.	P<0.05	(*),	P<0.01	(**),	P<0.001	(***),	P<0.0001	(****).	Calculations	were	performed	using	the	Prism	6	software	package.
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Table	2.5	List	of	qPCR	primers	
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3.1 Isolation	of	primary	ductal	cells	and	associated	stromal	
populations	in	the	liver		
The	liver	tissue	may	be	subdivided	into	histological	subunits	known	as	lobules,	which	span	from	the	portal	triad	–encompassing	the	portal	vein	(PV),	hepatic	artery	(HA)	and	biliary	duct	(BD)–	to	the	central	vein	(CV)	area.	In	between,	hepatocytes	are	arranged	in	linear	cords	and	are	irrigated	by	a	capillary	network	of	liver	sinusoidal	endothelial	cells	(LSECs)	(Figure	3.1A).	
	
Figure	 3.1.	 The	 cellular	microenvironment	 of	 the	 biliary	 duct	 epithelium	 in	 the	 liver.	 A)	 Schematic	depicting	a	cross	section	of	the	liver	lobule,	which	spans	from	the	central	vein	to	the	portal	triad.	The	biliary	duct	epithelium	lies	next	to	the	portal	vein	and	is	surrounded	by	a	mixture	of	endothelial,	hematopoietic	and	mesenchymal	cells.	B)	 Immunostainings	of	healthy	liver	frozen	sections	with	antibodies	against	biliary	duct	cells	(OPN,	PCK),	endothelial	cells	(CD31),	hematopoietic	cells	(CD45,	F4/80)	and	mesenchymal	cells	(Desmin).	PV:	portal	vein,	CV:	central	vein,	BD:	biliary	duct.	
Given	that	biliary	duct	cells	can	be	activated	upon	damage	into	a	progenitor-like	 state,	 and	 that	 a	 niche	 cell	 is	 defined	 by	 its	 proximity	 to	 the	 progenitor	compartment,	we	were	interested	in	studying	the	stromal	cells	that	reside	around	the	biliary	duct	network.	In	homeostasis,	the	most	proximal	microenvironment	of	ductal	cells	 –labelled	 by	 osteopontin	 (OPN)	 or	 pancytokeratin	 (PCK)–	 is	 composed	 of	
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leukocytes	(CD45+),	liver	resident	macrophages	or	Kupffer	cells	(F4/80+),	endothelial	cells	lining	the	portal	vein	(CD31+)	and	mesenchymal	cells	lining	both	the	vein	and	the	biliary	duct	itself	(Desmin+)	(Figure	3.1B).	To	 assess	 the	putative	niche	potential	 of	 these	diverse	 cell	 populations,	we	sought	to	isolate	them	from	the	tissue	and	study	them	ex	vivo.	Previous	work	from	our	laboratory	had	established	a	method	of	primary	biliary	tree	 isolation	to	grow	liver	organoids	 in	vitro	(Huch	et	al.,	2013).	Because	the	isolation	procedure	unavoidably	entails	 the	 co-extraction	 of	 biliary	 associated	 stroma	 –	 previously	 regarded	 as	‘contaminant’	 cells–	 we	 adapted	 the	 protocol	 to	 now	 preserve	 this	 non-epithelial	compartment	instead	of	discarding	it.	In	accordance,	murine	livers	are	first	digested	enzymatically	with	a	collagenase	and	dispase	mixture	until	enriching	for	biliary	duct	fragments	and	a	mixture	of	stromal	cells.	After	further	digestion	with	TrypLE,	a	final	suspension	 of	 single	 cells	 is	 FACS-sorted	 using	 fluorophore-conjugated	 antibodies	(Figure	3.2A).	
	
Figure	3.2	Isolation	strategy	of	primary	biliary	and	stromal	cell	populations	from	the	homeostatic	liver.		
A)	Schematic	depicting	 the	process	 of	 primary	 liver	 cell	 isolation.	 Livers	 are	harvested	 from	mice,	washed	thoroughly	and	digested	enzymatically	with	collagenase	and	dispase	in	order	to	enrich	for	biliary	ducts	and	their	associated	stroma.	The	tissue	is	further	processed	into	single	cells	and	FACS–sorted	with	cell-type	specific	antibodies.	B)	Live	cells	were	gated	based	on	their	forward	and	side	scatter	profile	(R1),	and	were	sorted	as	ductal	 cells	 (DC;	 EpCAM+CD45-CD11b-CD31-),	 hematopoietic/endothelial	 cells	 (H/E;	 EpCAM-CD45+CD11b+CD31+)	and	mesenchymal	cells	(Msc;	EpCAM-CD45-CD11b-CD31-).	
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Dead	cells	and	debris	are	excluded	through	forward	and	side	scatter	gating,	and	cells	are	parsed	out	according	to	their	expression	of	a	panel	of	 lineage-specific	cell	surface	markers:	EpCAM,	CD45,	CD11b	and	CD31.	As	in	Huch	et	al.,	EpCAM+	CD45-,	CD11b-,	CD31-	cells	correspond	to	the	ductal	cell		(DC)	population	(Figure	3.2B,	green	gate)	(Huch	et	al.,	2013).	We	defined	the	remaining	cells	as	putative	niche	populations	and	divided	them	into	two	broad	categories:	CD45+CD11b+CD31+EpCAM-	cells	of	the	hematopoietic/endothelial	(H/E)	 lineage	(Figure	3.2B,	blue	gate)	and	CD45-CD11b-CD31-EpCAM-	 cells,	 hypothesised	 to	 be	 predominantly	 mesenchymal	 (Msc)	 from	lineage	exclusion	(Figure	3.2B,	orange	gate).	
	
Figure	 3.3	 Biliary-associated	 stroma	 can	 be	 subdivided	 into	 hematopoietic/endothelial	 (H/E)	 and	
mesenchymal	(Msc)	cell	populations.	A)	qPCR	analysis	of	lineage-specific	(DC,	H/E,	Msc)	genes	expressed	by	the	 sorted	 populations	 in	 Fig3.2B.	 2∆Ct	 values	 are	 normalised	 to	 the	 housekeeping	 gene	 Hprt	 and	 are	represented	as	fold	change	relative	to	the	DC	fraction.	N=2	independent	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	 SD.	The	H/E	 fraction	 is	 enriched	 in	markers	of	 the	hematopoietic	 (Ptprc,	 Itgam,	
Adgre1)	and	endothelial	(Pecam1,	Cdh5,	Flt4,	Kdr)	lineage;	the	Msc	population	expresses	many	mesenchymal-associated	 genes	 (Acta2,	 Thy1,	 Desmin,	 Gfap,	 Vimentin)	 but	 also	 some	 endothelial	 and	 hepatocyte	markers.	
B)	Brightfield	pictures	of	the	sorted	cells	in	Fig3.2B	following	in	vitro	culture	(3D	matrigel,	EM	medium,	d7).	The	DC	fraction	gives	rise	to	organoids,	whereas	the	H/E	grows	predominantly	as	small	round	cells	and	the	Msc	population	as	larger	fibroblastic-looking	cells.	
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The	 cellular	 identities	 of	 the	DC,	H/E	 and	Msc	 populations	were	 confirmed	through	qPCR	analysis	of	 a	battery	of	 lineage-specific	genes	 (Figure	3.3A)	and	cell	morphology	 after	 in	 vitro	 culturing	 (Figure	 3.3B).	 As	 expected,	 the	 DC	 population	expresses	the	ductal	marker	Krt19	–but	not	any	stromal	genes–	and	gives	rise	to	3D	epithelial	 organoids	 in	 vitro.	 H/E	 cells	 exhibit	 high	 expression	 of	 hematopoietic-specific	 genes	 like	 Ptprc	 (CD45),	 Itgam	 (CD11b)	 and	 Adgre1	 (F4/80),	 as	 well	 as	endothelial	genes	such	as	Pecam1	 (CD31),	 Cdh5	 (VE-cadherin),	Kdr	 (VEGFR2),	 and	
Flt4	(VEGFR3);	morphologically	the	H/E	fraction	grows	as	colonies	of	small	spherical	cells.	 The	 Msc	 population	 expresses	 various	 mesenchymal	 genes	 including	 Acta2	(αSMA),	Thy1,	Desmin,	Vim	and	Gfap;	yet	also	 the	endothelial	markers	Pecam1	and	
Cdh5	(to	a	lesser	extent	than	H/E	cells)	and	Alb	(Albumin),	a	hepatocyte-specific	gene.	Although	 this	suggests	a	percentage	of	contaminating	cells	 in	 the	Msc	 fraction,	 the	population	 grows	 predominantly	 with	 large	 and	 fibroblast-like	 morphology,	indicating	prevalence	of	the	mesenchymal	lineage	in	vitro.	Whilst	our	organoid	culture	medium	(EM)	allows	the	long-term	expansion	of	DC-derived	progenitors,	 in	 vitro	 growth	of	 primary	 cells	 is	 challenging	 and	 can	be	greatly	influenced	by	medium	composition.	We	thus	tested	the	viability	of	the	primary	H/E	and	Msc	lineages	in	various	medium	compositions	(Basal,	Basal	+	WNT	CM,	Basal	+	 3%	 FBS	 and	 EM)	 using	 a	 live-dead	 assay	 that	 was	 first	 validated	 in	 human	mesenchymal	stem	cells	(hMSCs)	(Figure	3.4).		
	
Figure	3.4	Validation	of	the	cell	viability	assay.	Viability	staining	of	live	or	heat-killed	hMSCs	incubated	with	various	concentrations	of	Calcein	(green)	and	EthD-III	(red),	which	label	live	and	dead	cells	respectively.	The	concentration	of	4μM	calcein	AM	/	8μM	EthDII	was	selected	for	further	experiments.	
At	d2	of	culture,	H/E	cells	survive	best	in	Basal	+	WNT	CM	and	Basal	+	3%	FBS	medium,	with	close	to	40%	of	live	cells;	although	by	d7	survival	drops	and	Basal	+	
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WNT	CM	proves	the	best	medium	with	only	20%	survival	(Figure	3.5A,B).	The	Msc	cells	overall	survive	better	than	the	H/E	fraction	and	grow	best	in	Basal	+	WNT	CM	both	at	d2	and	d7	with	~40-50%	survival	(Figure	3.5A,B).	
Figure	3.5	Cell	viability	of	H/E	
and	Msc	populations	in	vitro.			
A)	 Quantification	 of	 cell	viability	of	the	H/E	and	Msc	cell	populations	in	various	medium	conditions	 at	 d2	 and	 d7	 of	culturing.	N=2	mice,	2	technical	replicates	per	mouse,	error	bars	denote	 mean	 ±	 SD.	 B)	Representative	 pictures	 of	 the	live-dead	staining	quantified	in	A)	at	d7	of	culture.	The	Calcein	(green)	 and	 EthD-III	 (red)	stains	denote	live	and	dead	cells	respectively.	
.
3.2 Co-culturing	 ductal	 cells	 with	 mesenchymal	 or	
hematopoietic/endothelial	populations	enhances	organoid	
formation	
In	 vivo,	 a	 niche	 cell	 that	 supports	 ductal-driven	 regeneration	 would	 be	expected	to	modulate	ductal	cell	behavior	in	terms	of	activation,	proliferation	and/or	differentiation.	We	thus	assessed	the	niche	potential	of	the	H/E	and	Msc	cells	based	on	 their	 ability	 to	 support	 the	 formation	of	DC-derived	organoids	 in	 vitro.	 Freshly	sorted	cells	were	cultured	as	follows:	DC	alone	(5000),	H/E	or	Msc	cells	alone	(25000)	and	DC	+	H/E	or	Msc	cells	co-cultured	together	(5000:25000)	(Figure	3.6A).	When	grown	 in	 the	standard	organoid	medium	(EM),	 the	DC	 fraction	generates	organoid	structures	 at	 an	 expected	mean	 efficiency	 of	 3.6%	 and	 a	median	 organoid	 area	 of	
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0.0024	mm2.	Co-culturing	DC	with	the	stromal	populations,	particularly	the	Msc	cells,	showed	a	trend	towards	increased	organoid	formation	efficiency	(up	to	5.9%)	(Figure	3.6B,C).	The	median	organoid	 area	was	 significantly	 augmented	 (Figure	3.6D)	 and	organoids	were	characterised	by	a	higher	percentage	of	proliferative	cells	as	judged	from	EdU	incorporation	(Figure	3.6E,F).	Of	note,	organoid	growth	was	detected	in	the	H/E	or	Msc	only	controls	at	an	efficiency	of	0.175%	and	0.38%,	respectively.	This	is	likely	due	to	contaminating	DC	cells	from	the	sort	(~	3%	verified	by	purity	check,	data	not	shown)	and	was	corrected	for	in	subsequent	co-culture	quantifications.	
	
Figure	3.6	Establishing	co-cultures	between	ductal	cells	and	H/E	or	Msc	populations.	A)	Schematic	of	co-culture	strategy:	5000	freshly	sorted	DC	are	either	cultured	on	their	own	or	with	25,000	primary	H/E	or	Msc	cells	within	a	matrigel	bubble	in	EM.	H/E	or	Msc	cells	(25,000)	are	also	cultured	on	their	own	as	controls.	B)	Brightfield	pictures	of	organoids	formed	within	the	matrigel	droplets	after	8	days	of	culture.	C)	Quantification	of	organoid	formation	efficiency	in	B).	Results	are	expressed	as	percentage	of	organoids	formed	with	respect	to	total	DC	seeded	(5000).	In	the	case	of	the	H/E	and	Msc	fractions,	organoid	formation	was	calculated	based	on	25000	cells	seeded.	N=3	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	D)	Quantification	of	 organoid	 area	 (mm2)	 in	 B).	 N=3	mice,	 2	 technical	 replicates.	 Values	 are	 plotted	 on	 a	 log	 scale	 and	 are	represented	as	violin	plots,	which	denote	population	density.	The	box	plots	within	 represent	 the	median	+	upper	and	lower	quartiles;	the	lines	denote	the	range	of	values	and	the	dots	are	outliers	defined	to	be	greater	than	1.5	interquartile	ranges	(IQR)	from	the	median.	E)	EdU	immunostaining	of	DC	cultured	alone	or	with	H/E	or	Msc.	F)	Quantification	of	the	percentage	of	EdU+	cells/organoid	in	E).	N=1	mouse,	2	technical	replicates	per	mouse.	Violin	plots	were	drawn	as	in	D).	p<0.0001	(****),p<0.001	(***),	p<0.01	(**),	p<0.05	(*),	p<0.05	(ns).	
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Immunostaining	of	 the	co-cultures	highlights	 the	co-existence,	and	at	 times,	physical	proximity	between	the	different	cell	lineages	in	vitro	(Figure	3.7).	Organoids	of	cystic	morphology	and	positive	for	the	epithelial	marker	E-cadherin	 intermingle	with	CD45+	and	F4/80+	cells	from	the	H/E	fraction	or	aSMA+	Msc	cells.	Notably,	no	CD31+	cells	were	detected,	suggesting	that	the	endothelial	subpopulation	of	the	H/E	fraction	 does	 not	 survive	 in	 vitro	 and	 thereby	 does	 not	 contribute	 to	 sustaining	organoid	formation.		
	
Figure	3.7	Ductal	and	stromal	cells	co-exist	in	vitro.	EM-grown	co-cultures	at	day	9	of	culture	stained	with	antibodies	against	epithelial	(E-cadherin),	hematopoietic	(CD45,	F4/80),	endothelial	(CD31)	and	mesenchymal	(aSMA)	proteins.	
The	 expansion	 and	 self-renewal	 of	 ductal	 progenitors	 in	 vitro	 relies	 on	 a	defined	cocktail	of	growth	factors	supplemented	to	the	culture	medium:	RSPO1	(LGR5	ligand	 and	 WNT	 agonist),	 the	 mitogens	 EGF,	 FGF10	 and	 HGF;	 and	 WNT3A-conditioned	 medium	 following	 DC	 isolation	 (Figure	 3.8A).	 Activation	 of	 the	WNT	pathway	 and	 signalling	 through	 receptor	 tyrosine	 kinases	 is	 likewise	 essential	 for	liver	regeneration	in	vivo	(Apte	et	al.,	2007;	Ishikawa	et	al.,	2012;	Takase	et	al.,	2013).	At	the	mRNA	level,	Msc	cells	express	Hgf,	Fgf7	(part	of	the	Fgf10	subfamily),	Rspo1	and	Rspo3;	while	H/E	cells	express	Wnt2	and	Rspo3	but	very	little	of	the	other	factors	(Figure	3.8B).	Expression	of	a	key	battery	of	pro-regenerative	cytokines,	as	in	the	case	of	the	Msc	cells,	could	provide	niche	support	for	the	ductal	progenitors	in	vitro,	but	this	is	likely	to	be	masked	when	culturing	in	a	growth	factor	saturated	medium	such	as	EM	 (Figure	3.6).	Co-cultures	were	 thus	performed	 in	Basal	+	WNT	CM	medium	(devoid	 of	 EGF,	 FGF10,	 HGF	 and	 RSPO1),	 a	more	 stringent	 culture	 condition	 that	deters	 organoid	 growth	 unless	 exogenous	 support	 (i.e.	 a	 functional	 niche	 cell)	 is	
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provided,	and	has	the	added	benefit	of	enhancing	H/E	and	Msc	cell	survival	according	to	 previous	 results	 (Figure	 3.5).	 Under	 these	 conditions,	 the	 DC	 +	Msc	 co-culture	exhibits	a	significant	3-fold	 increase	 in	organoid	formation	efficiency	and	2.25-fold	increase	in	organoid	area	compared	to	the	DC	control	(Figure	3.8C-E);	in	contrast,	co-culturing	with	the	H/E	fraction	leads	to	no	improvement	in	organoid	growth.	A	similar	trend	 was	 observed	 in	 Basal	 medium	 supplemented	 with	 3%	 FBS	 but	 not	 WNT	(Figure	3.8D),	as	well	as	in	Basal	medium	only,	although	the	latter	with	considerably	lower	levels	of	organoid	formation	(<0.5%	for	DC	+	Msc	co-cultures)	(Figure	3.8C,D).		
	
Figure	3.8	Msc	cells	support	organoid	formation	in	the	absence	of	exogenous	growth	factors.	A)	Schematic	of	the	growth	factor	composition	of	the	organoid	medium,	EM.	B)	qPCR	analysis	of	growth	factor	gene	expression	in	homeostatic	 DC,	 H/E	 and	Msc	 populations.	 2∆Ct	 values	 are	 normalised	 to	 the	 housekeeping	 gene	Hprt	 and	 are	represented	as	fold	change	relative	to	the	DC	fraction.	N=2	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	C)	Brightfield	pictures	of	organoid	 formation	after	8	days	of	 culture	 in	Basal	or	Basal	+	WNT	CM	D)	Quantification	of	organoid	formation	efficiency	in	C)	and	in	Basal	+	3%	FBS	medium.	N=3	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	Results	are	expressed	as	percentage	of	organoids	formed	with	respect	to	total	 DC	 seeded	 (5000)	 and	 are	 corrected	 for	 any	 contamination	 from	 the	 stromal	 fraction.	E)	Quantification	 of	organoid	area	(mm2)	in	the	Basal	+	WNT	CM	cultures	from	C).	N=2	mice,	2	technical	replicates	per	mouse.	Violin	plots	were	drawn	as	in	Figure	3.6D.	p<0.0001	(****),p<0.001	(***),	p<0.01	(**),	p>0.05	(*),	p<0.05	(ns).		
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	In	vivo,	 stromal	cells	may	cooperate	with	each	other	 to	 indirectly	modulate	progenitor	behaviour.		This	does	not	appear	to	be	the	case	between	H/E	and	Msc	cells,	at	least	in	vitro	under	Basal,	Basal	+	WNT	CM	or	Basal	+	3%	FBS	culture	medium,	given	that	 the	 triple	 DC	 +	 H/E	 +	 Msc	 co-culture	 does	 not	 enhance	 organoid	 formation	compared	to	DC	+	Msc	(Figure	3.9).		
	
Figure	3.9	Triple	co-culture	between	DC,	H/E,	Msc	cells	does	not	further	enhance	organoid	formation.	
A)	Brightfield	pictures	of	organoid	formation	after	8	days	of	culturing	DC,	DC	+	H/E,	DC	+	Msc	and	DC	+	H/E	+	Msc	in	Basal	+	WNT	CM	or	Basal	+	3%	FBS	medium.	B)	Quantification	of	organoid	formation	in	A),	including	controls	in	Basal	medium.	N=2	mouse,	2	technical	replicates	per	mouse.		
The	 organoid-supportive	 effect	 of	 the	 Msc	 population	 appears	 to	 be	 dose-dependent.	In	experiments	where	increasing	number	of	Msc	cells	are	co-cultured	with	fixed	 numbers	 of	 DC	 (Figure	 3.10A),	 a	 non-linear	 surge	 in	 organoid	 formation	 is	observed,	 reaching	a	mean	efficiency	of	up	 to	8.5%	even	 in	Basal	medium	(Figure	3.10B,C).	 This	 non-linear	 response	 could	 suggest	 a	 beneficial	 effect	 from	 culturing	numerous	Msc	 cells	 together	 in	 terms	 of	 their	 own	 survival,	 proliferation	 and/or	cytokine	secretion,	although	this	remains	to	be	formally	investigated.		
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Figure	3.10	Msc	cells	support	organoid	formation	in	a	dosage-dependent	manner.	A)	Design	of	the	co-culture	with	increasing	numbers	of	Msc	cells	(25000,	50000	or	100000)	and	a	fixed	number	of	DC	(5000).	B)	Brightfield	pictures	of	 organoid	 formation	after	11	days	of	 culturing	 in	Basal	medium.	C)	Quantification	of	organoid	formation	in	B).	N=2	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	
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4.1 SCA1+	 mesenchymal	 cells	 surround	 biliary	 ducts	 and	
expand	after	damage	
In	vitro	assays	from	Chapter	3	identified	Msc	cells	as	an	organoid-supportive	niche,	drawing	interest	in	studying	this	population	further.	However,	the	Msc	sorting	strategy	 was	 based	 on	 negative	 marker	 selection	 (EpCAM-CD31-CD45-CD11b-)	(Figure	 3.2B),	 and	 although	 bulk	 RNA	 analysis	 showed	 enrichment	 of	 classical	mesenchymal	markers	in	these	cells,	‘contaminant’	non-mesenchymal	markers	were	also	detected.	It	was	thus	necessary	to	find	a	mesenchymal	surface	marker	to	fine-tune	the	sorting	of	Msc	cells	and	corroborate	their	identity.		With	 this	 aim,	 we	 searched	 for	 commercially	 available	 flow	 cytometry	antibodies	against	mesenchymal	stromal	cells	and	found	a	panel	recognising	CD140a	(PDGFRa),	CD140b	(PDGFRb),	Stem	Cell	Antigen	1	(SCA1),	CD44	and	CD29;	which	have	 been	 previously	 used	 to	 characterise	 fibroblasts	 in	 the	 heart	 (Furtado	 et	 al.,	2014).	Validation	of	 these	markers	by	qPCR	confirmed	their	expression	 in	the	Msc	fraction	–Cd29	and	Ly6a	(SCA1)	being	the	most	highly	expressed–	yet	also	showed	their	promiscuity	at	labelling	other	cell	populations	such	as	H/E	and	DC	(Figure	4.1A).	By	flow	cytometry,	CD140a	and	CD140b	labelled	only	a	minimal	percentage	of	Msc	cells,	 whereas	 CD44	was	 predominantly	 expressed	 by	 H/E	 cells	 (20%).	 SCA1	 and	CD29,	on	 the	other	hand,	 labelled	20%	and	80%	of	 the	Msc	 cells	 respectively;	 the	sheer	abundance	of	CD29	staining	in	all	the	populations	(76%	of	H/E	cells,	100%	of	DC)	questioned	its	value	as	a	useful	marker	for	refining	the	Msc	sorting	(Figure	4.1B).	Considering	 that	 the	 whole	 panel	 of	 antibodies	 had	 been	 validated	 using	 mouse	embryonic	fibroblasts	(MEFs)	as	positive	controls	(Figure	4.2A),	the	apparent	lack	of	expression	of	CD140a	and	CD140b	in	the	Msc	population	was	unexpected.	Inferring	from	the	mRNA	analysis,	this	might	be	due	to	a	combination	of	low	levels	of	protein	abundance	and	low	antibody	sensitivity,	given	that	higher	antibody	concentrations	do	detect	up	to	16%	of	CD140a+	cells	in	the	liver	(Figure	4.2B).		
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Figure	4.1	Identification	of	cell	surface	markers	in	the	Msc	population.	A)	qPCR	analysis	of	mesenchymal	genes	 in	H/E,	Msc,	DC	and	total	 liver	cells.	2∆Ct	values	are	normalised	to	the	housekeeping	gene	Hprt.	N=1	mouse,	2	technical	replicates,	error	bars	denote	mean	±	SD.	B)	Flow	cytometry	profile	of	the	markers	 in	A)	amongst	the	H/E,	Msc	and	DC	populations.	Results	are	expressed	as	univariate	histograms	depicting	the	relative	fluorescence	 intensity	 of	 each	 fluorophore	 (x-axis)	 vs	 the	 number	 of	 detected	 cell	 events	 (y-axis).	 The	percentage	of	stained	cells	is	summarised	for	each	population	(N=1	mouse).		
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Figure	4.2	Validation	and	titration	of	mesenchymal	antibodies.	A)	Flow	cytometry	validation	of	the	SCA1-FITC,	CD140a-PE,	CD140b-PE,	CD44-PE	and	CD29-PE	antibodies	using	mouse	embryonic	fibroblasts	as	positive	control	(N=1).	B)	Titration	of	the	CD140a	antibody	staining	using	increasing	μg	of	antibody/100000	total	liver	cells.	The	percentage	of	stained	cells	and	their	relative	mean	fluorescence	intensity	(MFI)	are	displayed	in	dot-plots	and	histograms	respectively	(N=1	mouse).	
Having	found	SCA1	as	a	putative	marker	for	the	Msc	population,	we	wished	to	verify	the	existence	of	SCA1+	liver	mesenchymal	cells	in	vivo.	Immunostaining	of	liver	tissue	sections	shows	SCA1	positivity	localising	exclusively	at	the	portal	tract	of	the	lobule,	not	the	central	vein	(Figure	4.3A),	whereas	Vimentin+	stroma	is	found	on	both	areas.	To	identify	mesenchymal	populations	more	readily,	we	employed	the	Pdgfra-
H2B-GFP	knock-in	reporter	 line	(Hamilton	et	al.,	2003),	which	has	been	previously	used	 to	assess	 fibrogenic	 responses	 in	 the	 liver	 (Hayes	et	al.,	 2014).	SCA1	 labels	a	subpopulation	 of	mesenchymal	 cells	 (PDGFRα+)	 that	 closely	 associate	with	 biliary	ducts	(Figure4.3B-1),	 in	contrast,	SCA1-PDGFRα+	cells	are	found	spread	throughout	the	liver	parenchyma	(Figure4.3B-2).	Peribiliary	SCA1+	cells	are	negative	for	aSMA,	unlike	pericytes	wrapping	around	the	portal	vein	and	hepatic	artery;	but	they	do	co-express	CD34	and	in	some	cases	Elastin,	a	marker	of	portal	fibroblasts	(Figure	4.3C)	
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Amongst	 the	 other	 stromal	 cells	 of	 the	 portal	 tract,	 a	 population	 of	 SCA1+	 CD31+	endothelium	 lines	 the	 portal	 vein;	 the	 surrounding	 LSECs	marked	 by	 VEGFR3	 are	negative	for	SCA1,	as	is	the	case	for	F4/80+	macrophages	(Figure	4.3D).		
	
Figure	4.3	SCA1	labels	a	subpopulation	of	periportal	mesenchymal	cells.	A)	Immunostaining	of	the	portal	tract	and	central	vein	areas	of	WT	livers	with	mesenchymal/stromal	(SCA1,	Vimentin)	and	epithelial	(OPN)	markers.	SCA1+	cells	localise	exclusively	to	the	portal	tract	of	the	liver	lobule,	where	the	biliary	duct	epithelium	(OPN+)	is	confined.	B)	Immunostaining	of	Pdgfra-H2B-GFP	mouse	livers	with	SCA1	and	OPN	antibodies.	SCA1+	PDGFRα+	cells	(B1)	reside	in	close	proximity	to	the	ductal	epithelium	(OPN+),	whereas	SCA1-PDGFRα+	cells	(B2)	are	spread	throughout	the	liver	parenchyma.	C,D)	Immunostaining	of	WT	livers	with	SCA1,	CD34,	mesenchymal	(αSMA,	 Elastin),	 endothelial	 (CD31,	 VEGFR3)	 and	 hematopoietic	 (F4/80)	 markers.	 The	 F4/80	 and	 SCA1	stainings	were	compared	 in	consecutive	 (c)	sections	as	both	antibodies	were	raised	 in	 the	same	host	 (rat).	Biliary-associated	SCA1+	cells	co-express	CD34	(yellow	asterisk)	and	in	some	cases	Elastin	(C2,	yellow	asterisk	
vs	C1	arrow),	while	they	stain	negative	for	αSMA	as	well	as	endothelial	and	hematopoietic	markers	(yellow	arrows).			
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The	vicinity	of	SCA1+	PDGFRα+	cells	 to	 the	bilary	duct	epithelium	speaks	 in	favour	 of	 these	 cells	 as	 a	 putative	 niche	 population.	 Periportal	 liver	 stromal	 cells	including	Thy1+	mesenchyme	(Takase	et	al.,	2013)	have	been	shown	to	expand	as	a	response	to	tissue	damage,	and	thus	draw	the	question	of	whether	SCA1+	Msc	cells	could	behave	similarly.	Liver	damage	can	be	induced	in	mice	by	supplementing	their	diet	with	3,5-diethoxycarbonyl-1,4-dihydrocollidine	(DDC),	a	xenobiotic	that	inhibits	heme	metabolism	in	hepatocytes	and	leads	to	their	death	(Magnus,	Roe	and	Bhutani,	1969).	 Accordingly,	 we	 utilised	 a	 protocol	 in	 which	 mice	 are	 fed	 with	 a	 DDC-supplemented	diet	for	5	days	and	are	subsequently	allowed	to	recover	with	normal	diet	 for	7	days	(Figure	4.4A).	This	experimental	model	 leads	to	a	well-documented	expansion	of	periportal	ductal	progenitors	(OPN+)	which	we	indeed	observe	(Figure	4.4B,D);	 and	 interestingly,	 these	 cells	 are	 closely	 accompanied	 by	 a	 population	 of	SCA1+PDGFRα+	 mesenchymal	 cells	 (Figure	 4.4A-1).	 Already	 at	 d5	 post-diet	administration,	numerous	mesenchymal	SCA1+	cells	co-expressing	Vimentin,	yet	not	the	classic	myofibroblast	marker	aSMA,	are	detected	at	the	periphery	of	biliary	ducts	(Figure	 4.4C).	 Whilst	 the	 total	 number	 of	 SCA1+PDGFRα+	 cells	 per	 portal	 vein	increases	from	DDC	d0	to	DDC	d12,	this	is	not	the	case	for	SCA1-	PDGFRα+	cells	(Figure	4.4D).	Moreover,	there	is	an	increase	in	the	ratio	of	SCA1+	PDGFRα+	cells/	OPN+	ductal	cells	from	DDC	d0	to	DDC	d12	(Figure	4.4E).	Together,	these	data	confirm	the	close	association	 that	 exists,	 in	 homeostasis	 and	 in	 damage,	 between	 SCA1+Msc	 and	DC/progenitors,	 and	 heightens	 the	 interest	 in	 studying	 this	 mesenchymal	microenvironment	further.		
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Figure	4.4	Mesenchymal	SCA1+	cells	increase	in	numbers	following	liver	damage.		A)	Timeline	of	the	DDC	model	of	liver	damage	and	regeneration.	Mice	are	administered	DDC	in	their	diet	for	a	period	of	5	days	and	are	then	allowed	to	recover	for	7	days.	B)	Immunostaining	of	Pdgfra-H2B-GFP	livers	at	DDC	d0	and	DDC	d12	with	SCA1	and	OPN.	Magnified	images	of	SCA1+PDGFRα	+	(1)	and	SCA1-	PDGFRα	+	(2)	cells	in	the	DDC	d12	livers	are	shown.	C)	Immunostaining	of	WT	livers	at	DDC	d5	with	SCA1,	OPN,	Vimentin	and	αSMA.	D)	Quantification	of	absolute	SCA1+	PDGFRα	+,	SCA1-PDGFRα+	and	OPN+	PDGFRα	-	liver	cell	counts	per	portal	vein	(PV)	frame	at	DDC	d0	and	DDC	d12.	N=2	mice,	9	PVs;	median	±	interquartile	range	(IQR)	is	plotted.	OPN+	ductal	cells	and	SCA1+,	but	not	SCA1-,	mesenchymal	cells	increase	in	numbers	following	liver	damage.	E)	The	absolute	counts	in	D)	are	expressed	as	a	ratio	of	PDGFRα+	SCA1+	cells/	OPN+	ductal	cells	in	both	timepoints.	The	ratio	of	mesenchymal	to	ductal	cells	increases	after	damage.	
4.2 Molecular	 characterisation	 of	 primary	 SCA1+	
mesenchymal	cells	in	homeostasis	
To	better	understand	the	molecular	make-up	of	liver	mesenchymal	cells,	we	isolated	SCA1+	Msc	and	SCA1-	Msc	cells	from	homeostatic	livers	following	a	strategy	modified	from	Figure	3.2B	to	include	SCA1	discrimination	(Figure	4.5A)	and	analysed	their	global	gene	expression	through	RNA	sequencing;	SCA1+	and	SCA1-	cells	from	the	
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H/E	and	DC	lineages	were	also	included	as	controls.	Unsupervised	clustering	analysis	of	the	6	populations	separates	them	into	two	major	branches:	an	epithelial	DC	branch	and	a	stromal	branch	that	 is	 further	subdivided	 into	the	H/E	and	the	Msc	 lineages	(Figure	4.5B).	Interestingly,	SCA1	expression	defines	two	subgroups	within	the	Msc	and	H/E	fractions	respectively,	whilst	this	is	not	the	case	for	the	DC	cells,	as	samples	cluster	 by	 biological	 replicate	 rather	 than	 by	 SCA1	 expression	 (SCA1+	 or	 SCA1-)	(Figure	4.5B).	In	line	with	this,	the	demarcation	of	SCA1	staining		in	the	FACS	plots	is	not	very	 clear	 for	 the	DC	compared	 to	 the	H/E	and	Msc	 (Figure	4.5A);	 this	 is	 also	reflected	 at	 the	 mRNA	 level	 as	 there	 is	 only	 a	 mild	 enrichment	 of	 Ly6a	 (SCA1)	expression	in	SCA1+	DC	compared	to	SCA1-	DC	(Figure	4.6A).		
Figure	 4.5	 SCA1+	 and	
SCA1-	 Msc	 cells	 are	
molecularly	 distinct	
from	 each	 other	 and	
from	 SCA1+/-	 DC	 and	
SCA1+/-	 H/E	 cells.	 	 A)	FACS	 strategy	 for	 the	isolation	 of	 hepatic	primary	DC	 (SCA1+,	 SCA1-),	H/E	 (SCA1+,	 SCA1-)	 and	Msc	 (SCA1+,	 SCA1-)	populations.	 B)	Hierarchical	 clustering	 of	gene	 expression	 from	 the	populations	 in	 A)	sequenced	 by	 RNAseq	(N=2	 mice,	 the	 replicates	are	 denoted	 as	 1	 and	 2).	The	three	cell	lineages	(DC,	H/E,	Msc)	are	molecularly	distinct	 and	 SCA1	expression	 defines	 two	clear	subgroups	within	the	Msc	 and	 H/E	 lineages	respectively.	
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We	assessed	the	expression	of	lineage-specific	genes	across	the	6	populations	and	represented	them	as	a	heatmap	(Figure	4.6A).	Compared	to	the	SCA1-	Msc	cells	and	 the	 other	 lineages,	 the	 SCA1+	 Msc	 fraction	 is	 enriched	 in	 several	 classical	fibroblast/mesenchymal	genes	including	Eln,	Pdgfra,	Pdgfrb,	Vim,	Col1a1	and	Col1a2;	as	well	as	more	lineage-fluid	genes	like	Cd34	and	Thy1,	the	latter	of	which	has	been	used	to	identify	both	hepatic	mesenchyme	and	‘oval’	cells	in	the	liver	(Petersen	et	al.,	1997;	Takase	et	al.,	2013).	
	
Figure	4.6	Expression	profile	of	lineage	specific	genes	in	the	SCA1+	and	SCA1-	fractions	of	the	H/E,	Msc	
and	DC	populations.	A)	Gene	expression	heatmap	(RPKM	values)	of	mesenchymal,	H/E,	DC	and	hepatocyte	(HC)	genes	across	the	H/E	(SCA1+,	SCA1-),	Msc	(SCA1+,	SCA1-)	and	DC	(SCA1+,	SCA1-)	populations	sequenced	in	Figure	4.5.	B)	qPCR	validation	of	selected	genes	from	A).	2∆Ct	values	are	normalised	to	the	housekeeping	gene	
Hprt.	N=2	mouse,	2	technical	replicates,	error	bars	denote	mean	±	SD.	
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	The	SCA1-	Msc	fraction	expresses	many	of	the	aforementioned	genes	but	to	a	lower	extent,	and	 is	particularly	enriched	 in	Acta2	and	Des.	Similar	 to	Figure	3.3A,	some	hepatocyte	(HC)	contamination	is	found	within	the	SCA1-	Msc	fraction	(sorted	using	negative	selection),	 judging	from	the	expression	of	HC-specific	genes	like	Alb	and	Ttr.		The	 H/E	 cells	 express	 all	 the	 expected	 genes	 of	 their	 lineage,	 although	interestingly,	 there	 is	 a	 separation	 of	 endothelial-	 (Pecam1,	 Cdh5,	 Flt4)	 and	hematopoietic-	 (Itgam,	 Prtprc)	 specific	 genes	 in	 the	 SCA1+	 and	 SCA1-	 fractions	respectively.	 The	 cluster	 of	DC-specific	 genes	 (Krt19,	 EpCAM,	 Sox9,	 Cdh1,	 Krt7	 and	
Prom1)	is	selectively	upregulated	in	the	DC	fraction	(SCA1+	and	SCA1-),	and	no	other	H/E,	Msc	or	HC-specific	genes	(with	the	exception	of	Hnf4a)	appear	to	be	expressed	by	DC.	The	above	RNAseq	pattern	of	 gene	expression	was	validated	by	qPCR	with	primers	against	a	selected	panel	of	lineage-specific	genes	(Figure	4.6B).	Niche	cells	may	modulate	DC	behaviour	through	paracrine	signalling.	We	thus	assessed	the	6	populations	for	expression	of	growth	factors	and/or	cell-bound	ligands	from	regeneration-relevant	signalling	pathways	(WNT,	FGF,	HGF,	EGF,	Notch,	TGFβ,	etc).	 Unsurprisingly,	 the	 DC	 fraction	 does	 not	 express	 the	 vast	 majority	 of	 these	factors,	as	it	relies	on	exogenous	sources	for	their	supply.	Some	exceptions	are	Wnt7a	and	Wnt7b,	particularly	expressed	on	the	SCA1+	cells,	Fgf12	and	Tgfb2,	enriched	more	on	the	SCA1-	cells,	as	well	as	Wnt5b,	Dll1	and	Tnf,	expressed	on	both	(Figure	4.7A,B).	Compared	 to	 the	 other	 stromal	 populations,	Msc	 SCA1+	 cells	 express	 the	 greatest	number	of	signalling	molecules	from	the	selected	list.	Notable	factors	are:	Hgf,	various	
Fgf	genes	(including	Fgf7),	 Igf1,	 Igf2,	 the	WNT	agonists	Rspo1	and	Rspo3,	 the	WNT	ligands	Wnt5a,	Wnt6,	Wnt9a	and	Wnt9b,	but	also	WNT	inhibitors	Wif1,	Dkk2,	Dkk3;	Notch	 ligands	 and	 receptors	 like	 Jag1	and	Notch1,	as	well	 as	 Tgfb1,	 Tgfb3,	 Il6	 and	
Cxcl12.	The	latter	two	genes	show	the	highest	level	of	expression	in	the	Msc	SCA1+	cells,	 followed	by	Dkk3,	Rspo3	 and	Tgfb3	 (Figure	4.7B).	 Il6	 is	of	particular	 interest	because	it	is	a	reported	marker	of	portal	fibroblasts	in	the	liver	(Wells,	2014).	The	Msc	SCA1-	fraction	shares	expression,	although	diminished,	of	many	of	the	above	genes;	while	there	are	other	genes	like	Fgf1	that	it	uniquely	overexpresses.	The	H/E	cells,	particularly	the	SCA1+	subpopulation,	are	enriched	in	WNT	agonists	and	ligands	such	
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as	Rspo3	 (expressed	more	 than	 in	 the	Msc	SCA1+	cells),	Wnt2	 and	Wnt9b,	but	also	other	molecules	like	the	Notch	ligand	Dll4	and	the	pro-inflammatory	Tnf.	As	in	Figure	4.6B,	 selected	 genes	 from	 the	 RNAseq	 were	 validated	 by	 qPCR.	 Although	 overall	concordance	is	observed,	the	relative	levels	of	gene	expression	vary	for	some	genes,	as	is	the	case	for	Hgf,	which	is	more	highly	expressed	than	Rspo3	(Figure	4.7C).	
	
Figure	4.7	Expression	profile	of	growth	factors	and	cell-bound	ligands	in	the	SCA1+	and	SCA1-	fractions	
of	the	H/E,	Msc	and	DC	populations.	A)	Gene	expression	heatmap	of	growth	factors	and	cell	surface	ligands	of	 various	 signalling	 pathways	 across	 the	 H/E	 (SCA1+,	 SCA1-),	 Msc	 (SCA1+,	 SCA1-)	 and	 DC	 (SCA1+,	 SCA1-)	populations	sequenced	in	Figure	4.5.	B)	Plot	of	RPKM	values	of	the	genes	in	A).	Each	dot	represents	the	mean	of	two	biological	replicates.	C)	qPCR	validation	of	selected	genes	from	A).	2∆Ct	values	are	normalised	to	the	housekeeping	gene	Hprt.	Pooled	H/E	cells	(purple	bars)	instead	of	H/E	Sca1+	and	H/E	Sca1-	subpopulations	(light	blue	and	dark	blue	bars,	 respectively)	were	used	 for	 screening	expression	of	 the	genes	Rspo1,	Wnt2,	
Wnt5a	and	Wnt9b.	N=1	mouse,	2	technical	replicates,	error	bars	denote	mean	±	SD.	
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4.3 Primary	SCA1+	mesenchymal	 cells	 can	be	expanded	 in	
vitro		
The	enrichment	of	pro-regenerative	paracrine	signals	within	the	SCA1+	Msc		–including	agonists	of	the	ERK/MAPK	and	WNT	pathways–	portrayed	these	cells	as	a	niche	population	worthy	of	study.	Due	to	the	lack	of	suitable	mouse	models	to	study	their	role	in	vivo	(see	Section	4.7),	we	took	the	alternative	approach	of	characterising	the	 crosstalk	 between	 these	 cells	 and	 DC/progenitors	 ex	 vivo.	 For	 this,	 it	 was	paramount	to	achieve	a	certain	level	of	expansion	of	the	SCA1+	Msc	cells	as	primary	cultures.		
	
Figure	4.8	In	vitro	expansion	of	primary	Msc	SCA1+	cells.	A)	Schematic	of	primary	SCA1+	Msc	cell	isolation	and	 in	vitro	passaging	at	a	1:3	ratio.	B)	Brightfield	images	of	SCA1+	Msc	cells	at	p1,	p2	and	p5	of	culture	on	plastic	or	matrigel	in	Basal	+	WNT	CM	medium.	
We	isolated	SCA1+	Msc	as	in	Figure	4.5A	and	tested	their	growth	capacity	upon	serial	passaging	(in	a	1:3	ratio)	on	either	plastic	or	matrigel	as	 the	culture	surface	
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(Figure	 4.8A).	 Basal	 +	WNT	 CM	was	 chosen	 as	 the	 growth	medium	 based	 on	 the	enhanced	survival	of	Msc	cells	 in	 it	 (Figure	3.5).	On	plastic,	SCA1+	Msc	cells	can	be	expanded	for	up	to	5	passages,	after	which	they	become	senescent-looking	and	arrest	growth,	as	expected	from	a	primary	cell	population.	In	contrast,	matrigel	allows	very	little	expansion	of	SCA1+	Msc	cells	and	 they	cannot	be	cultured	beyond	2	passages	(Figure	4.8B).		Beyond	expanding	the	SCA1+	Msc	cells	in	vitro,	we	wished	to	ascertain	whether	their	original	cell	identity	remained	unaltered	with	time	in	culture.	To	investigate	this,	we	collected	SCA1+	Msc	cells	for	RNA	sequencing	immediately	after	sorting	and	after	15	days	of	in	vitro	culture	in	Basal	+	WNT	CM	medium	(Figure	4.9A).	SCA1+	Msc	cells	retain	expression	of	the	gross	majority	of	mesenchymal-specific	genes,	many	of	which	become	upregulated,	as	is	the	case	of	Ly6a	itself	but	also	Pdgfra,	Pdgfrb,	Acta2,	Col1a1	and	Col1a2	(Figure	4.9B);	notably,	the	latter	three	genes	are	expressed	at	relatively	high	levels	(Figure	4.9C).	Gene	down-regulation	is	only	observed	for	the	case	of	Eln,	
Cd34,	and	mildly	for	Vim.	Hepatocyte-	and	H/E-specific	genes,	with	the	exception	of	
Cdh5,	also	become	downregulated	in	culture	(Figure	4.9B).	This	is	likely	due	to	non-mesenchymal	contaminating	cells	–present	in	the	SCA1+	Msc	fraction	at	t=d0–	that	do	not	 survive	 or	 become	 outcompeted	 in	 vitro.	 Exemplifying	 this	 are	 Alb	 and	 Ttr,	hepatocyte-specific	 genes	 that	 transition	 from	 well-expressed	 at	 t=0	 to	 non-detectable	in	culture	(Figure	4.9C).	The	expression	of	growth	factors	and	cell-bound	ligands	 in	 SCA1+	 Msc	 cells	 is	 relatively	 more	 susceptible	 to	 change	 upon	 in	 vitro	culture	(Figure	4.10).	A	fraction	of	the	genes	augment	expression	compared	to	t=0,	as	is	 the	 case	of	Fgf2,7,18,	Rspo1,3,	 Igf1,2,	Wnt5a,9a,	Dkk2,3,	Dll4	and	Cxcl12.	De	novo	expression	 is	much	more	 rare,	Fgf9	 is	 one	 such	 case,	 although	only	 low	 levels	 are	detected	(Figure	4.10B,C).	Loss	of	expression	–to	different	degrees–	is	observed	for	
Hgf,	Wnt2,2b,6,9b,11,	Wif,	 Jag1,	Dll1,	Notch1,2,	 Il6,	 Cxcl10	and	Tgfb1,	with	 the	most	dramatic	changes	detected	in	Cxcl10	and	Il6	(Figure	4.10B,C).	Whilst	all	other	genes	in	our	list	remained	relatively	stable,	differential	expression	should	be	assessed	in	the	future	at	the	whole-transcriptome	level	to	thoroughly	characterise	the	identity	of	in	
vitro	cultured	Msc	SCA1+	cells.	
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Figure	4.9	Lineage	identity	of	Msc	SCA1+	cells	after	in	vitro	culturing.	A)	Strategy	of	collection	and	RNA	sequencing	of	freshly	isolated	(t=d0)	and	in	vitro	cultured	(t=d15)	SCA1+	Msc	cells.	B)	Gene	expression	heatmap	of	mesenchymal,	H/E,	DC	and	hepatocyte	genes	in	Msc	SCA1+	cells	sequenced	at	d0	vs	d15	in	culture.	DC	at	d0	
vs	d15	are	also	included	as	controls	(N=2	mice,	mean	RPKM	values	were	plotted).	C)	Plot	of	RPKM	values	of	the	genes	in	B).	Each	dot	represents	the	mean	of	two	biological	replicates.		
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Figure	4.10	Expression	profile	of	growth	factors	and	cell-bound	ligands	in	Msc	SCA1+	cells	after	in	vitro	
culturing.	A)	Strategy	of	collection	and	RNA	sequencing	of	freshly	isolated	(t=d0)	and	in	vitro	cultured	(t=d15)	SCA1+	Msc	cells.	B)	Gene	expression	heatmap	of	growth	factors	and	cell	surface	ligands	of	various	signalling	pathways	in	Msc	SCA1+	cells	sequenced	at	d0	vs	d15	in	culture.	DC	at	d0	vs	d15	are	also	included	as	controls	(N=2	mice,	mean	RPKM	values	were	plotted).	C)	Plot	of	RPKM	values	of	the	genes	in	B).	Each	dot	represents	the	mean	of	two	biological	replicates.	
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4.4 SCA1+	 mesenchyme	 supports	 organoid	 formation	 in	
vitro	via	soluble	factors	
Similar	to	Section	3.2,	we	aimed	to	perform	co-culture	assays	with	the	SCA1+	subpopulation	of	 the	Msc	cells	 to	determine	 their	organoid-supportive	potential	 in	
vitro.	We	cultured	 the	cells	within	 the	same	3D	matrigel	droplet	 (Figure	4.11A)	or	separately	 using	 a	 transwell	 system	 with	 a	 porous	 cell-impermeable	 membrane	(Figure	4.11C).	As	previously	observed,	the	DC	+	Msc	co-culture	enhances	organoid	formation	efficiency	compared	to	DC	alone	(Figure	4.11A,B);	interestingly,	this	effect	is	significantly	pronounced	when	co-culturing	with	the	SCA1+	Msc	cells,	but	not	the	SCA1-	Msc	nor	the	H/E	SCA1+	fractions	(Figure	4.11A,B).		
	
Figure	4.11	Co-culturing	of	DC	with	Msc	SCA1+	cells	enhances	organoid	formation.	A)	Same	droplet	co-cultures	between	freshly	sorted	DC	(5000	cells)	and	stromal	cells	-H/E	SCA1+,	Msc	SCA1+,	Msc	SCA1-	or	Msc	–	(25000	cells)	in	Basal	+	WNT	CM	medium.	B)	Quantification	of	organoid	formation	efficiency	in	A).	N=3	mice,	2	technical	 replicates	per	mouse,	error	bars	denote	mean	±	SD.	C)	Transwell	 co-cultures	 in	Basal	+	WNT	CM	medium	between	freshly	sorted	DC	(5000	cells,	top	insert)	and	Msc	SCA1+	expanded	in	vitro	for	7	days	(bottom	well).	A	control	with	DC	cultured	alone	in	standard	EM	is	also	included.	D)	Quantification	of	organoid	formation	efficiency	in	C).	N=3	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	In	both	types	of	co-culture	(A,C),	Msc	SCA1+	cells	promote	robust	organoid	formation.	p<0.0001	(****),p<0.001	(***),	p<0.01	(**),	p>0.05	(*),	p<0.05	(ns).	
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Even	 when	 physically	 separated	 from	 the	 DC,	 the	 SCA1+	Msc	 cells	 sustain	organoid	formation	at	an	efficiency	(4.4%)	that	closely	matches	the	one	in	the	mixed	co-culture	as	well	as	that	of	DC	grown	alone	in	the	growth	factor-saturated	EM	(Figure	4.11C,D).	In	the	presence	of	the	SCA1+	Msc	cells,	organoid	growth	is	observed	even	in	Basal	medium	lacking	WNT	CM	(2.5%	efficiency),	which	precludes	any	confounding	contribution	 from	 serum	 factors	 present	 in	 the	 WNT	 CM	 (Figure	 4.11C,D).	 As	 a	fortuitous	observation,	we	also	noticed	that	the	SCA1+	Msc	cells	grow	more	densely	when	 co-cultured	 with	 DC	 in	 Basal	 medium	 compared	 to	 cultured	 on	 their	 own	(Figure	4.11C),	leading	to	further	investigation	in	Figure	4.14.	The	transwell	co-cultures	suggested	that	secreted	factors	and	not	cell-bound	molecules	mediate	 the	paracrine	effect	of	SCA1+	Msc	cells	on	organoid	growth.	We	strove	 to	 reinforce	 this	 idea	making	use	of	 the	Pdgfra-H2B-GFP	 reporter	 line,	 as	 it	would	 allow	 us	 to	 refine	 the	 sorting	 strategy	 of	 the	 mesenchyme	 (Figure	 4.12A).	Whilst	both	PDGFRα+SCA1+	Msc	and	PDGFRα+SCA1-	Msc	cells	can	be	expanded	in	vitro	and	retain	PDGFRα	expression,	the	latter	population	grows	comparatively	slower	and	splitting	ratios	must	be	adjusted	accordingly	(see	Methods);	in	contrast,	the	PDGFRα-SCA1+	Msc	fraction	does	not	grow	at	all	under	our	in	vitro	conditions	(Figure	4.12B).	We	 incubated	 the	 in	 vitro	 expanded	 cells	 (PDGFRα+SCA1+	Msc	 and	 PDGFRα+SCA1-	Msc)	with	Basal	+	WNT	CM	medium	for	48h,	 thus	generating	conditioned	medium	(CM)	rich	in	mesenchymal-secreted	factors	for	testing	on	freshly	sorted	DC	(Figure	4.12C).	 Conditioned	medium	 from	 PDGFRα+SCA1+	Msc	 cells	 supports	 the	 greatest	organoid	 formation	 from	DC,	with	a	mean	efficiency	of	3.9%,	which	 is	significantly	higher	 than	 that	 of	 PDGFRα+SCA1-	 CM	 (2.8%)	 (Figure	 4.12D,E),	 and	 is	 roughly	equivalent	 to	 the	 organoid	 formation	 sustained	 by	 SCA1+	 Msc	 in	 Figure	 4.11.	 In	contrast,	non-conditioned	Basal	+	WNT	CM	medium	only	sustains	organoid	growth	of	around	 1%	 (Figure	 4.12D,E).	 These	 experiments	 further	 suggest	 that	 in	 vitro	expansion	 of	 SCA1+	 (PDGFRα+)	 Msc	 cells	 does	 not	 alter	 their	 ability	 to	 sustain	organoid	formation.	
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Figure	 4.12	 Conditioned	medium	 from	Msc	 PDGFRα+	 SCA1+	 cells	 supports	 organoid	 formation.	 	A)	Sorting	 strategy	 of	 Pdgfra-H2B-GFP	 mouse	 livers	 to	 isolate	 different	 Msc	 fractions:	 PDGFRα+SCA1+,	PDGFRα+SCA1-	and	PDGFRα-SCA1+.	B)	Brightfield	and	fluorescence	pictures	of	expanded	(p=2)	mesenchymal	populations	(PDGFRα+	SCA1+	Msc,	PDGFRα+	SCA1-	Msc)	sorted	in	A).	The	PDGFRα-	SCA1+	Msc	cells	did	not	grow	
in	vitro.	C)		Schematic	of	the	experimental	design:	expanded	Msc	fractions	are	incubated	with	fresh	Basal	+	WNT	CM	medium	for	48h	and	the	resulting	conditioned	medium	(CM)	is	added	to	freshly	sorted	DC.	D)	Organoid	formation	from	DC	cultured	with	unconditioned	medium	(Basal	+	WNT	CM),	Msc	PDGFRα+	SCA1+	CM	or	Msc	PDGFRα+	SCA1-	CM.	E)	Quantification	of	organoid	formation	efficiency	from	D).	N=3	mice,	2	technical	replicates	per	mouse,	error	bars	denote	mean	±	SD.	Organoid	formation	is	best	supported	by	CM	from	Msc	PDGFRα+	SCA1+	cells.	p<0.0001	(****),	p<0.001	(***),	p<0.01	(**),	p>0.05	(*),	p<0.05	(ns).	
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4.5 Molecular	 characterisation	 of	mesenchyme-supported	
organoids	
Beyond	 morphology,	 we	 wished	 to	 characterise	 the	 molecular	 identity	 of	mesenchyme-supported	organoids	to	determine	if	they	indeed	recapitulate	classical	EM-grown	cultures.	We	designed	a	strategy	to	compare	DC	by	RNAseq	at	d0	of	sorting	and	after	15	days	of	transwell	culture	alone	in	EM	or	in	co-culture	with	SCA1+	Msc	cells	 in	Basal	+	WNT	CM	medium	(Figure	4.13A).	Of	note,	control	organoids	grown	alone	 in	Basal	 +	WNT	CM	displayed	minimal	 growth	 and	 could	not	 be	 sequenced.	Based	 on	 hierarchical	 clustering,	 organoids	 supported	 by	 SCA1+	 Msc	 distance	themselves	molecularly	from	DC	at	t=d0	and	instead	resemble	organoids	cultured	in	EM	(Figure	4.13B).		Notwithstanding,	 the	mesenchyme	 and	 EM-supported	 organoids	 do	 exhibit	certain	key	differences.	Whilst	the	progenitor	marker	Lgr5	becomes	upregulated	in	EM	 cultures	 relative	 to	 t=d0	 DC,	 this	 is	 not	 the	 case	 for	 mesenchyme-supported	organoids,	 at	 least	 at	 d15.	 qPCR	 analysis	 of	 an	 earlier	 co-culture	 (time	point	 72h)	suggests	 that	 Lgr5	 is	 in	 fact	 expressed,	 although	 at	 lower	 levels	 than	 in	 the	 EM	organoids	 (Figure	4.13D),	whilst	Lgr5	was	undetectable	 in	 control	DC	at	 t=d0	and	SCA1+	Msc	cells	 (Figure	4.13D).	When	compared	to	EM-grown	organoids	and	even	freshly	sorted	DC,	mesenchyme-supported	organoids	are	also	enriched	in	a	panel	of	differentiated	ductal	cell	markers	such	as	Krt19,	Aldoa,	Cilc3,	S100a6,	S100a11	and	more	mature	markers	 like	Krt7.	Conversely,	 they	 exhibit	 decreased	 expression	 of	some	hepatocyte-specific	genes	like	Ttr,	Rbp4	and	C3	(Figure	4.13C).	The	enrichment	of	 differentiated	 ductal	 markers	 –and	 diminished	 Lgr5	 expression-	 could	 be	suggestive	 of	 a	 more	 mature	 ductal	 phenotype	 in	 the	 mesenchyme-supported	organoids.	 Evidence	 supporting	 this	 is	 that	 the	 organoids	 do	 not	withstand	 serial	passaging,	as	shown	in	Figure	4.13E.	
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Figure	4.13	Mesenchyme-supported	organoids	resemble	EM-grown	organoids.		A)	Schematic	of	co-culture	for	RNA	sequencing:	freshly	sorted	DC	are	collected	at	t=d0	or	cultured	alone	in	standard	EM	or	in	Basal	+	WNT	CM	medium	with	Msc	SCA1+	cells	on	the	bottom	of	the	transwell.	After	15	days,	the	organoids	formed	are	sequenced.	B)	Hierarchical	clustering	of	gene	expression	from	DC	(t=d0),	organoids	(EM,	t=d15)	and	organoids	cultured	with	Msc	SCA1+	(t=d15)	sequenced	by	RNAseq	(N=2	mice).	C)	Gene	expression	heatmap	of	progenitor	and	differentiated	(DC,	hepatocyte)	markers	across	the	populations	in	B).	D)	qPCR	analysis	of	Lgr5	expression	in	DC	at	t=0	of	isolation,	at	t=72h	of	EM	culture	or	at	t=72h	of	co-culture	with	Msc	SCA1+	cells.	Msc	SCA1+	cells	are	included	as	negative	control.	N=1,	2	technical	replicates,	error	bars	denote	mean	±	SD.	E)	Brightfield	pictures	of	DC	serially	passaged	in	unconditioned	medium	(Basal	+	WNT	CM)	or	Msc	SCA1+	CM.	
.
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4.6 Liver	 organoids	 support	 the	 growth	 of	 mesenchymal	
SCA1+	cells	
A	timely	observation	 from	Figure	4.11C	 led	us	 to	believe	 that	 the	paracrine	signalling	between	SCA1+	Msc	cells	and	ductal	cells	may	be	bidirectional	instead	of	just	 mesenchyme-derived.	 We	 designed	 a	 similar	 experiment	 as	 in	 Figure	 4.12C,	except	that	this	time	CM	was	generated	from	organoids	incubated	in	Basal	medium	without	WNT	CM	(Figure	4.14A).	Conditioning	cells	included	liver	organoids	at	high	and	 low	 density,	 and	 two	 technical	 replicates	 of	 low-density	 small	 intestinal	 (S.I.)	organoids;	 after	 the	24h-period,	 CM	was	 collected	 and	 the	 cells	were	 assessed	 for	viability	to	ensure	quality	of	the	CM	(Figure	4.14A).	Both	the	conditioning	liver	and	S.I.	organoids	contained	a	percentage	of	live	cells	comparable	to	their	respective	EM-cultured	 controls	 (Figure	 4.14B),	 suggesting	 that	 Basal	 culture	 for	 24h	 did	 not	adversely	affect	their	cell	viability.		
	
Figure	4.14	Conditioned	medium	 from	 liver	organoids	 supports	Msc	SCA1+	 cell	 growth	 	 (part	1).	A)	Strategy	to	generate	conditioned	medium	(CM)	from	liver	and	small	intestinal	organoids	at	different	seeding	densities.	B)	Quantification	of	organoid	cell	viability	after	conditioning.	N=1,	2	technical	replicates.	Organoids	grown	in	standard	EM	are	included	as	positive	controls.		To	test	the	CM	from	liver	and	control	S.I.	organoids,	we	added	it	to	freshly	split	SCA1+	Msc	cells	–	previously	maintained	in	their	standard	Basal	+	WNT	CM	medium	–	and	assessed	mesenchymal	cell	numbers	24h	later	(Figure	4.14C).	Remarkably,	whilst	CM	from	S.I.	organoids	did	not	appear	to	provide	any	benefit	in	growth	compared	to	non-conditioned	 Basal	 controls,	 liver	 organoid	 CM	 did:	 SCA1+	 Msc	 cell	 numbers	increased	by	2.8	and	2.2	fold	when	cultured	in	high-density	and	low-density	liver	CM,	respectively	 (Figure	4.14D).	Morphologically,	SCA1+	Msc	cells	 looked	healthier	and	
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only	 displayed	 their	 typical	 elongated	 shape	 when	 cultured	 in	 liver	 organoid	 CM	(Figure	4.14E).	
	
Figure	 4.14	 Conditioned	medium	 from	 liver	 organoids	 supports	Msc	 SCA1+	 cell	 growth	 (part	 2).	 C)	Strategy	to	test	organoid	CM:	Msc	SCA1+	cells	are	split	at	a	1:3	ratio	and	are	cultured	for	24h	with	control	or	organoid	CM	generated	in	Figure	4.14A.	D)	Quantification	of	Msc	SCA1+	cell	numbers	after	culturing	as	in	C)	with	Basal	 unconditioned	medium,	 liver	 organoid	CM	 (from	organoids	 at	 high	 and	 low	density)	 and	 Small	Intestinal	(S.I.)	organoid	CM	(from	organoids	at	low	density).	Counts	of	Msc	SCA1+	cells	are	normalised	to	Basal	control	 and	expressed	as	 relative	numbers.	N=1,	2	 technical	 replicates.	E)	Brightfield	pictures	 showing	 the	morphology	of	Msc	SCA1+	cells	after	culturing	in	conditions	of	D).	F)	Flow	cytometry	analysis	of	EdU+	Msc	SCA1+	cells	after	culturing	in	conditions	of	D).	Dens.=	organoid	density	at	the	time	of	conditioning	in	Figure	4.14A.	
The	 increase	 in	 SCA1+	 Msc	 cell	 numbers	 could	 be	 caused	 by	 a	 boost	 in	proliferation,	 survival	 or	both.	To	begin	 to	discern	between	 these	possibilities,	we	evaluated	SCA1+	Msc	proliferation	using	EdU	incorporation	as	a	proxy.	An	average	of	6.3%	 of	 SCA1+	Msc	 cells	were	 positive	 for	 EdU	when	 incubated	 in	 Basal	medium,	compared	 to	 10.7%	 and	 10.6%	 in	 high-	 and	 low-density	 liver	 organoid	 CM,	respectively.	Although	this	would	seem	to	suggest	a	pro-proliferative	mode	of	action	of	the	liver	organoid	CM,	the	CM	from	the	S.I.	organoids	supported	a	similar	average	of	9.25%	of	EdU+	SCA1+	Msc	cells	(Figure	4.14F)	despite	not	promoting	SCA1+	Msc	
4.6	Liver	organoid	cells	support	the	growth	of	mesenchymal	SCA1+	
99	
growth	in	Figure	4.14D,E.	It	is	thus	unlikely	that	liver	organoids	sustain	SCA1+	Msc	growth	 only	 via	 mitogens,	 and	 pro-survival	 factors	 may	 also	 be	 involved.	Notwithstanding,	 these	 conclusions	 must	 be	 tested	 further	 in	 light	 of	 the	 lack	 of	biological	replicates.	In	an	independent	experiment,	we	confirmed	the	enhanced	growth	of	SCA1+	Msc	 cells	 in	 the	 presence	 of	 liver	 organoid	 CM,	 and	 found	 that	 it	 was	 almost	comparable	to	culturing	in	the	standard	Basal	+	WNT	CM;	this	was	evident	from	both	the	morphology	and	the	relative	number	of	SCA1+	Msc	cells	(Figure	4.14G,H).	Despite	being	preliminary,	these	results	point	towards	a	soluble	signal	crosstalk	between	liver	SCA1+	Msc	and	ductal/organoid	cells.		
	
Figure	 4.14	 Conditioned	medium	 from	 liver	 organoids	 supports	Msc	 SCA1+	 cell	 growth	 (part	 3).	G)	Brightfield	pictures	of	Msc	SCA1+	cells	after	culturing	 in	unconditioned	Basal	medium,	 liver	organoid	CM	or	standard	 Basal	 +	 WNT	 CM	 medium.	H)	 Quantification	 of	 Msc	 SCA1+	 cell	 numbers	 in	 G).	 Cell	 counts	 are	normalised	to	Basal	control.	N=1,	2	technical	replicates.		
4.7 Strategies	for	the	in	vivo	ablation	of	SCA1+	mesenchymal	
cells	
In	vivo	 loss-of-function	studies	are	necessary	to	 formally	prove	a	regulatory	role	of	SCA1+	Msc	cells	in	ductal-driven	regeneration.	We	deem	best	an	experimental	approach	in	which	the	whole	cell	population	is	ablated,	considering	the	rich	battery	of	signalling	molecules	that	these	cells	express	(Figure	4.7).	The	ideal	strategy	would	thus	 entail	 crossing	 a	 CreERT2	 mouse	 line	 under	 the	 control	 of	 a	 SCA1+	Msc	 cell	specific-promoter	 with	 the	 inducible	 diphtheria	 toxin	 receptor	 mice	 (Buch	 et	 al.,	
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2005),	such	that	temporally	controlled	administration	of	diphtheria	toxin	(DT)	would	result	 in	 specific	ablation	of	 the	CreERT2-expressing	population,	 i.e.	 the	SCA1+	Msc	cells.	Despite	Ly6a	expression	not	being	exclusive	to	the	SCA1+	Msc	population,	we	investigated	the	suitability	of	a	Ly6-Cre	transgenic	mouse	generated	by	Mainardi	and	colleagues	for	our	approach	(Mainardi	et	al.,	2014).	As	a	first	step,	we	crossed	the	Ly6-
Cre	line	with	a	Rosa26-stop-tdTomato	reporter	mouse	in	order	to	assess	the	extent	of	transgene	 expression	 in	 the	 liver	 (Figure	 4.15A).	 Macroscopic	 examination	 of	 the	tissue	 revealed	 extensive	 tomato	 fluorescence	 throughout	 the	 liver	 and	 the	 small	intestine	(Figure	4.15B),	as	well	as	other	examined	organs	like	the	kidney,	the	spleen	and	the	stomach	(data	not	shown).	Such	a	widespread	pattern	of	tdTomato	labelling	is	 suggestive	 of	 early	 embryonic	 expression	 of	 the	 Ly6-Cre	 transgene	 and	consequently	 precludes	 the	 use	 of	 this	mouse	 line	 for	 specifically	 ablating	 hepatic	SCA1+	Msc	in	the	adult.		As	an	alternative,	we	are	planning	to	test	the	suitability	of	a	
Pdgfra-CreERT2	mouse	line	(Rivers	et	al.,	2008).	In	addition	to	Pdgfra	being	a	more	exclusive	 mesenchymal	 marker	 than	 Ly6a	 (Figure	 4.6A),	 the	 use	 of	 a	 tamoxifen-inducible	Cre	should	provide	temporal	control	for	targeting	mice	in	adulthood	only.		
	
Figure	4.15	Ly6-Cre	expression	is	not	exclusive	to	the	liver.		A)	Schematic	of	the	breeding	between	Ly6-Cre	and	Rosa26-stop-tdTomato	mice	to	genetically	label	Ly6	expressing	cells	with	the	tdTomato	reporter	allele.	B)	Brightfield	and	epifluorescence	images	of	WT	liver;	and	Ly6-Cre,	Rosa26-stop-Tomato	liver	and	small	intestine.	Widespread	Ly6	expression	is	detected	in	the	liver	but	also	other	organs	like	the	small	intestine.	
In	 parallel	 to	 CreloxP/iDTR-based	 ablation	 strategies,	 we	 explored	 the	possibility	of	delivering	lentiviral	gene	constructs	to	the	liver	in	collaboration	with	the	laboratory	of	Dr.	Luigi	Naldini	(Figure	4.16,	Figure	4.17).	Although	we	made	use	of	a	ubiquitously	 expressed	PGK-GFP	 lentiviral	 vector	 for	 preliminary	 experiments,	 the	final	 strategy	would	 consist	on	delivering	a	SCA1+	Msc-specific	Cre	 vector	 into	 the	
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Rosa26-iDTR	mice.	Young	pups	(P2)	were	first	injected	with	a	low	viral	dose	(1x107	TU/pup)	of	PGK-GFP	and	were	analysed	for	GFP	fluorescence	4	weeks	later	(Figure	4.16A).	Macroscopically,	very	 little	 fluorescence	was	detected	 in	 the	 injected	 livers	(Figure	4.16B).	H/E	cells	were	 the	most	 targeted	cell	 lineage	 (close	 to	6%	of	GFP+	cells),	whereas	DC	and	SCA1+	Msc	cells	had	minimal	GFP	expression	(less	than	0.5%)	(Figure	4.16C,D).		
	
Figure	4.16	Targeting	of	the	liver	with	low	titre	lentiviruses.		A)	Schematic	depicting	the	delivery	of	low	titre	 (1x107	 TU/pup)	 GFP-expressing	 lentiviruses	 (PGK-GFP	 LV)	 into	 P2	 pups	 and	 analysis	 at	 4	weeks.	B)	Brightfield	 and	 epifluorescence	 images	 of	 uninjected	 and	 LV-injected	 livers.	 Minimal	 GFP	 fluorescence	 is	observed	 in	 the	 treated	 livers.	 C)	 Flow	 cytometric	 analysis	 of	 LV-injected	 livers	 and	 quantification	 of	 the	percentage	of	GFP+	cells	within	the	H/E,	Msc	and	DC	fractions.	N=3	mice,	error	bars	denote	mean	±	SD.	Msc	SCA1+	GFP+	cells	represent	less	than	1%	of	all	Msc	SCA1+	cells.	
Given	the	poor	targeting	of	SCA1+	Msc	cells,	we	tested	two	new	approaches:	a	higher	 viral	 titre	 in	 pups	 (2.5x108	 TU/pup)	 and	 injection	 of	 adult	 mice	 with	 an	immune-evading	 vector	 PGK-GFP.142T	 at	 two	 different	 titres	 (1x109	 and	 3x109)	(Figure	4.17A,B)	(Schmitt	et	al.,	2010).	Already	at	the	whole-mount	level,	livers	were	more	 evidently	 fluorescent	 compared	 to	Figure	4.16B	 (Figure	4.17C).	 Isolated	bile	ducts	did	not	appear	to	be	fluorescent	themselves	but	contained	associated	GFP+	cells	of	different	morphologies	between	the	pup	and	the	adult	(Figure	4.17D).		
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Figure	4.17	Targeting	of	the	liver	with	high	titre	lentiviruses.	A)	Delivery	strategy	of	high	titre	(2.5x108	TU/pup)	GFP-expressing	lentiviruses	(PGK-GFP	LV)	into	P2	pups	and	analysis	at	4	weeks.	B)	Delivery	strategy	of	 low	 (1x109	 TU/adult)	 and	 high	 titre	 (3x109	 TU/adult)	 immune-evasive	 GFP-expressing	 lentiviruses	(PGK.GFP.142T)	 into	8-week	adults	 and	analysis	 at	10	weeks.	C)	Brightfield	 and	epifluorescence	 images	of	uninjected	and	LV-injected	livers	of	pups	and	adults.	Hepatic	GFP	fluorescence	is	much	more	evident	than	in	the	 livers	 of	 Figure	 4.16.	D)	 Brightfield	 and	 epifluorescence	 images	 of	 isolated	 biliary	 ducts.	 GFP+	 biliary-associated	 stromal	 cells	 of	 different	 morphologies	 are	 observed	 between	 the	 injected	 pups	 and	 adults.	
E)	Quantification	of	the	percentage	of	GFP+	cells	within	the	respective	H/E,	Msc	SCA1+	and	DC	fractions	of	the	liver.	N=3	pups,	N=2	adults	with	medium	viral	titre,	N=1	adult	with	high	viral	titre;	error	bars	denote	mean	±	SD.	The	highest	percentage	of	Msc	SCA1+	GFP+	cells	is	~15%.	F)	Immunostaining	of	pup	and	adult	LV-injected	livers	with	SCA1	and	OPN	antibodies.	Periportal	GFP+	SCA1+	Msc	cells	can	be	found	in	the	pup	livers	(arrow	and	magnified	insert),	whereas	adult	livers	exhibit	altered	histology	and	widespread	parenchymal	GFP	positivity.		
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Quantification	of	GFP	expression	in	the	pups	continued	to	show	H/E	cells	as	the	most	infected	lineage,	this	time	with	more	than	20%	of	GFP+	cells.		SCA1+	Msc	cells	showed	an	improved	mean	of	13.3%	GFP	positivity,	compared	to	the	3.9%	of	GFP+	DC.	Of	note,	the	percentage	of	GFP+	cells	decreases	with	time	in	all	lineages	(8	weeks	vs	4	weeks),	likely	due	to	cellular	turnover	(Figure	4.17E).		In	adults,	lentiviral	targeting	is	more	skewed	towards	the	H/E	lineage	(>	30%	GFP+	cells)	regardless	of	the	dose,	whereas	the	percentages	of	GFP+	SCA1+	Msc	and	GFP+	DC	 at	 the	higher	dose	 are	 comparable	 to	 those	of	 the	pups	 at	 4	weeks	post-injection	(Figure	4.17E).	Notably,	2	out	3	of	the	high-dose	injected	adults	died	during	the	course	of	the	experimental	procedure.	Liver	tissue	sections	of	the	surviving	animal	exhibited	widespread	parenchymal	GFP+	cells	and	altered	histology	reminiscent	of	a	damaged	liver	(Figure	4.17F).	In	contrast,	the	livers	of	the	pups	appeared	normal	and	contained,	 amongst	 other	 GFP+	 cells,	 periportal	 GFP+	 SCA1+	 Msc	 cells.	 Still,	 the	percentage	of	SCA1+	Msc	targeting	remains	very	low,	making	it	insufficient	for	in	vivo	cell	ablation.		
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5.1 Generation	 of	mouse	 and	 organoid	 tools	 to	 study	 cell	
aggregation	
Evidence	 in	 Chapter	 4	 highlights	 the	 ability	 of	 SCA1+	 Msc	 cells	 to	 sustain	organoid	growth	via	secreted	paracrine	factors	in	vitro.	Yet,	in	the	homeostatic	liver,	SCA1+	 Msc	 cells	 are	 found	 in	 the	 immediate	 vicinity	 of	 DC,	 at	 times	 physically	wrapping	around	the	biliary	duct	epithelium	(Figure	4.3B-1),	raising	the	question	of	whether	direct	cell-cell	contact	could	contribute	to	the	crosstalk	between	these	two	cell	populations.	A	 critical	 prerequisite	 for	 contact-based	 experiments	 is	 the	 ability	 to	unequivocally	 distinguish	 and	 follow	 the	 spatial	 coordinates	 of	 the	 two	 cell	populations	in	time	(DC	and	SCA1+	Msc).	To	do	so,	we	chose	to	utilise	cells	indelibly	marked	with	different	 fluorescent	 reporters,	 taking	 advantage	of	 the	Rosa26-nTnG	and	 the	 Rosa26-mTmG	 mouse	 lines.	 The	 Rosa26-nTnG	 allele	 consists	 of	 a	 CMV	enhancer/chicken	 beta-actin	 core	 promoter,	 a	 loxP-flanked	 nuclear	 tdTomato	cassette	and	a	nuclear	GFP	cassette	inserted	in	the	endogenous	Rosa26	locus	(Figure	5.1A)	 (Prigge	 et	 al.,	 2013).	 In	 the	 absence	 of	 Cre	 mediated	 recombination,	 the	
tdTomato	gene-	not	the	GFP-	is	constitutively	expressed	and	is	effectively	targeted	to	the	nucleus	by	the	C-terminus	SRm160	domain	(Figure	5.1A).		We	analysed	the	livers	of	Rosa26-nTnG	mice	by	flow	cytometry	according	to	our	standard	protocol	(Figure	3.2B)	and	gated	for	Msc	and	DC	cells.	As	expected,	both	populations	were	almost	exclusively	tdTomato+	-95%	of	Msc	cells	and	99.2%	of	DC-	while	there	was	a	negligible	percentage	of	GFP+	cells	(Figure	5.1B).	What	this	signifies	is	 that	both	nuclear	 tdTomato-labelled	DC	and	Msc	cells	can	be	effectively	 isolated	from	 these	 mice	 when	 necessary	 (e.g.	 Figure	 5.7).	 In	 addition,	 given	 that	 DC	 are	capable	of	long-term	in	vitro	expansion	as	organoid	cultures	(Huch	et	al.,	2013),	we	isolated	 tdTomato+	 DC	 and	 generated	 a	 line	 of	 liver	 organoids	 constitutively	expressing	 nuclear	 tdTomato+	 for	 use	 in	 further	 experiments	 (Figure	 5.1C).	Epifluorescence	 of	 the	 organoids	 confirmed	 the	 nuclear	 pattern	 of	 tdTomato	expression	and	a	lack	of	GFP	fluorescence	(Figure	5.1C).		
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Figure	5.1	Analysis	of	Rosa26-nTnG	livers	and	generation	of	nuclear	tdTomato	reporter	organoids.	A)	Schematic	 explaining	 the	 Rosa26-nTnG	mouse	 line,	 which	 exhibits	 constitutive	 nuclear	 expression	 of	 the	tdTomato	 reporter	 in	 all	 cells.	 B)	 Flow	 cytometry	 analysis	 of	 tdTomato	 fluorescence	 in	 the	 DC	 and	 Msc	populations	of	Rosa26-nTnG	livers.	C)	Establishment	of	a	Rosa26-nTnG	liver	organoid	line	from	tdTomato+	DC	sorted	in	B).	The	pattern	of	tdTomato	fluorescence	appears	to	be	nuclear	and	no	green	fluorescence	is	observed.	
Being	loxP-flanked,	the	nuclear	tdTomato	cassette	of	the	Rosa26-nTnG	can	be	excised	through	Cre-mediated	recombination,	leading	to	in-frame	expression	of	the	newly	created	Rosa26-nGFP	allele.	We	thus	crossed	the	Rosa26-nTnG	line	with	a	Sox2-
Cre	transgenic	mouse	aiming	to	generate	another	reporter	line	for	our	cultures;	we	hypothesised	that	the	early	developmental	expression	of	Sox2	(Wood	and	Episkopou,	1999)	would	result	in	nearly	ubiquitous	Cre-mediated	recombination	of	the	Rosa26-
nTnG	allele	in	most	tissues	of	the	mouse	(Figure	5.2A).	Earclip	biopsies	of	F1	pups	are	a	 simple	 and	 accessible	 means	 of	 assaying	 recombination.	 In	 Figure	 5.2B,	representative	earclips	 from	Rosa26-nTnG	and	Sox2-Cre,	Rosa26-nGFP	pups	display	tdTomato	and	GFP	fluorescence	respectively.	Recombination	was	also	evident	in	the	livers	of	Rosa26-nGFP	mice,	although	with	different	degrees	of	efficiency	according	to	the	cell	lineage:		22.6%	of	Msc	cells	were	GFP+	and	0.9%	were	tdTomato+,	while	84.8%	of	DC	were	GFP+	and	14.5%	were	tdTomato+	(Figure	5.2C).	Sectioned	livers	confirmed	the	above	results,	as	the	tissue	predominantly	displays	GFP+	cells	and	only	a	handful	of	 tdTomato+	 cells	 (Figure	 5.2D).	 As	 done	 in	 Figure	 5.1C,	 we	 sorted	 GFP+	 DC	 and	established	 Rosa26-nGFP	 organoids	 that	 exclusively	 express	 nuclear	 GFP	 (Figure	5.2E).	
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Figure	5.2	Analysis	of	Sox2-Cre,	Rosa26-nGFP	livers	and	generation	of	nuclear	GFP	reporter	organoids.	
A)	Breeding	strategy	between	Rosa26-nTnG	and	Sox2-Cre	mice.	In	the	F1	pups,	Sox2Cre-mediated	excision	of	the	tdTomato	cassette	should	give	rise	to	constitutive	nuclear	expression	of	the	GFP	reporter	in	most	tissues	of	the	mouse.	B)	Epifluorescence	pictures	of	ear	clips	from	the	F1	pups.	The	Sox2-Cre,	Rosa26-nGFP	pup	expresses	GFP	 but	 not	 tdTomato.	 C)	 Flow	 cytometry	 analysis	 of	 GFP	 and	 tomato	 fluorescence	 in	 the	 DC	 and	 Msc	populations	of	Rosa26-nTnG	 livers.	D)	Tissue	section	of	a	Rosa26-nTnG	 liver	displaying	predominantly	GFP+	cells	and	some	residual	tdTomato+	cells.	E)	Establishment	of	a	Sox2-Cre,	Rosa26-nGFP	liver	organoid	line	from	GFP+	DC	sorted	in	C).	The	pattern	of	GFP	fluorescence	appears	to	be	nuclear	and	no	tdTomato	fluorescence	is	observed.	
A	main	advantage	of	nuclear	reporter	lines	like	the	ones	generated	above	is	the	straightforward	 quantification	 of	 individual	 cell	 numbers,	 assuming	 that	mononuclear	 cells	 are	 utilised.	 One	 drawback,	 however,	 is	 the	 lack	 of	 visibility	 of	cellular	outlines	and	membrane	processes.	A	complementary	model	thus	lies	in	the	
Rosa26-mTmG	allele,	which	essentially	represents	the	membrane	counterpart	of	the	
Rosa26-nTnG	 construct	 -containing	 a	 CMV	 enhancer/chicken	 beta-actin	 core	promoter,	 a	 loxP-flanked	membrane-targeted	 tdTomato	 cassette	 and	 a	membrane-
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targeted	GFP	cassette	inserted	in	the	Rosa26	 locus	(Muzumdar	et	al.,	2007)	(Figure	5.3A).	 Analysis	 of	 a	 Rosa26-mTmG	 liver	 showed	 the	 totality	 of	 DC	 labelled	 with	tdTomato	 fluorescence,	whilst	 75%	 of	 Msc	 cells	 were	 tdTomato+	 and	 25%	 	 were	unlabelled	 (Figure	 5.3B).	 We	 generated	 organoids	 expressing	 the	 membrane	tdTomato	reporter	(Figure	5.3C)	and	crossed	the	Rosa26-mTmG	and	Sox2-Cre	mouse	lines	to	obtain	F1	pups	with	membrane	GFP	expression	(Figure	5.4A).	Earclip-based	genotyping	 of	 the	 first	 litter	 has	 shown	 cases	 of	 successful	 recombination	 (Figure	5.4B).	The	liver	of	these	mice	will	thus	be	analysed	as	in	Figure	5.2	and	membrane	GFP+	organoids	will	be	established.		
	
Figure	5.3	Analysis	of	Rosa26-mTmG	livers	and	generation	of	membrane	Tomato	reporter	organoids.		
A)	Schematic	explaining	the	Rosa26-mTmG	mouse	line,	which	exhibits	constitutive	membrane	expression	of	the	tdTomato	 reporter	 in	 all	 cells.	 B)	 Flow	 cytometry	 analysis	 of	 tdTomato	 fluorescence	 in	 the	 DC	 and	 Msc	populations	of	Rosa26-mTmG	livers.	C)	Establishment	of	a	Rosa26-mTmG	liver	organoid	line	from	tdTomato+	DC	sorted	in	B).	The	pattern	of	tomato	fluorescence	appears	to	be	localised	to	the	cell	membrane	and	no	green	fluorescence	is	observed.	
In	vivo,	damage-induced	bi-potential	progenitors	are	labelled	by	the	stem	cell	marker	Lgr5	(Huch	et	al.,	2013).	Although	mesenchyme-sustained	organoids	express	
Lgr5	 (Figure	 4.13D),	 the	 spatial	 resolution	 of	 Lgr5+	 cells	 within	 the	 organoid	 is	unknown,	 which	 becomes	 of	 particular	 relevance	 in	 the	 face	 of	 contact-based	 co-cultures.	Given	the	lack	of	good	antibodies	against	LGR5,	we	generated	Lgr5-CreERT,	
Rosa26-stop-tdTomato	mice	by	breeding	Lgr5-CreERT2	 (Huch	et	al.,	2013)	with	the	
Rosa26-stop-tdTomato	reporter	(Figure	5.5A)	and	derived	an	organoid	line	from	these	mice.	Administration	of	4-hydroxytamoxifen	(4-OHT)	to	the	organoids	is	expected	to	
Chapter	5	Ductal	cell	expansion	is	regulated	by	contact	from	SCA1+	mesenchymal	cells	
in	a	ratio-dependent	manner	
110	
switch	on	expression	of	the	tdTomato	reporter	in	Lgr5+	cells	(Figure	5.5B).	Indeed,	we	 observed	 that	 while	 DMSO	 controls	 showed	 no	 fluorescence,	 4-OHT-treated	organoids	 (at	 both	 1	µM	 and	 10	µM)	 contained	 scattered	 tdTomato+	 cells	 at	 24h,	whose	numbers	increased	when	the	culture	was	left	to	grow	for	8	days	(Figure5.5C).	
	
Figure	5.4	Analysis	of	Sox2-Cre,	Rosa26-mGFP	livers.	A)	Breeding	strategy	between	Rosa26-mTmG	and	Sox2-
Cre	mice.	In	the	F1	pups,	Sox2Cre-mediated	excision	of	the	tdTomato	cassette	should	give	rise	to	constitutive	membrane	expression	of	the	GFP	reporter	in	most	tissues	of	the	mouse.	B)	Epifluorescence	pictures	of	ear	clips	from	the	F1	pups.	The	Sox2-Cre,	Rosa26-mGFP	pup	expresses	GFP	but	not	tdTomato.	
Beyond	fluorescent	reporter	 lines,	we	wished	to	generate	tools	 to	modulate	the	presence	of	the	mesenchymal	and	epithelial	fractions	within	the	co-cultures.	With	that	aim,	we	have	crossed	Rosa26-stop-iDTR	mice	with	Ly6-Cre	and	Rosa26-CreERT2	mice	respectively	(Figure	5.6A,B),	and	have	already	obtained	heterozygous	pups	for	both	genotypes	(Figure	5.6C,D).	The	rationale	for	these	crosses	is	to	isolate	primary	liver	DC	(Rosa26-CreERT2,	Rosa26-stop-iDTR)	and	SCA1+	Msc	cells	(Ly6-Cre,	Rosa26-
stop-iDTR)	 that	 can	 be	 inducibly	 ablated	 during	 in	 vitro	 co-culturing.	 Due	 to	 time	constraints,	 these	 experiments	 will	 be	 carried	 out	 after	 submission	 of	 this	dissertation.	
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Figure	 5.5	 Generation	 and	 validation	 of	 Lgr5-CreERT2;	 Rosa26-Stop-tdTomato	 reporter	 organoids.	
A)	Breeding	 strategy	 between	Rosa26-Stop-tdTomato	 and	Lgr5-CreERT2	mice.	 F1	 pups	 containing	 both	 alleles	(Lgr5-CreERT2,	Rosa26-Stop-tdTomato)	were	selected	for	liver	harvest	and	organoid	generation.	B)	Schematic	of	the	 pulse-treatment	 of	 Lgr5-CreERT2,	 Rosa26-Stop-tdTomato	 organoids	with	 4-hydroxytamoxifen	 (4-OHT)	 for	24h.	Lgr5-expressing	cells	are	expected	to	start	expressing	the	tdTomato	reporter.	C)	Brightfield	and	fluorescence	images	of	DMSO	or	4-OHT	(1	μM	and	10	μM)	pulse-treated	organoids	at	24h	and	8	days	following	treatment.	Lgr5+	cells	are	labelled	with	tdTomato	fluorescence	and	expand	with	time.	
	
	
Figure	5.6	Generation	of	mouse	lines	to	inducibly	ablate	cell	populations.	A)	Breeding	strategy	between	
Rosa26-Stop-iDTR	and	Ly6-Cre	mice	to	generate	F1	pups	heterozygous	for	both	alleles	(Ly6-Cre,	Rosa26-Stop-
iDTR).	B)	PCR-based	genotyping	of	an	F1	litter	from	A).	Representative	gel	electrophoresis	showing	that	pups	‘d’	and	 ‘e’	have	 inherited	both	 the	Ly6-Cre	 allele	 (top	panel,	mutant	band)	and	 the	Rosa26-Stop-iDTR	 	 allele	(bottom	panel,	mutant	band).	C)	Breeding	strategy	between	Rosa26-Stop-iDTR	and	Rosa26-CreERT2	mice	to	generate	F1	pups	heterozygous	for	both	alleles	(Rosa26-CreERT2,	Rosa26-Stop-iDTR).	D)	PCR-based	genotyping	of	an	F1	litter	from	C).	Representative	gel	electrophoresis	showing		that	all	pups	have	inherited	both	the	Rosa26-
CreERT2	allele	(top	panel,	mutant	band)	and	the	Rosa26-Stop-iDTR		allele	(bottom	panel,	mutant	band).	
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5.2 Using	 microfluidics	 to	 promote	 aggregation	 between	
organoids	and	SCA1+	mesenchymal	cells	
Our	 in	 vitro	 3D	 Matrigel	 co-cultures	 (Figure	 4.11A)	 were	 unsuitable	 for	assaying	 cell-cell	 contact	 due	 to	 the	 large	 volume	 of	 matrix	 in	 which	 the	 cell	populations	were	cultured,	resulting	in	only	spontaneous	-and	rare-	meeting	of	the	two	 cell	 types.	To	 circumvent	 this	problem,	we	 tested	microfluidics	 as	 a	means	of	encapsulating	cells	into	smaller-sized	gels.	The	hypothesis	being	that	confining	cells	within	smaller	volumes	would	increase	chances	of	cell-cell	contact.		
	
Figure	 5.7	Micro-gel	 encapsulation	 of	 liver	 organoid	 and	Msc	 SCA1+	 cells.	A,B)	 Diagram	 detailing	 the	process	of	cell	encapsulation:	organoid	and	Msc	SCA1+	cells	expressing	two	different	fluorescent	reporters	are	trypsinised,	resuspended	in	agarose	and	inserted	into	microfluidic	chips	in	order	to	generate	agarose	micro-droplets	containing	one	cell	type	(A)	or	a	mixture	of		the	two	(B).		
The	 experimental	 set-up	 consists	 in	 dissociating	 cultures	 (organoids	 and	SCA1+	Msc	 cells)	 into	 single	 cells,	 resuspending	 them	 in	 a	matrix	 of	 choice	 –	 low-melting	point	agarose	for	ease	of	manipulation–	and	feeding	the	cell/matrix	mixture	into	custom-designed	microchips	(Figure	5.7A,B).	Two-inlet	chips	were	designed	to	load	the	organoid	and	SCA1+	Msc	cells	separately	and	to	mix	 them	within	 the	chip	(Figure	5.7B),	control	organoid	cells	are	loaded	alone	and	mixed	with	an	equivalent	volume	 of	 empty	 matrix	 (Figure	 5.7A).	 Microgel	 droplets	 are	 formed	 on	 the	 chip	
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through	 non-miscibility,	when	 the	 cell/matrix	 solution	 is	 injected	with	 flowing	 oil	(refer	to	Figure	2.1	in	Materials	and	Methods).	Given	that	the	dimensions	of	the	chip	channels	determine	 the	 size	of	 the	microgels	 formed,	we	 limited	 their	diameter	 in	order	 to	 generate	 small	 microgels	 and	 thus	 maximise	 the	 likelihood	 of	 contact	between	any	 co-encapsulated	 cells.	 Theoretically,	 the	mixing	of	 cells	 in	 a	1:1	 ratio	should	 give	 rise	 to	microgels	 containing	 at	 least	 one	 cell	 of	 each	 type;	 in	 practice,	however,	multiple	permutations	are	observed	as	depicted	in	Figure	5.7B	(scheme),	and	the	majority	of	gels	contain	no	cells.	Once	demulsified,	the	cell-containing	microgels	can	be	manipulated	as	desired.	We	seeded	them	into	8	µ-well	ibidi	dishes	layered	with	either	agarose	or	matrigel	as	3D	matrix	(Figure	5.8A).	As	with	our	standard	co-cultures	in	Basal	+	WNT	CM	medium	(Figure	4.11),	robust	organoid	formation	is	supported	only	in	the	presence	of	SCA1+	Msc	 cells	 (Figure	 5.8B).	 Moreover,	 despite	 choosing	 agarose	 as	 a	 matrix	 for	encapsulation,	 it	 was	 clear	 that	 the	 organoids	 do	 not	 grow	well	 in	 it	 and	 require	seeding	into	Matrigel	instead	(Figure	5.8B).	Of	utmost	importance	was	the	fact	that,	within	the	cultures,	we	managed	to	find	chimeric	organoid	structures	containing	both	epithelial	(GFP+)	and	mesenchymal	(tdTomato+)	cells	(Figure	5.8C-1).	The	layout	of	the	 chimeras	 is	 reminiscent	 of	 the	 spatial	 arrangement	between	ductal	 and	SCA1+	mesenchymal	 cells	 in	 vivo	 (Figure	 5.8C-2),	 whereby	 the	 mesenchymal	 cell(s)	 are	found	on	the	outer	surface	of	the	biliary	epithelium,	never	on	the	inside.			
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Figure	 5.8	 Aggregation	 of	 liver	 organoid	
and	Msc	SCA1+	cells	via	microfluidic-based	
encapsulation.	A)	The	cell-containing	agarose	gels	 generated	 in	 Figure	 5.7	were	 embedded	within	agarose	or	matrigel	 layers	 in	μ-slide	8	well	 ibidi	 dishes	 for	 imaging.	 B)	 Organoid	formation	of	cells	seeded	as	in	A)	and	cultured	for	8	days	in	Basal	+	WNT	CM.	Organoids	only	grow	robustly	in	matrigel	and	in	the	presence	of	 the	 Msc	 SCA1+	 cells.	 C1)	 Confocal	 image	(single	z-stack)	of	a	chimeric	3D	structure	from	B)	 (Matrigel)	 containing	 aggregated	organoid	cells	(nGFP)	and	Msc	SCA1+	cells	(ntdTomato).	
C2)	 Confocal	 image	 (single	 z-stack)	 of	 a	zoomed-in	 biliary	 duct	 structure	 from	 a	
Pdgfra-H2B-GFP	mouse	liver	containing	ductal	cells	(OPN,	white)	and	mesenchymal	(PDGFRα,	red)	SCA1+		(green)	cells.	Nuclei	are	labelled	by	Hoechst	(blue).		
The	 generation	 of	 ductal/mesenchymal	 chimeras	 via	 microfluidic	encapsulation	 is	 inefficient	 (<25%);	 accordingly,	 we	 opted	 to	 locate	 and	 follow	aggregated	 structures	 via	 in	 vivo	 time-lapse	 imaging.	 Moreover,	 because	 the	 vast	majority	of	ductal	cells	never	become	competent	to	re-form	organoids	after	single	cell	seeding	(efficiency	is	rarely	above	10%),	we	filmed	structures	from	day	4	to	day	5	of	seeding,	when	 the	 process	 of	 organoid	 formation	 (if	 any)	 has	 already	 begun.	 In	 a	microfluidic-based	 co-culture	 between	 GFP+	 organoid	 and	 tdTomato+	 SCA1+	mesenchymal	cells,	we	noticed	that	non-chimeric	organoids	(GFP+	only)	augment	in	size	as	time	progresses	and	maintain	a	standard	cystic	morphology	(Figure	5.9,	blue	arrowheads),	 as	 expected	 from	 the	positive	 effect	 of	 SCA1+	Msc-derived	mitogenic	factors;	 in	 contrast,	 chimeric	 organoids	 (where	 ductal	 GFP+	 and	 mesenchymal	tdTomato+	cells	contact	each	other)	appear	to	shrink	over	time	and	exhibit	an	altered	morphology	(Figure	5.9,	orange	arrowheads).	
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Figure	 5.9	 Chimeric	 organoids	
exhibit	 altered	 growth	 dynamics.	Video	 stills	 of	 max-projected	 non-chimeric	(nGFP+)	and	chimeric	(nGFP+	tdTomato+)	organoids	 from	the	same	well	 of	 a	 d4	 co-culture	 (as	 in	Figure5.8B,	matrigel)	 filmed	during	a	10-hour	 interval.	 The	 orange	 arrows	point	 to	 chimeric	organoids	 reducing	in	 size	 over	 time.	 The	 blue	 arrows	show	 non-chimeric	 organoids	growing	as	expected.		
	When	 studied	 systematically,	 it	 seems	 that	 organoid	 growth	 dynamics	 are	indeed	altered	upon	contact	with	SCA1+	mesenchymal	cells,	and	this	is	dependent	on	the	ratio	of	mesenchymal	to	ductal	cells	per	structure	(Figure	5.10).	We	followed	a	series	 of	 organoid	 structures	 and	 categorised	 them	 according	 to	 ranges	 of	 SCA1+	Msc/organoid	 cell	 ratios:	 0,	 >0-0.1,	 >0.1-1,	 >1-10,	 >10-100.	 Immunofluorescent	images	 at	 d4	 and	 d5	 show	 a	 very	 evident	 inverse	 correlation	 between	 SCA1+	Msc/organoid	 cell	 ratio	 and	 organoid	 growth	 (Figure	 5.10A).	 When	 an	 organoid	structure	does	not	contact	the	mesenchyme	or	only	contacts	a	small	ratio	of	these	cells	(0-0.1),	nGFP+	organoid	cells	double	in	numbers	from	d4	to	d5	(Figure	5.10B).	On	the	other	hand,	 organoid	 cell	 numbers	do	not	 tend	 to	 increase	 at	mesenchymal	 ratios	higher	than	0.1	(Figure	5.10B).	A	very	similar	trend	was	observed	for	organoid	area	(Figure	5.10C).	Of	note,	 chimeric	 structures	with	 ratios	of	1-10	or	10-100	are	 less	represented	in	the	quantifications	because	they	are	rare	in	culture.	SCA1+	Msc	cells	do	not	appear	to	proliferate	within	the	chimeric	structures,	as	their	numbers	remain	relatively	steady	for	all	SCA1+	Msc/organoid	ratios	(Figure	5.10D).	This	remains	to	be	verified	 for	periods	 longer	 than	24h,	as	 the	mesenchymal	 cell-cycle	may	be	 longer	than	the	ductal	one.	
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Figure	5.10	High	ratios	of	contacting	Msc	SCA1+	cells	inhibit	organoid	growth.	A)	Video	stills	of	organoid	structures	with	increasing	ratios	of	aggregated	Msc	SCA1+	to	organoid	cells	(ranges	of	0,	>0-0.1,	>0.1-1,	>1-10,	>10-100)	filmed	from	d4	to	d5	of	culture	in	Basal	+	WNT	CM	medium.	B,C,D)	Quantification	of	the	organoid	structures	filmed	in	A)	in	terms	of	the	change	in	number	of	GFP+	organoid	cells	(B),	change	in	organoid	area	(C)	and	change	in	number	of	tdTomato+	Msc	SCA1+	cells	(D)	from	d4	to	d5.	Results	are	expressed	as	fold	change	of	d4.	N=2	independent	experiments,	median	±	IQR	is	plotted.	High	ratios	of	Msc	SCA1+	to	organoid	cells	hinder	organoid	growth.	
We	 hypothesised	 that	 the	 contact-based	 reduction	 in	 organoid	 growth	 in	Figure	5.10	is	at	least	partly	due	to	a	diminished	rate	of	ductal	cell	proliferation.	We	assayed	this	through	staining	of	EdU	incorporation,	which	very	clearly	demonstrates	a	proliferative	dichotomy	between	mesenchyme	contacted	(GFP+	+	tdTomato+)	and	non-contacted	 (GFP+)	 organoid	 structures	 (Figure	 5.11A).	 The	 latter	 contain	 an	average	of	50%	of	EdU+	cells,	whereas	this	is	almost	halved	for	structures	containing	0-0.1	 SCA1+	 mesenchymal/organoid	 cells;	 higher	 ratios	 of	 mesenchymal	 cells	completely	abolish	ductal	cell	proliferation	(Figure	5.11B).		
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Figure	5.11	High	ratios	of	contacting	Msc	SCA1+	cells	inhibit	ductal	proliferation.	A)	EdU	immunostaining	of	non-chimeric	(nGFP+)	and	chimeric	(nGFP+	tdTomato+)	organoids	from	the	same	well	of	a	d5	co-culture.	B)	Quantification	 of	 the	 percentage	 of	 EdU+	 organoid	 cells	 according	 to	 the	 ratio	 of	 aggregated	Msc	 SCA1+	 to	organoid	cells.	High	ratios	of	Msc	SCA1+	to	organoid	cells	reduce	ductal	cell	proliferation	N=2,	median	±	IQR	is	plotted.	OC:	organoid	cell.		
	
Figure	 5.12	 High	 ratios	 of	 contacting	 Msc	 SCA1+	 cells	 induce	 non-cystic	 organoid	 morphology.	 A)	Confocal	 images	 (single	 z-stacks)	 of	 chimeric	 organoids	 displaying	 cystic	 morphology	 with	 single	 layer	epithelium	 (left	 panel)	 vs	 non-cystic	 morphology	 with	 pseudo-stratified	 epithelium	 (right	 panel).	 B)	Quantification	of	organoid	morphology	according	to	the	ratio	of	aggregated	Msc	SCA1+	to	organoid	cells.	High	ratios	of	Msc	SCA1+	to	organoid	cells	 induce	non-cystic	morphology	with	pseudo-stratified	epithelium.	N=2,	mean	percentages	are	plotted.	
The	 proliferative	 defect	 of	 the	 mesenchyme-contacted	 organoids	 is	accompanied	by	an	altered	epithelial	morphology	that	is	particularly	conspicuous	in	single	 z-stack	 confocal	 images	 (Figure	 5.12A).	 Traditionally,	 liver	 organoids	 are	characterised	by	a	single	 layer	epithelium	and	cystic-like	morphology	containing	a	lumen.	Organoids	containing	a	 low	ratio	of	SCA1+	mesenchymal	cells	preserve	 this	traditional	epithelial	morphology	(Figure	5.12A,	left	panel);	whereas	an	often	pseudo-stratified	epithelium	is	commonly	observed	in	chimeras	of	higher	mesenchymal	ratios	(Figure	5.12A,	right	panel).	As	before,	results	were	quantified	and	validated	according	to	the	ranges	of	SCA1+	Msc/organoid	cell	ratios	(Figure	5.12B).	
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Because	 dying	 or	 overgrown	 organoids	may	 exhibit	 altered	morphology	 as	that	 of	 the	 chimeras,	 we	wished	 to	 assess	whether	mesenchymal	 contact	 induces	epithelial	apoptosis.	We	first	evaluated	the	quality	of	cleaved	caspase	3	staining	–a	marker	 of	 apoptosis–	 in	 3D	 matrigel	 embedded	 cultures,	 given	 that	 antibody	penetration	 can	 be	 hindered	 by	 the	 matrigel	 matrix.	 For	 this	 we	 used	 healthy	organoids	 and	 organoids	 treated	 with	 the	 apoptosis-inducing	 drug	 camptothecin	(CPT);	as	expected,	cleaved	caspase	3	staining	was	observed	in	CPT-treated	but	not	healthy	Ki67+	organoids	(Figure	5.13A),	thus	validating	the	staining.	In	the	contact-based	co-culture,	we	did	detect	cleaved	caspase	3+	cells	within	the	chimeras	(Figure	5.13B),	seemingly	more	frequently	in	those	with	higher	number	of	mesenchymal	cells.	This	 was	 nonetheless	 a	 preliminary	 experiment	 and	 formal	 quantifications	 are	pending.	
	
Figure	5.13	Contact	 from	Msc	SCA1+	cells	may	induce	apoptosis.	A)	Validation	of	 the	cleaved	caspase	3	immunostaining	 in	 healthy	vs	 camptothecin	 (CPT,	 10μM,	 24h)	 treated	 organoids.	 Cells	 positive	 for	 cleaved	caspase	3	are	only	observed	in	the	CPT-treated	organoids.	B)	Immunostaining	of	chimeric	(nGFP+	tdTomato+)	organoids	of	a	d5	co-culture	with	Ki67	and	cleaved	caspase	3	antibodies.	
Altered	organoid	morphology	may	also	bespeak	of	a	differentiation	switch:	the	epithelium	 of	 progenitor-enriched	 organoids	 differs	 from	 that	 of	 more	 columnar	mature	ductal	cells	and	cuboidal	hepatocytes.	Because	of	this,	we	wished	to	evaluate	the	 differentiation	 status	 of	 chimeric	 organoids	 in	 culture.	 The	 low	 efficiency	 of	chimera	formation	meant	that	whole-well	RNA	analysis	of	the	co-cultures	could	not	be	 carried	 out;	 instead,	we	devised	 a	 strategy	 in	which	 individual	 organoids	were	handpicked	based	on	 their	morphology	(cystic	vs	non	cystic),	 scored	 for	 tdTomato	
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fluorescence	and	sorted	 in	 the	 following	4	populations:	 cystic	 chimera,	 cystic	non-chimera,	 non-cystic	 chimera	 and	 non-cystic	 non-chimera	 (Figure	 5.14A).	 Most	abundant	 amongst	 the	 picked	 organoids	were	 cystic	 non-chimeras	 and	 non-cystic	chimeras,	as	shown	in	Figure	5.14B.		Gene	expression	analysis	of	the	picked	structures	showed	 very	 variable	 results	 amongst	 biological	 replicates.	 Chimeric	 organoids,	particularly	non-cystic	ones,	showed	a	tendency	towards	increased	hepatocyte	gene	expression	–	Glu1,	Ttr	and	Hnf4a,	but	not	the	more	mature	marker	Alb,	which	was	not	detected.	In	contrast,	the	progenitor	and	ductal	markers,	Tacstd2	(TROP2)	and	Krt19	respectively,	appeared	to	be	expressed	more	 in	the	cystic	chimeras	(Figure	5.14C).	The	pronounced	variability	in	gene	expression	is	likely	reflective	of	the	low	number	of	picked	organoids	per	biological	replicate	(see	Figure	legend),	and	call	for	a	more	in-depth	transcriptomic	analysis.	
	
Figure	5.14	Gene	expression	analysis	of	aggregated	organoids.	A)	Strategy	for	sorting	chimeric	and	non-chimeric	 organoids	 in	 a	 mixed	 co-culture	 as	 in	 Figure5.9:	 structures	 are	 mouth	 pipetted	 based	 on	 their	morphology	(cystic,	non-cystic),	sorted	according	to	tomato	fluorescence	and	collected	for	RNA.	A	total	of	8	cystic	chimeric	organoids,	35	cystic	non-chimeric	organoids,	33	non-cystic	chimeric	organoids	and	9	non-cystic	non-chimeric	organoids	were	collected	from	2	independent	experiments.	B)	Representative	images	of	a	picked	cystic	non-chimeric	organoid	(left)	and	a	non-cystic	chimeric	organoid	(right).	C)	qPCR	analysis	of	the	organoids	from	A,B).	2∆Ct	values	are	normalised	to	the	housekeeping	gene	Hprt	and	are	expressed	as	fold	change	relative	to	the	cystic	non-chimeric	organoids	(green	dots).		N=2,	except	for	non-chimera	non-cystic	organoids	(blue	dots,	N=1);	mean	±	SD	values	are	plotted.		
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5.3 An	 alternative	 2D	 matrigel	 co-culture	 system	 to	
promote	cell-cell	aggregation	
A	key	disadvantage	of	the	microfluidic-based	co-cultures	in	Section	5.2	is	the	lack	of	control	on	the	cell-to-cell	ratios	that	aggregate	with	each	other,	not	to	mention	the	 low	 efficiency	 of	 aggregation.	 In	 addition,	 the	 technique	 relies	 on	 high	 cell	concentrations,	 which	 is	 often	 difficult	 to	 achieve	 for	 freshly	 sorted	 primary	populations	 like	 SCA1+	Msc	 and	DC.	 For	 this	 reason,	we	developed	 a	 new	 contact-permissive	 co-culture	method	wherein	 limited	 cell	 numbers	 (as	 low	as	5000	 from	each	population)	are	seeded	in	96-well	plates	on	a	2D	layer	of	matrigel	(Figure	5.15A).	In	 the	 immediate	 hours	 after	 seeding,	 tdTomato+	 organoid	 and	 nGFP+	 SCA1+	mesenchymal	cells	are	found	randomly	interspersed	on	the	2D	matrix,	yet	by	day	2,	self-organised	3D	aggregates	containing	both	cell	types	are	observed	(Figure	5.15A).	At	a	1:1	ratio	of	cell	mixing,	this	method	generates	chimeras	at	much	higher	efficiency	compared	to	microfluidics	(almost	100%).	Because	of	this,	we	can	study	the	effect	of	mesenchymal-to-ductal	 cell	 contact	 at	 the	 whole	 population	 level	 and	 not	 on	 an	organoid	per	organoid	basis.		
	
Figure	5.15	An	alternative	2D	matrigel	co-culture	method	to	promote	cell-cell	aggregation.	Strategy	for	the	co-culture:	a	low	number	of	the	two	cell	populations	(e.g.	5000	DC	and	5000	Msc	SCA1+	cells)	are	mixed	together	and	seeded	in	a	96-well	plate	on	top	of	a	2D	layer	of	matrigel.	At	d0	the	two	cell	 types	are	evenly	scattered	on	the	matrigel	surface,	but	within	2	days	they	aggregate	into	3D	organoids	structures	containing	ductal	cells	(ntdTomato+)	and	Msc	SCA1+	cells	(nGFP+).	
Using	 this	 novel	 method,	 we	 performed	 experiments	 in	 which	 increasing	numbers	of	PDGFRα+	SCA1+	Msc	(nGFP+)	are	seeded	with	a	fixed	number	of	sorted	DC	(unlabelled)	or	organoid	cells	(OC,	nuclear	tdTomato+)	(Figure	5.16A).	The	cells	were	cultured	 in	Basal	+	WNT	CM,	or	 in	EM	supplemented	with	WNT	CM	in	an	effort	 to	boost	 SCA1+	 Msc	 survival.	 In	 the	 absence	 of	 mesenchyme	 (0:1	 ratio),	 organoid	
5.3	An	alternative	2D	matrigel	co-culture	system	to	promote	cell-cell	aggregation	
121	
formation	is	more	efficient	when	starting	the	culture	with	OC	than	DC,	as	expected	since	organoid	cells	are	highly	proliferative,	and	in	EM	+	WNT	CM	than	in	Basal	+	WNT	CM	medium,	given	 that	exogenous	growth	 factors	are	supplemented	 in	 the	 former	(Figure	5.16A	first	column,	Figure	5.16B).	In	Basal	+	WNT	CM,	a	co-culturing	ratio	of	0.1:1	 (PDGFRα+	 SCA1+	 Msc	 to	 DC)	 –where	 mesenchymal	 contact	 is	 rare	 (Figure	5.16A)–	leads	to	enhanced	organoid	formation	efficiency	compared	to	when	DC	are	seeded	 alone.	 Yet,	 remarkably,	 this	 is	 gradually	 reversed	with	 increasing	 ratios	 of	mesenchyme	(>0.5:1)	until	nearly	abolishing	organoid	growth	(>1:1)	(Figure	5.16B,	top	 panel).	 At	 these	 higher	 ratios,	 there	 is	 instead	 substantial	 growth	 of	 the	 GFP+	mesenchymal	fraction	(Figure	5.16A).			
Whilst	 the	 trend	 in	 decreased	 organoid	 formation	 at	 high	 ratios	 of	mesenchyme-to-DC	(>1:1)	is	conserved	in	EM	+	WNT	CM,	there	is	no	clear	benefit	of	co-culturing	with	a	low	mesenchymal	ratio	(0.1:1)	in	this	growth-factor	rich	medium	
	
Figure	5.16	The	ratio	of	Msc	SCA1+	to	DC	cells	determines	the	fate	of	organoid	growth.	
	A)	A	2D	matrigel	co-culture	in	EM	+	Wnt	CM	or	Basal	+	Wnt	CM	medium	between	increasing	numbers	of	Msc	PDGFRα+	SCA1+	cells	(GFP+)	and	5000	organoid	cells	(Tomato+)	or	DC	(uncoloured)	to	achieve	cell-to-cell	ratios	of	0:1,	0.1:1,	0.5:1,	1:1,	5:1.	Representative	pictures	of	organoid	formation	at	d8	are	shown.	DC:	ductal	cell,	OC:	organoid	cell.	B)	Quantification	of	organoid	formation	efficiency	in	A)	from	DC	+	Msc	SCA1+	aggregates	(top	panel,	N=2)	and	OC	+	Msc	SCA1+	aggregates	(bottom	panel,	N=1).		
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(Figure	5.16A,B).	Overall,	the	above	observations	(in	both	media	compositions)	hold	true	 for	 co-cultures	 between	 PDGFRα+	 SCA1+	 Msc	 and	 OC,	 although	 the	 peak	 in	organoid	formation	at	the	0.1:1	ratio	in	Basal	+	WNT	CM	is	much	less	discernible	for	OC	 (Figure	 5.16B,	 bottom	 panel).	 It	 should	 be	 emphasised	 that	 the	mesenchymal	inhibition	 on	 organoid	 growth	 is	 reliant	 on	 both	 cell-cell	 ratios	 and	 physical	contact/proximity,	as	previous	transwell	experiments	(Figure	4.11B)	performed	at	a	10:1	SCA1+	Msc-to-DC	ratio	robustly	sustained,	never	inhibited,	organoid	formation.	
	
Figure	5.17	The	ratio	of	Msc	SCA1-	to	DC	cells	also	determines	 the	 fate	of	organoid	growth.	A)	A	2D	matrigel	co-culture	in	EM	+	WNT	CM	medium	between	increasing	numbers	of	Msc	PDGFRα+	SCA1-	cells	(GFP+)	and	5000	DC	(tdTomato+).	Representative	pictures	of	organoid	formation	at	d8	are	shown.	B)	Quantification	of	mean	organoid	formation	efficiency	in	A)	(N=1).	
As	an	additional	assay,	contact-permissive	co-cultures	(as	in	Figure	5.16)	were	performed	between	DC	and	PDGFRα+	SCA1-	Msc	in	EM	+	WNT	CM	medium	(Figure	5.17).	 To	 our	 surprise,	 a	 very	 similar	 pattern	 of	 organoid	 growth	 inhibition	 was	observed	 at	 high	 ratios	 of	 SCA1-	 Msc	 cells,	 suggesting	 that	 this	 may	 be	 a	 general	property	of	hepatic	mesenchymal	cells	instead	of	being	PDGFRα+	SCA1+	Msc-specific.	
In	 vivo	 experiments	 in	 Chapter	 4	 had	 shown	 temporal	 fluctuations	 in	 the	absolute	numbers,	and	ultimately	cell-to-cell	ratios,	of	PDGFRα+	SCA1+	Msc	relative	to	DC/progenitors	following	liver	damage.	These	results	became	of	particular	interest	in	light	of	the	ratio-dependent	modulation	of	organoid	growth	by	the	PDGFRα+	SCA1+	Msc	cells	in	vitro.	We	thus	projected,	as	a	colour	coded	gradient,	the	ratio-dependent	(PDGFRα+	SCA1+	Msc/DC)	 levels	of	organoid	growth	 in	vitro	 (Figure	5.16B,	Basal	+	WNT	CM)	onto	the	in	vivo	ratios	of	PDGFRα+	SCA1+	cells/	OPN+	ductal	cells	at	DDC	d0	and	 DDC	 d12	 (Figure	 4.4).	 In	 vivo,	 the	 transition	 from	 DDC	 d0	 to	 DDC	 d12	 is	accompanied	by	a	higher	median	ratio	of	PDGFRα+	SCA1+/	OPN+	cells	(0.53),	which	according	 to	 our	 in	 vitro	 assays,	 falls	 within	 a	 less	 permissive	 range	 of	 organoid	
5.3	An	alternative	2D	matrigel	co-culture	system	to	promote	cell-cell	aggregation	
123	
formation	 (Figure	5.18)	and	could	be	a	mechanism	to	 terminate	 regeneration	 (see	Discussion).	It	would	be	of	interest	to	investigate	if	the	organoid-sustaining	ratio	of	0.1:1	is	observed	at	any	intermediate	time-points	between	homeostasis	and	DDC	d12.	
Figure	5.18	 In	 vitro	 and	 in	 vivo	 ratios	 of	
Msc	SCA1+	to	DC	cells	can	be	correlated	to	
infer	ductal	cell	proliferation.		The	in	vitro	ratio-dependent	levels	of	organoid	formation	in	 the	 co-culture	 between	 PDGFRα+	 SCA1+	cells	and	DC	in	Basal	+	WNT	CM	(from	Figure	5.16B)	 were	 projected	 as	 a	 colour-coded	gradient	 (green=minimal	 organoid	formation,	 red=maximal	 organoid	formation)	onto	the	in	vivo	ratios	of	PDGFRα+	SCA1+	cells/	OPN+	ductal	 cells	 (from	Figure	4.4)	at	DDC	d0	and	DDC	d12.	At	DDC	d12,	a	median	 ratio	 of	 0.53	 is	 reached,	 which	corresponds	 to	 a	 less	 permissive	 rate	 of	organoid	 growth	 in	 vitro	 compared	 to	DDC	d0.		
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6.1 Isolation	 and	 co-culture	 of	 primary	 ductal	 cells	 with	
associated	stromal	populations	in	the	liver		
The	process	of	wound	healing	is	a	cooperative	endeavour	that	requires	timely	interactions	 between	 the	 epithelium	and	 the	 cells	 of	 the	 stroma,	 regardless	 of	 the	affected	 tissue.	 In	 the	 liver,	ductular	cell	expansion	 is	a	common	 feature	of	human	pathologies	 and	 recent	 publications	 have	 highlighted	 the	 potency	 of	 these	 cells	 in	replenishing	 tissue	 parenchyma	 following	 chronic	 damage	 or	 when	 hepatocyte	proliferation	is	impaired	(Lu	et	al.,	2015;	Raven	et	al.,	2017;	Deng	et	al.,	2018).	Whilst	the	stroma	has	been	implicated	in	the	activation	and	cell-fate	commitment	of	ductal	progenitors	 (Boulter	 et	 al.,	 2012;	 Takase	 et	 al.,	 2013),	 the	 cell	 identity,	molecular	signature	and	spatiotemporal	dynamics	of	a	regenerative	‘ductal	niche’	have	not	been	fully	characterised,	partly	due	to	the	difficulty	of	assessing	niche	potential	in	vivo.			Making	 use	 of	 tissue	 microdissection	 and	 explant	 culture	 techniques	 –commonplace	in	the	field	of	chick	embryology	–	Nicole	Le	Douarin	performed	a	series	of	 seminal	 experiments	 to	 elucidate	 the	 mesoderm-to-endoderm	 signalling	 that	underlies	 hepatic	 development	 (Le	 Douarin,	 1968,	 1975).	 	 This	 contributed	 to	 a	widespread	assessment	of	‘stromal	guidance’	in	hepatogenesis,	either	via	similar	co-culture	 assays	 between	 purified	 hepatic	 cell	 populations	 or	 via	 robust	 step-wise	protocols	 for	 the	 directed	 differentiation	 of	 hepatocytes	 and	 cholangiocytes	 from	pluripotent	stem	cells	(refer	to	Section	1.2.1	and	1.3).	Our	approach	of	primary	cell	isolation	and	ex	vivo	co-cultures	between	adult	duct	epithelium	and	stroma	aimed	to	assess	 ‘niche’	 potential	 as	 it	 has	 been	 done	 in	 the	 embryo,	 but	 using	 organoid	formation	 as	 a	 functional	 readout	 of	 regeneration.	 A	 key	 difference	 between	 our	strategy	and	Le	Douarin’s	is	the	isolation	of	cells	via	tissue	digestion	and	FACS	sorting	as	 opposed	 to	 microdissection,	 which	 removes	 key	 information	 about	 the	 spatial	coordinates	 of	 the	 cells	within	 the	 tissue.	 Hepatic	 stroma	may	 co-fractionate	with	ductal	 cells	 in	 “non-parenchymal	 cell”	 isolation	 protocols	 not	 because	 of	 spatial	proximity	but	because	of	their	comparable	cell	size	–in	contrast	to	the	much	larger	hepatocytes	 (Wang,	 Foster,	 et	 al.,	 2003);	 this	 is	 particularly	 cumbersome	 for	circulating	hematopoietic	cells	that	do	not	reside	long-term	within	the	tissue	but	are	very	abundant	in	this	highly	vascularised	organ	(Lautt,	2009).	The	identification	of	
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the	Msc	fraction	as	a	putative	ductal	niche	in	Chapter	3	thus	required	us	to	validate	the	co-localisation	of	these	two	cell	populations	in	situ,	as	was	done	in	Chapter	4.		Compared	to	the	embryo,	the	adult	liver	displays	a	greater	diversification	of	stromal	cell	populations:	hepatic	stellate	cells,	portal	fibroblasts,	liver	sinusoidal	cells,	arterial	 and	 venous	 endothelial	 cells,	 macrophages,	 NK	 cells,	 T	 cells,	 etc;	 not	 to	mention	 the	 heterogeneity	 that	 exists	 within	 each	 population.	 Our	 reductionist	approach	of	H/E	(EpCAM-	CD45+	CD31+	CD11b+)	vs	MSc	(EpCAM-	CD45-	CD31-	CD11b-)	is	thus	limited	in	that	organoid-supportive	fractions	may	be	masked	within	the	bulk	populations,	 either	 due	 to	 insufficient	 cell	 numbers	 or	 inhibitory	 effects	 from	 one	fraction	to	another.		For	instance,	immune	cells	may	induce	‘tolerance’	amongst	each	other	and	suppress	pro-inflammatory	signalling	thought	to	be	important	for	ductal	cell	 expansion	 (Knolle	 and	 Gerken,	 2000).	 Moreover,	 our	 assay	 assumes	 that	 cell	survival	and	behaviour	in	vitro	are	equivalent	to	the	physiological	context,	despite	the	variable	 of	 culturing	 in	 3D	 matrigel	 and	 Basal	 +	 WNT	 CM	 medium;	 but	 these	conditions	 are	 evidently	 not	 optimal	 for	 all	 cell	 subpopulations	 given	 the	underrepresentation	of	CD31+	endothelial	cells	 in	vitro.	Accordingly,	our	co-culture	assay	cannot	rule	out	the	capacity	of	the	H/E	fraction	to	sustain	ductal	cell	expansion,	but	does	highlight	this	role	for	the	Msc	population.	
6.2 SCA1+	 mesenchymal	 cells	 surround	 biliary	 ducts	 and	
expand	after	damage	
In	many	respects,	the	pinpointing	of	mesenchymal	cells	as	being	ductal	cell-supportive	 in	 the	adult	 liver	was	not	 surprising	given	 the	co-dependency	between	mesodermal	and	endodermal	lineages	throughout	the	ontogeny	of	this	organ	(refer	to	Section	1.2.1	on	Development).	Interestingly,	our	surface	marker	screen	identified	that	the	stem	cell	antigen	1	(SCA1)	labels	a	percentage	of	the	Msc	fraction,	though	not	exclusively,	and	that	SCA1+	mesenchymal	(PDGFRα+)	cells	are	localised	periportally	in	the	liver,	in	very	close	proximity	to	the	biliary	ducts.		SCA1	(or	lymphocyte	antigen	6A-2/6E-1)	is	a	member	of	the	multi-gene	Ly6	family	 comprised	 of	 highly	 homologous,	 cross-hybridising	 genes	 tightly	 linked	 on	
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mouse	chromosome	15;	and	which	are	thought	to	have	arisen	from	gene	duplication	events	(LeClair	et	al.,	1986,	1987;	Shevach	and	Korty,	1989).	Adding	to	the	complexity,	SCA1	is	encoded	by	two	strain-specific	allelic	variants	at	the	Ly6a	 locus	–	Ly6a.1	or	
Ly6e.1	and	Ly6a.2–	(Palfree,	Dumont	and	Hammerling,	1986)	that	differ	by	only	two	amino	acids	yet	show	dramatic	differences	in	cell-type	specific	expression	(Spangrude	and	Brooks,	1993).	A	human	orthologue	of	SCA1	does	not	exist;	in	fact,	a	500	kilobase	region	of	the	murine	chromosome	15	was	lost	from	mouse	to	rat	speciation,	deleting	
Ly6a	together	with	five	additional	Ly6	members	(Holmes	and	Stanford,	2007).	This	has	fuelled	the	belief	that	SCA1	function,	if	any	(see	below),	has	been	made	redundant	during	evolution.	SCA1	 was	 first	 identified	 more	 than	 40	 years	 ago	 in	 thymus-resident	 and	peripheral	lymphocytes	(Yutoku,	Grossberg	and	Pressman,	1974;	McKenzie,	Cherry	and	Snell,	1977),	but	rose	to	fame	as	the	phenotypic	marker-of-choice	for	 isolating	bone	 marrow-repopulating	 hematopoietic	 stem	 cells	 in	 conjunction	 with	 other	lineage	antigens	(Spangrude,	Heimfeld	and	Weissman,	1988;	Spangrude	et	al.,	1989).	Its	expression	has	since	been	linked	to	multipotent	bone	marrow	mesenchymal	stem	cells	(BM-MSC)	(Baddoo	et	al.,	2003;	Meirelles	Lda	and	Nardi,	2003;	Sun	et	al.,	2003),	as	 well	 as	 progenitor	 populations	 in	 the	 musculoskeletal	 system	 (Torrente	 et	 al.,	2001;	Qu-Petersen	et	al.,	2002;	Tamaki	et	al.,	2002),	prostate	(Burger	et	al.,	2005;	Xin,	Lawson	and	Witte,	2005),	skin	(Toma	et	al.,	2001;	Fernandes	et	al.,	2004),	heart	(Oh	
et	al.,	2003),	mammary	gland	(Welm	et	al.,	2002),	lung	(Bender	Kim	et	al.,	2005)	and	even	liver	(Petersen	et	al.,	2003;	Dorrell	et	al.,	2008).		Our	studies	do	confirm	expression	of	SCA1	on	liver	ductal	cells,	but	suggest	a	broader	hepatic	staining	pattern	that	includes	mesenchymal	(PDGFRα+),	endothelial	(CD31+)	 and	 hematopoietic	 cells	 (CD45+)	 –but	 not	 macrophages	 (F4/80+)–	exclusively	at	the	portal	tract.	Freshly	isolated	LSECs,	which	in	situ	are	spread	across	the	 liver	 lobule,	express	SCA1	constitutively	and	upregulate	 it	upon	challenge	with	tumour	necrosis	factor	a	(TNFa)	(Luna,	Paez	and	Cardier,	2004)	.	Although	this	would	seem	to	be	at	odds	with	the	portal	tract	specificity	we	report	for	SCA1,	it	may	simply	indicate	a	gradient	of	expression,	where	the	highest	protein	levels	of	SCA1	demarcate	periportal	cells.		This	is	in	some	ways	reminiscent	of	the	lobule	zonation	discussed	in	Section	 1.1,	 and	 it	 would	 be	 interesting	 to	 explore	 whether	 high	 oxygen	
6.2	SCA1+	mesenchymal	cells	surround	biliary	ducts	and	expand	after	damage	
129	
concentrations	 or	 specific	 signals	 from	 the	 portal	 vein	 circulation	 regulate	 SCA1	expression	in	homeostasis.	Alternatively,	shared	SCA1	expression	amongst	some	of	these	 cells	 could	 reflect	 a	 common	 developmental	 origin	 (see	 Section	 6.3).	 The	anatomical	 coordinates	of	SCA1+	PDGFRα+	mesenchymal	cells,	 residing	 in	exquisite	proximity	to	the	biliary	ducts,	coupled	to	their	expression	of	Elastin	and	Il6	match	at	least	partially	the	description	of	portal	fibroblasts	(Wells,	2014).	SCA1	had	not	been	previously	 reported	as	 a	marker	of	 these	 cells	 and	 its	 specificity	 could	be	of	 great	interest	for	the	field,	given	that	non-periportal	PDGFRα+	cells	–	likely	corresponding	to	HSCs	–	show	no	detectable	SCA1	expression,	and	the	distinction	between	these	two	cell	lineages	has	proven	historically	difficult	(Wells,	2014).		Considering	 the	 widespread	 use	 of	 SCA1	 as	 a	 phenotyping	 marker	 for	progenitors,	it	is	somewhat	surprising	that	its	biological	function	remains	shrouded	in	mystery.		Ly6	family	members	are	glycosyl	phosphatidylinositol-anchored	proteins	(GPI-AP)	that	localise	to	lipid	rafts	of	the	plasma	membrane	and	can	from	complexes	with	tyrosine	kinases	(Štefanová	et	al.,	1991).	Most	famously,	cross-linking	of	SCA1	by	 specific	 monoclonal	 antibodies	 provokes	 T	 lymphocyte	 activation	 and	proliferation,	whilst	SCA1	inhibition	prevents	it	(Malek	et	al.,	1986;	Flood,	Dougherty	and	Ron,	1990).	Although	a	tentative	SCA1	ligand	was	once	suggested	(English	et	al.,	2000),	the	identity	of	this	protein	remains	unknown	and	no	evidence	so	far	supports	a	traditional	ligand-receptor	signalling	activity	for	SCA1.	Ly6a	(SCA1)	null	mice	are	viable	and	display	no	overt	phenotype	in	homeostasis	besides	minor	hematopoietic	lineage	skewing	(Stanford	et	al.,	1997;	Ito	et	al.,	2003);	they	do	however	exhibit	stress	or	age-related	phenotypes	including	osteoporosis	(Bonyadi	et	al.,	2003;	Holmes	et	al.,	2009)	and	reduced	muscle	size	in	older	animals	(Mitchell	et	al.,	2005).	Interestingly,	Holmes	 and	 colleagues	 showed	 that	 osteoclastogenesis	 was	 defective	 in	 the	 bone	marrow	due	to	stem	cell-intrinsic	effects	but	also	because	of	reduced	stromal	support	towards	osteoclast	differentiation	(Holmes	et	al.,	2009).	Loss	of	SCA1	has	also	been	linked	with	defective	ECM	production/remodelling	both	in	bone	and	muscle	(Bonyadi	
et	al.,	2003;	Kafadar	et	al.,	2009);	which	in	turn	associates	with	impaired	regeneration	in	 the	 latter.	 Based	 on	 the	 above,	 it	would	 be	 of	 interest	 to	 examine	whether	 the	presence	of	SCA1	in	the	periportal	mesenchyme	is	biologically	relevant	or	simply	a	convenient	marker	for	cell	isolation.	A	partial	answer	to	this	may	be	obtained	from	
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the	 RNAseq	 analysis	 of	 SCA1+	 vs	 SCA1-	 populations,	 but	will	 undoubtedly	 require	additional	loss-of-function	studies.	Of	note,	another	GPI-AP	member	(Štefanová	et	al.,	1991),	Thy1,	labels	portal	mesenchyme	in	the	liver	(Takase	et	al.,	2013),	which	means	there	could	be	 functional	 redundancy	between	SCA1	and	Thy1	 if	 they	do	 label	 the	same	cell	population.	Following	liver	damage,	the	absolute	number	of	periportal	SCA1+	PDGFRα+		–	but	 not	 SCA1-	 PDGFRα+–	 mesenchymal	 cells	 increases	 along	 with	 the	 ductal	 cell	fraction.	Although	we	propose	this	is	an	expansion	of	the	homeostatic	SCA1+	PDGFRα+		cells,	two	other	alternatives	are	possible:	a) SCA1+	PDGFRα+	cells,	potentially	bone	marrow-derived,	are	brought	into	the	tissue	 through	 the	 portal	 circulation	 as	 a	 damage	 response	 mechanism.	Chimeric	mice	transplanted	with	Col1a1-GFP	reporter	bone	marrows	and	then	subjected	to	bile	duct	ligation	contain	GFP+	‘fibrocytes’	(co-expressing	Cd45+)	within	 the	 liver	 parenchyma	 (Kisseleva	 et	 al.,	 2006),	 although	 a	 SCA1+	PDGFRα+		signature	has	not	been	reported	so	far	for	fibrocytes.	b) SCA1	expression	may	be	upregulated	in	resident	SCA1-	cells,	particularly	the	SCA1-	PDGFRα+	fraction.	For	this	to	be	the	case,	SCA1-	PDGFRα+	cells	may	also	have	to	migrate	closer	to	the	portal	area,	as	they	localise	more	intra-lobularly	compared	to	the	SCA1+	PDGFRα+	cells	according	to	our	results.				The	second	scenario	is	worthy	of	attention	given	that	SCA1	expression	appears	to	 be	 tuneable	 in	 the	 context	 of	 injury.	 In	 LSECs,	 in	 vitro	 challenge	with	 the	 pro-inflammatory	 cytokine	 TNFa	 leads	 to	 increased	 SCA1	 expression	 (Luna,	 Paez	 and	Cardier,	 2004),	 while	 extract	 from	 crushed	 muscle	 upregulates	 SCA1	 in	 cultured	myoblasts,	 both	 reversibly	 and	 independently	 of	 cell	 proliferation	 (Kafadar	 et	 al.,	2009).		To	formally	prove	the	in	situ	expansion	of	SCA1+	PDGFRα+	cells	in	our	system,	we	 require	 evidence	 of	 the	 proliferative	 capacity	 of	 these	 cells	 after	 damage	 (e.g.	assessed	via	EdU	incorporation)	and,	ideally,	confirmation	via	CreloxP-based	lineage	tracing.	The	former	has	been	technically	challenging	due	to	the	inability	to	co-stain	SCA1,	 a	 surface-bound	 protein,	 with	 nuclear	 markers	 like	 EdU/Ki67.	 In	 addition,	currently	 available	 mesenchymal	 CreloxP	 lines	 (e.g.	 Ly6-Cre,	 Pdgfra-CreER,	 Sm22-
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CreER)	would	most	likely	label	other	populations	apart	from	SCA1+	PDGFRα+	cells	(see	more	on	Section	6.7).		Regardless	of	their	provenance,	it	is	clear	that	SCA1+	PDGFRα+	cells	do	increase	their	numbers	periportally	as	a	consequence	of	tissue	damage,	and	this	alters	their	ratio	 with	 respect	 to	 the	 ductal	 cells.	 In	 muscle,	 SCA1+CD31-	 fibro-adipogenic	progenitors	 (FAPs)–	with	 bipotency	 towards	 fibrocytes	 and	 adipocytes–	 reside	 in	close	proximity	 to	myogenic	progenitors	 (MP)	 and	proliferate	upon	damage.	 FAPs	expand	from	d2-d3	after	damage,	nearly	equalling	MPs	in	number,	but	by	day	5	the	FAP:MP	ratio	has	returned	to	pre-damage	(Joe	et	al.,	2010).	Our	model	differs	in	that,	by	day	7,	 the	SCA1+	PDGFRα+:	ductal	cell	 ratio	does	not	return	to	homeostasis	and	begs	the	question	of	whether	at	later	timepoints	it	would.	Likewise,	earlier	timepoints	are	of	interest	in	order	to	sample	the	dynamics	of	cell	expansion	immediately	after	damage	(see	more	on	Section	6.8).		
6.3 Molecular	 characterisation	 of	 primary	 SCA1+	
mesenchymal	cells	in	homeostasis	
Despite	reportedly	labelling	ductal	progenitors,	the	lack	of	separation	between	SCA1+	 and	 SCA1-	 ductal	 cells	 in	 the	 unsupervised	 clustering	 analysis	 of	 gene	expression	suggests	that	SCA1,	on	its	own,	does	not	demarcate	a	molecularly	distinct	subpopulation	within	the	ductal	compartment.	On	the	contrary,	SCA1	expression	does	segregate	the	sorted	H/E	and	Msc	populations.	The	portal	fibroblast	identity	of	the	Msc	 SCA1+	 cells	 is	 supported	 by	 enrichment	 of	 classical	 mesenchymal	 markers	(Pdgfra,	 Pdgfrb,	 Col1a1,	 Col1a2)	 but	 also	 portal-specific	ones	 (Eln,	 Il6),	 and	 by	 the	diminished	 expression	of	markers	 of	HSCs	 (Des)	 and	 smooth	muscle	 cells	 (Acta2),	which	instead	cluster	in	the	Msc	SCA1-	fraction.	Also	noteworthy	is	the	expression	of	
Cd34	in	the	Msc	SCA1+	cells;	a	marker	that	shares	progenitor-specific	links	with	SCA1	across	diverse	lineages	(Brown,	Greaves	and	Molgaard,	1991;	Torrente	et	al.,	2001),	including	mesenchymal	cells		(Hittinger	et	al.,	2013).	In	the	liver,	CD34	expression	is	most	commonly	linked	with	abnormal	angiogenesis	in	hepatocellular	carcinoma	(Cui	
et	al.,	1996;	Kimura	et	al.,	1998),	but	has	also	been	detected	on	homeostatic	portal	blood	vessels	and	biliary	epithelium,	as	well	as	in	damage-induced	ductular	reactions	(Omori	 et	 al.,	 1997).	 Lineage	 tracing	 experiments	 in	 chick	 embryos	 have	 shown	 a	
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shared	mesothelial	ancestor	between	endothelial	and	stellate	cells	of	adult	hepatic	sinusoids	 (Perez-Pomares	 et	 al.,	 2004).	 Given	 that	 portal	 fibroblasts	 may	 also	originate	 from	mesothelial	 cells	 (Asahina	 et	 al.,	 2011),	 it	 would	 be	 interesting	 to	investigate	whether	the	ontogeny	of	portal	SCA1+	endothelial	and	mesenchymal	cells	can	be	traced	back	to	a	shared	mesothelial	progenitor	expressing	SCA1.		
6.4 SCA1+	mesenchymal	cells	can	be	expanded	in	vitro		
When	 grown	 in	 vitro	 on	 standard	 tissue	 culture	 plastic,	 HSCs	 undergo	progressive	 cellular	 activation	 towards	 a	 myofibroblast-like	 phenotype	 –	 as	characterised	by	 loss	of	vitamin	A,	 increased	collagen	synthesis	and	aSMA	(Acta2)	expression	(Geerts	et	al.,	1989;	Bachem	et	al.,	1992);	whilst	 they	retain	 features	of	quiescence	 in	 a	 basement	membrane	matrix	 like	Matrigel	 (Friedman	 et	 al.,	 1989).	Conversely,	 the	 myofibroblast	 fate	 can	 be	 partially	 reversed	 when	 cells	 are	 re-inserted	into	Matrigel	(Sohara	et	al.,	2002).	Portal	fibroblasts	undergo	similar,	if	not	more	 pronounced,	 phenotypic	 activation	 when	 cultured	 in	 vitro	 (Lepreux	 and	Desmoulière,	2015).	In	line	with	this,	we	demonstrated	that	primary	SCA1+	Msc	cells	can	be	 serially	 passaged	 (up	 to	 p5)	 on	plastic	 but	 not	Matrigel,	where	 they	 arrest	growth	much	sooner;	and	expanded	cells	upregulate	various	myofibroblast	markers	including	 Acta2,	 Col1a1	 and	 Col1a2.	 Given	 that	 a	 proliferative	 myofibroblastic	signature	is	characteristic	of	wound	healing	across	many	tissues	(Gabbiani,	2003),	in	
vitro	 expanded	SCA1+	Msc	 cells	may	model	more	 accurately	 the	hepatic	periportal	niche	in	the	context	of	regeneration	than	in	homeostasis.	Differentially	up	and	down-regulated	 genes	 from	 the	 t=0	 to	 d15	 transition	 of	 SCA1+	Msc	 cells	 should	 then	 be	studied	more	thoroughly	in	order	to	understand	the	paracrine	signalling	capacity	of	these	cells	after	activation	as	well	as	the	underlying	molecular	identity	that	drives	it.	Returning	to	the	contested	idea	of	a	biological	role	for	SCA1,	it	was	interesting	that	SCA1+PDGFRα+	Msc	cells	expanded	more	readily	than	SCA1-	PDGFRα+	Msc	in	our	
in	 vitro	 system.	Although	 this	 could	 simply	 reflect	differing	proliferative	 capacities	between	two	distinct	mesenchymal	lineages,	Bonyadi	et	al.	have	shown	that	loss	of	SCA1	in	bone	marrow	mesenchymal	progenitor	cells	severely	hampers	their	ability	to	be	serially	passaged	(Bonyadi	et	al.,	2003).	The	knock-down	of	Ly6a	in	our	cultures	
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could	 then	 ascertain	 if	 any	 proliferative,	 as	 well	 as	 niche	 signalling,	 defects	 may	develop	as	a	consequence	of	SCA1	loss.	
6.5 SCA1+	 mesenchyme	 supports	 organoid	 formation	 in	
vitro	via	soluble	factors		
Making	 use	 of	 distinct	 methods	 for	 co-culturing	 cells,	 mainly	 cell-contact	independent	ones,	we	confirmed	that	primary	SCA1+	Msc	cells	support	the	transition	of	 single	 EpCAM+	 ductal	 epithelial	 cells	 into	 proliferative,	 self-organising	 3D	organoids	that	morphologically	and	molecularly	resemble	the	cultures	grown	in	full	growth	 factor	 medium.	 Both	 freshly	 sorted	 and	 expanded	 SCA1+	 Msc	 cells	 were	capable	of	this,	albeit	with	the	confounding	variable	of	culturing	on	matrigel	vs	plastic.	This	 implies	that	 it	 is	 the	SCA1+	Msc	signature	retained	after	 in	vitro	culturing	that	promotes	organoid	growth.	SCA1+	Msc	cells	indeed	express	various	mitogenic	factors	(Hgf,	Fgf7,	Rspo1	and	Rspo3)	normally	supplemented	 in	EM	and	implicated	 in	 liver	regeneration	 (Ishikawa	 et	 al.,	 2012;	 Takase	 et	 al.,	 2013;	 Planas-Paz	 et	 al.,	 2016).	Whilst	Egf	expression	was	not	detected,	both	HGF	and	EGF	signal	through	receptor	tyrosine	kinases	and	are	functionally	redundant	in	the	lung	(Engelman	et	al.,	2007)	and	in	PHx-induced	liver	regeneration	(Paranjpe	et	al.,	2016).	Even	if	the	SCA1+	Msc	‘secretome’	does	encompass	most	EM	growth	factors,	their	blockade	via	monoclonal	antibodies	and/or	small	molecule	inhibitors	is	still	required	to	confirm	contribution	towards	 organoid	 sustenance,	 particularly	 since	 SCA1+	Msc	 cells	 express	 multiple	other	cytokines	that	have	not	been	directly	associated	with	liver	regeneration	yet.		An	 ‘ideal’	 combination	 and	 concentration	 of	 signalling	 factors	must	 exist	 to	sustain	hepatic	regeneration.	Michalopoulos	et	al.	reported	early	on	that	HGF,	EGF	and	the	corticoid	dexamethasone	are	essential	factors	for	culturing	adult	primary	hepatic	cells	in	a	way	that	retains	histological	organisation,	although	these	conditions	do	not	support	ductal	progenitor	expansion	(Michalopoulos	et	al.,	2001).	Ex	vivo	studies	with	E10	embryonic	livers	have	on	the	other	hand	shown	that	the	WNT	+	HGF	combination	is	 sufficient	 for	 maintaining	 hepatocytes,	 cholangiocytes	 and	 progenitor	 cells	(Hussain	 et	 al.,	 2004).	 	 In	 the	 case	 of	 standard	 adult	 organoids,	 removal	 of	 either	FGF10,	EGF,	HGF	or	RSPO1	from	the	complete	culture	medium	prevents	their	long-term	passaging	(Huch	et	al.,	2013).	Organoids	sustained	by	soluble	factors	from	SCA1+	
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Msc	cells	do	grow	in	vitro	but	have	limited	expansion	potential,	and	their	molecular	signature	shows	skewing	towards	a	more	differentiated	ductal	state.	This	could	be	due	to	insufficient	secretion	of	mitogens	by	the	mesenchyme,	or	contrary,	a	supply	of	pro-differentiation	 signals.	 In	 the	muscle,	 FAPs	 that	 co-expand	with	myofibroblast	progenitors	after	damage	promote	their	differentiation	in	ex	vivo	co-cultures	(Joe	et	
al.,	2010).	Periportal	SCA1+	mesenchyme	could	then	entertain	a	similar	relationship	with	 the	 ductal	 progenitors	 following	 injury,	 so	 that	 their	 ductal	 de-differentiated	state	is	only	maintained	transiently.	Extrapolating	from	this,	and	from	the	concept	of	local	cell-fate	choice	(Boulter,	Lu	and	Forbes,	2013),	SCA1+	mesenchymal	signals	may	act	as	molecular	‘reminders’	of	homeostatic	cell	identity	for	ductal	cells	in	the	portal	area.	 Such	 a	 mechanism	 is	 observed	 in	 skin,	 where	 the	 site-specific	 HOX	transcriptional	 program	 of	 fibroblasts	 regulates	 epidermal	 fate	 and	 thus	 acts	 as	positional	memory	to	pattern	the	epithelia	(Rinn	et	al.,	2008).			
6.6 Liver	 organoids	 support	 the	 growth	 of	 SCA1+	
mesenchyme	
In	 the	 mid-to-late	 phases	 of	 epidermal	 wound	 healing,	 fibroblasts	 receive	keratinocyte-derived	stimuli	such	as	PDGF,	IL-1	and	TGFb	that	in	a	positive	feedback	loop	 potentiate	 myofibroblast	 differentiation	 for	 the	 continuous	 support	 of	keratinocyte-driven	 regeneration	 (Werner,	 Krieg	 and	 Smola,	 2007).	 This	bidirectionality	 of	 epithelial-to-mesenchymal	 communication	 holds	 true	 for	 many	other	wounded	adult	tissues	(Holgate	et	al.,	2004;	Chapman,	2011;	Ding	et	al.,	2012),	possibly	 including	the	 liver.	 In	rat	models	of	biliary	 fibrosis,	ductal	cells	have	been	shown	to	express	PDGF-B,	connective	tissue	growth	factor	(CTGF)	and	TGFb2	(Milani	
et	al.,	1991;	Grappone	et	al.,	1999;	Sedlaczek	et	al.,	2001);	although	these	are	well-established	mesenchymal	mitogens	and/or	activators	(of	both	portal	fibroblasts	and	hepatic	 stellate	 cells)	 (Li	et	al.,	 2007;	Friedman,	2008),	most	of	 these	 studies	have	been	 correlational	 and	 the	 mesenchymal	 response	 to	 purported	 biliary-derived	stimuli	 requires	 further	characterisation.	 In	our	system,	conditioned	medium	from	liver,	but	apparently	not	small	intestinal,	organoids	enhances	the	growth	of	SCA1+	Msc	cells	 after	 splitting,	 suggesting	 that	 there	 could	 indeed	 be	 a	 signalling	 crosstalk	between	ductal	epithelium	and	SCA1+	Msc	during	liver	regeneration.	At	present,	the	
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identity	and	mode	of	action	(pro-proliferation	or	pro-survival)	of	this	ductal	derived	signal(s)	remains	unknown,	but	we	have	RNAseq	data	of	both	DC	and	SCA1+	Msc	cells	cultured	 alone	 or	 in	 a	 transwell	 co-culture	 which	 could	 shed	 some	 light	 on	 key	signalling	pathways	for	mesenchymal	growth.		The	power	of	our	in	vitro	co-culture	system	 is	 that	 can	 we	 can	 directly	 probe	 the	 effect	 of	 previously	 reported	mesenchymal	mitogens/activators	(PDGF-B,	CTGF	and	TGFb2)	but	also	novel	ones	via	gene	knock-down	and/or	small	molecule	inhibitors.	Given	that	SCA1+	Msc	cells	grow	well	in	Basal	+	WNT	CM	medium,	and	that	addition	of	the	GSK-b	inhibitor,	CHIRON,	enhances	mesenchymal	cell	survival	in	vitro	(data	not	shown),	we	could	hypothesise	that	 one	 of	 the	 ductal-derived	 signals	 is	 a	 WNT	 ligand	 such	 as	 Wnt7,	 which	 is	expressed	by	DC	and	organoids,	but	not	SCA1+	Msc,	in	our	RNAseq.	In	breast	cancer,	epithelial	cells	secrete	WNT7A	to	recruit	and	activate	cancer	associated	fibroblasts	in	a	TGFb-like	mechanism,	which	 subsequently	 feeds	back	on	 tumour	aggressiveness	(Avgustinova	et	al.,	2016).	The	exclusive	growth	response	of	SCA1+	Msc	cells	to	liver	organoid	CM	tantalisingly	suggests	tissue	specificity	in	signalling.	Organ-specific	gene	signatures	have	been	 identified	 in	 stellate	 cells	of	 the	adult	 liver	and	 the	pancreas	despite	their	suspected	shared	developmental	origin	(Buchholz	et	al.,	2005),	whilst	in	the	 embryo,	 Sneddon	 and	 colleagues	 have	 shown	 that	 co-culturing	 ESC-derived	pancreatic	 progenitors	 with	 organ-matched	 mesenchyme	 is	 crucial	 for	 the	 self-renewal	 and	proliferation	 of	 the	 latter.	 Extrapolating	 from	 this,	we	 could	 envision	liver-specific	 interactions	 between	 hepatic	 ductal	 cells	 and	 SCA1+	 Msc.	 Future	experiments	should	 include	pancreatic	cells	as	an	additional	control	given	that	 the	liver	shares	more	features	with	the	pancreas	(both	in	development	and	in	adulthood)	than	with	the	rapidly	self-renewing	small	intestine.		
6.7 Strategies	for	the	in	vivo	ablation	of	SCA1+	mesenchymal	
cells	
Judging	 from	the	contested	biological	 function	of	SCA1	 in	other	 tissues	(see	section	6.2),	knocking	out	this	gene	in	the	periportal	mesenchyme	is	unlikely	to	reveal	any	niche-related	phenotype.	Instead,	we	strove	to	ablate	the	population	as	a	whole,	on	the	basis	of	a	CreloxP,	 iDTR	 system.	The	 lack	of	 temporal	control	of	 the	Ly6-Cre	transgenic	 line	 renders	 it	 unsuitable	 for	 this	 purpose,	 considering	 that	 Ly6a	
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expression	 is	 reported	 as	 early	 as	 E9	 on	 the	 endothelial	 layer	 of	 the	 dorsal	 aorta,	concurrent	with	the	emergence	of	hematopoietic	progenitors	(De	Bruijn	et	al.,	2002).	The	 multi-organ	 pattern	 of	 Ly6	 tracing	 we	 observed	 in	 adulthood	 could	 reflect	 a	variety	 of	HSC-derived	blood	 lineages,	 although	 at	 the	macroscopic	 level,	 reporter	fluorescence	did	not	appear	to	localise	within	vessels.	Specifically	for	the	liver,	SCA1	expression	has	also	been	reported	in	putative	foetal	liver	hepatoblasts	(Nierhoff	et	al.,	2005),	which	could	explain	a	more	widespread	epithelial	staining	in	the	adult	organ.	Closer	analysis	of	the	tissue	would	be	required	to	properly	assess	the	extent	and	types	of	cell	lineages	traced,	but	it	is	clear	that	Ly6-Cre	expression	would	not	be	restricted	to	hepatic	periportal	cells.		To	circumvent	the	hurdle	of	constitutive	transgenics,	we	turned	to	postnatal	gene	 transfer	 with	 viral	 vectors.	 Lentiviruses	 are	 capable	 of	 infecting	 quiescent	and/or	non-dividing	cells	(Naldini	et	al.,	1996),	which	makes	them	advantageous	for	targeting	 tissues	 with	 slow	 turnover	 like	 the	 liver.	 Transduction	 efficiency	 may	nonetheless	be	higher	in	cells	that	do	cycle,	as	evidenced	after	partially	hepatectomy	(Park	et	al.,	2000),	but	other	reports	have	shown	no	such	bias	towards	cell	cycle	state,	and	discrepancies	may	be	due	to	vector	design	(Pfeifer	et	al.,	2001).	In	homeostasis,	our	experiments	showed	preferential	viral	infection	of	the	H/E	fraction,	particularly	in	adults,	where	there	were	signs	of	tissue	damage	and/or	inflammation.	Pfeifer	and	colleagues	 have	 similarly	 demonstrated	 that	 the	 bulk	 of	 viral	 load	 (78.7%)	 in	transduced	adult	livers	is	found	within	non-parenchymal	cells	(Pfeifer	et	al.,	2001).	This	is	caused	by	immune	recognition	and	sequestration	of	the	virus,	predominantly	by	 professional	 scavengers	 like	 Kupffer	 cells	 (van	 Til	 et	 al.,	 2005),	 although	 both	endothelial	cells	and	HSCs	are	competent	for	antigen	uptake	and	presentation	(Knolle	and	Gerken,	2000;	Viñas	et	al.,	2003).	In	line	with	this,	inhibition	of	the	innate	immune	response	results	in	increased	parenchymal	cell	targeting	(van	Til	et	al.,	2005;	Brown	
et	al.,	2007).	Lentiviral	infection	was	attempted	in	pups	because	their	immune	system	is	relatively	immature	compared	to	adults	(Simon,	Hollander	and	McMichael,	2015);	however,	 despite	 the	 feasibility	 of	 targeting	 of	 SCA1+	 Msc	 cells	 in	 vivo,	 efficiency	remains	 too	 low	 for	 the	 purpose	 of	 cell	 ablation.	 In	 the	 future,	 infection	 can	 be	enhanced	 by	 screening	 naturally	 occurring	 viruses	with	 tropism	 for	mesenchymal	cells	or	via	pseudotyping	(Cronin,	Zhang	and	Reiser,	2005).	This	has	been	shown	for	
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adenoviral-associated	viruses	(AAVs)	(Di	Pasquale	et	al.,	2003;	Rezvani	et	al.,	2016),	of	which	AAV5	is	of	particular	interest	because	it	is	recognised	by	PDGFR	(Di	Pasquale	
et	al.,	2003).	In	its	current	form,	the	strategy	of	lentiviral	infection	could	be	used	for	lineage	tracing	of	SCA1+	Msc	cells	at	the	clonal	level	in	order	to	address	if	they	indeed	expand	in	situ	following	damage.	
6.8 Contact	 between	 SCA1+	 Msc	 and	 ductal	 cells	 inhibits	
organoid	growth	in	a	ratio-dependent	manner	
The	cellular	proximity	between	ductal	epithelium	and	SCA1+	Msc	cells	in	vivo	made	 us	 reassess	 the	 nature	 of	 the	 signalling	 interactions	 between	 these	 two	 cell	types.	Taking	Le	Douarin’s	work	as	an	example	again,	close	contact	between	hepatic	mesenchyme	and	endodermal	cells	is	required	for	stimulating	the	proliferation	and	differentiation	of	the	latter	population	during	embryogenesis	(Le	Douarin,	1975).	We	thus	generated,	via	two	different	methods,	chimeric	organoids	that	incorporate	adult	ductal	and	SCA1+	Msc	cells.	Interestingly,	the	arrangement	of	these	two	populations	within	 the	 organoid	 structure	 appears	 to	 respect	 the	 in	 vivo	 rules	 of	 cellular	organisation:	mesenchyme	surrounding	the	ductal	epithelium	from	the	‘outside’,	with	no	 apparent	disruption	of	 inter-epithelial	 cell	 junctions.	Our	method	of	 promoting	cell-cell	to	aggregation	relies	on	confining	the	two	cell	populations	in	small	spaces	to	increase	 their	 likelihood	of	meeting,	 after	which	 the	cells	assemble	spontaneously,	perhaps	due	to	combined	cell-autonomous	and	neighbour-to-neighbour	cues.	This	is	conceptually	different	from	conventional	tissue	engineering	methods	which	rely	on	artificial	scaffolds	to	force	complex	cellular	structures,	as	opposed	to	allowing	3D	self-organisation	(Woodford	and	Zandstra,	2012;	Sasai,	2013).	The	‘self-renewal’	of	our	DC/SCA1+	 Msc	 chimeras	 in	 vitro	 remains	 uncertain;	 once	 assembled,	 ductal	 cells	proliferate	depending	on	the	ratio	of	mesenchymal	cells	(see	below)	but	SCA1+	Msc	cells	 rarely	 do	 so	 within	 the	 chimera.	 Although	 potentially	 unsuitable	 for	 in	 vitro	expansion,	mesenchyme-contacted	organoids	may	better	recapitulate	the	physiology	of	healthy	liver	precisely	because	of	their	low	proliferative	nature,	given	that	hepatic	parenchymal	 cells	 divide	 seldomly	 (MacDonald,	 1961);	 standard	 EM-grown	 liver	organoids	 on	 the	 other	 hand	mimic	 the	 transient	 proliferative	 state	 of	 the	 ductal	epithelium	following	tissue	damage.		
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	Using	both	the	microfluidic-based	and	2D	Matrigel	method	of	cell	aggregation,	we	 found	 that	 the	 ratios	 of	 mesenchyme-to-epithelial	 cells	 contacting	 each	 other	determines	 whether	 SCA1+	 Msc	 promotes	 or	 inhibits	 organoid	 growth	 and	proliferation.	 A	 ratio	 of	 0.1:1	 (SCA1+	Msc	 :	 DC)	 in	 growth-factor	 reduced	medium	enhances	 organoid	 formation	 compared	 to	 controls	 lacking	 mesenchyme,	 whilst	higher	 ratios	 gradually	 supress	 organoid	 growth	 until	 completely	 impairing	 it.	Consistent	with	 our	 data	 from	 cell-contact	 independent	 co-cultures,	 the	mitogenic	effect	of	 the	SCA1+	Msc	at	0.1:1	 is	 likely	due	 to	 the	 soluble	 factors	 that	 these	 cells	express	(e.g.	Hgf,	Rspo1,	Fgf7),	and	indeed,	the	phenotype	is	abolished	when	culturing	in	 growth	 factor	 complete	 medium.	 In	 the	 microfluidic	 co-cultures,	 because	 all	chimeric	and	non-chimeric	organoids	grow	within	the	same	well,	paracrine	signalling	from	 neighbouring	 SCA1+	 Msc	 cells	 likely	 affects	 non-chimeric	 organoids	 (which	would	otherwise	grow	poorly	 in	Basal	+	WNT	CM	medium),	 thus	 confounding	 the	analyses	of	growth	dynamics	and	justifying	the	lack	of	increased	organoid	growth	at	0.1:1.		 What	is	so	special	about	the	0.1:1	ratio?	We	entertain	two	possibilities:	either	a	single	mesenchymal	cell	is	unable	to	physically	contact	all	organoid	cells	and	inhibit	their	 proliferation,	 or	 it	 cannot	 synthesise	 sufficient	 amounts	 of	 a	 short-range	cytostatic	factor.	In	both	cases,	after	the	threshold	is	surpassed	(>0.1:1),	the	cytostatic	effect	of	the	mesenchyme	outcompetes	its	mitogenic	capacity.	To	discern	if	actual	cell-to-cell	contact	is	required	for	the	block	of	proliferation,	we	will	make	use	of	SCA1+	Msc	cells	expressing	membrane	reporters	(mTmG	or	mGFP)	to	delineate	all	cytoplasmic	projections	that	may	be	contacting	the	ductal	cells.	Likewise,	we	can	make	use	of	Lgr5-
Cre,	R26-stop-tdTomato	reporter	ductal	cells	to	see	if	mesenchymal	contact	somehow	targets	Lgr5+	progenitors	within	the	organoid.		Beyond	 arrest	 of	 proliferation,	 the	 final	 fate	 of	 the	 mesenchyme-contacted	ductal	 cells	 remains	 unclear.	 Some	 cells	 stained	 positive	 for	 cleaved	 caspase	 3,	 a	marker	 of	 apoptosis,	 and	 there	 was	 variable	 upregulation	 of	 differentiated	 cell	markers	 accompanied	 of	 non-cystic	 morphology.	 The	 mechanism	 through	 which	SCA1+	 Msc	 cells	 hinder	 organoid	 growth	 is	 as	 yet	 undetermined;	 we	 disfavour	
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nutrient	competition	as	a	hypothesis	given	that	transwell	co-cultures	of	a	10:1	(SCA1+	Msc	 :	 DC)	 ratio	 do	 support	 robust	 organoid	 formation	 (Figure	 4.14).	 Unlike	 their	mitogenic	‘secretome’,	the	cytostatic	signal	of	SCA1+	Msc	cells	must	be	shared	with	the	SCA1-	 Msc	 population	 given	 that	 they	 both	 induce	 contact-dependent	 organoid	growth	arrest.	On	that	note,	Le	Douarin’s	studies	in	the	embryo	had	hinted	at	the	non-specificity	of	mesenchymal	cells	(e.g.	hepatic	mesenchyme,	lateral	plate	mesoderm)	in	regulating	hepatic	endodermal	cell	behaviour	via	contact-dependent	mechanisms	(Le	Douarin,	1975).	Suitable	candidate	molecules	must	either	be	membrane-bound	or	known	 to	 act	within	 a	 short	 range;	meeting	 these	 requirements	 are	 ligands	of	 the	Notch,	TGFb	and	Hippo	pathway,	which	according	to	our	RNAseq	data	are	expressed	by	the	mesenchyme	and	their	corresponding	receptors	by	the	ductal	cells	(data	not	shown).	In	the	liver,	the	TGFb	and	Hippo	pathway	in	particular	have	been	proposed	to	terminate	regeneration	and/or	control	organ	size	(Michalopoulos,	1990;	Lee	et	al.,	2010;	Lu	et	al.,	2010).	Although	TGFb	is	not	membrane	bound,	it	is	secreted	in	a	latent	form	 and	must	 be	 processed	 extracellularly	 (Lyons	 et	 al.,	 1990;	 Shi	 et	 al.,	 2011).	Efficient	 TGFb	 activation	 in	 dermal	 fibroblasts	 requires	 contact-dependent	 co-cultures	with	keratinocytes	(Shephard	et	al.,	2004),	an	observation	that	holds	true	for	co-cultures	 of	 other	 cell	 types	 (Sato	 and	 Rifkin,	 1989;	 Sato	 et	 al.,	 1990).	 Inhibitor	studies	will	be	performed	in	the	future	to	 identify	the	signal	 that	rescues	organoid	growth	arrest	upon	mesenchymal	contact.		A	fraction	of	the	SCA1+	Msc	:	DC	ratios	that	we	‘engineered’	in	vitro,	and	that	modulate	organoid	growth,	do	exist	in	homeostatic	and	DDC-damaged	mouse	livers.	In	the	absence	of	damage,	we	detect	a	ratio	of	0.3:1,	which	in	vitro	falls	within	a	range	that	would	allow	organoid	growth	though	not	to	its	maximum.	Given	that	homeostatic	livers	 proliferate	 very	 rarely,	 the	 0.3:1	 ratio	 could	 represent	 a	 ‘poised’	 state	 for	expansion	 in	 the	 case	of	damage.	At	 the	 late	 stage	of	 regeneration	 (d12),	 the	 shift	towards	a	higher	(0.5:1)	SCA1+	Msc	:	DC	ratio	is	expected	to	limit	ductal	cell	expansion	even	further	compared	to	homeostasis,	and	could	thus	be	a	mechanism	to	terminate	regeneration.	That	being	the	case,	for	ductal	expansion	to	occur	between	d0	and	d12,	our	 in	 vitro	 data	 suggests	 that	 the	 SCA1+	Msc	 :	 DC	 ratio	 should	 drop	 transiently.	Although	 results	 are	 still	 preliminary,	we	have	 indeed	detected	a	pro-proliferative	
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ratio	close	to	0.1:1	around	d4	after	liver	damage	(data	not	shown).	Tuchweber	et	al.	had	measured	the	kinetics	of	portal	fibroblast	and	ductal	cell	expansion	in	the	early	stages	of	cholestatic	fibrosis	in	rats	(Tuchweber	et	al.,	1996),	showing	that	24h	post	BDL	ductal	 cells	and	periductular	 fibroblasts	exhibit	proliferative	 indices	of	36.8%	and	16.7%	respectively,	whilst	they	switch	to	29.5%	and	31%	at	48h	and	to	12.0%	and	 11.6%	 at	 7	 days.	 These	 data	 suggest	 delayed	 expansion	 of	 the	 periportal	mesenchyme	compared	to	ductal	cells	immediately	after	damage,	which	would	fit	well	with	 the	 drop	 in	 SCA1+	Msc	 :	 DC	 ratio	 at	 d4	 that	 we	 predict	 permits	 ductal	 cell	proliferation.	 At	 the	 later	 stages,	 the	 converse	 situation	 (increased	 SCA1+Msc	 cell	numbers)	 may	 be	 necessary	 for	 cessation	 of	 epithelial	 growth.	 Regenerative	processes	must	indeed	be	self-limiting,	because	if	left	unchecked,	they	may	progress	into	pathologies	like	cancer	(Tang	et	al.,	2008).	In	our	 in	vitro	 system,	SCA1+	Msc	 :	DC	ratios	higher	 than	1:1	nearly	abolish	organoid	 growth;	 despite	 failing	 to	 detect	 such	 ratios	 in	 the	mouse	 liver	 so	 far,	 it	would	 be	 interesting	 to	 re-assess	 tissues	 in	 the	 context	 of	 chronic	 damage.	 As	introduced	 in	 Chapter	 1,	 the	 activation	 and	 proliferation	 of	 ECM-depositing	myofibroblasts	is	a	normal	process	of	regeneration,	but	when	overstimulated	due	to	repeated	 injury,	 it	 leads	 to	 scarring	of	 the	 tissue	 (fibrosis)	 and	 impaired	epithelial	replacement.	We	could	thus	hypothesise	that	ratios	of	>1:1	(SCA1+	Msc	:	DC)	may	be	relevant	 for	 chronically	 damaged	 livers.	 Particularly	 interesting	 would	 be	 if	 an	increased	ratio	of	SCA1+Msc	per	se,	and	not	their	ECM	depositing	capacity,	proves	to	be	 inhibitory	 for	 ductal	 cell	 proliferation.	 This	 scenario	 would	 fit	 well	 with	 the	apparently	 low	 contribution	 (compared	 to	 HSCs)	 of	 periportal	 fibroblasts	 to	myofibroblast	 generation	 and	 ECM	 deposition	 in	 fibrotic	 livers	 (Mederacke	 et	 al.,	2013).	To	verify	 this	 is	 the	case,	we	will	probe	 the	ECM	depositing	capacity	of	 the	SCA1+	 Msc	 cells	 across	 different	 SCA1+Msc	 :	 DC	 ratios	 in	 vitro	 and	 in	 vivo,	 and	considering	 that	 fibrosis	 is	 reversible,	we	will	make	use	of	 the	 iDTR	 lines	we	have	generated	 to	 inducibly	 ablate	 SCA1+	 Msc	 cells	 and	 assess	 the	 effect	 on	 organoid	growth.
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6.9 Conclusion	and	working	hypothesis	
In	 this	dissertation,	we	have	made	use	of	 co-culture	 assays	 to	highlight	 the	mesenchymal	 (Msc)	 cell	 compartment	 of	 the	 liver	 as	 a	 niche	 cell	 population	 that	supports	 organoid	 growth	 in	 vitro,	 and	 which	 may	 consequently	 be	 relevant	 for	ductal-driven	 liver	 regeneration.	 Mesenchymal	 cells	 expressing	 the	 cell-surface	antigen	SCA1	localise	periportally,	in	the	immediate	vicinity	of	biliary	ducts	(Figure	6.1,	in	vivo),	whilst	SCA1-	cells	are	interspersed	throughout	the	hepatic	parenchyma.	Judging	from	their	anatomical	coordinates	and	the	expression	of	markers	like	Elastin,	SCA1+	Msc	cells	are	likely	to	overlap	–	at	least	partially	–	with	the	previously	described	portal	fibroblast	lineage	of	the	liver.	When	tissues	are	challenged	with	damage	models	that	induce	ductal-driven	regeneration	(such	as	DDC),	the	in	situ	expansion	of	DC	is	seemingly	 mirrored	 by	 the	 periportal	 SCA1+	 Msc	 population;	 yet	 with	 distinct	dynamics,	given	that	the	ratio	of	SCA1+	Msc	:	DC	changes	with	time:	we	observed	an	increase	from	0.3:1	to	0.5:1	(SCA1+	Msc	:	DC)	between	homeostasis	and	the	late	phase	of	the	regenerative	response	(DDC	d12),	respectively;	and	according	to	preliminary	data,	there	could	be	a	transient	drop	(~0.1:1)	soon	after	damage	(DDC	d4)	(Figure	6.1,	
in	vivo).	Primary	and	 in	vitro	expanded	SCA1+	Msc	cells	are	enriched	in	a	battery	of	pro-regenerative	 growth	 factors	 (Rspo1/3,	 Hgf,	 Fgf7)	 and	 robustly	 support,	 in	 a	contact-independent	manner,	the	transition	of	differentiated	EpCAM+	DC	into	highly	proliferative	 organoid	 structures.	 Organoid-secreted	 factor(s),	 yet	 to	 be	 identified,	also	 support	 SCA1+	Msc	 growth	 in	 a	 positive	 feedback	 loop	 (Figure	 6.1,	 in	 vitro).	Although	this	would	seem	to	suggest	that	the	SCA1+	Msc-to-DC	crosstalk	is	designed	to	promote	DC	expansion,	our	in	vitro	data	also	suggests	that	physical	contact	and/or	proximity	 from	 the	 SCA1+	 Msc	 cells	 inhibits	 ductal	 cell	 proliferation	 in	 a	 ratio-dependent	manner.	At	 levels	of	0.1:1	SCA1+	Msc	:	DC,	the	mitogens	secreted	by	the	SCA1+	 Msc	 cells	 override	 their	 contact-dependent	 cytostatic	 action	 on	 the	 DC;	 in	contrast,	 progressively	 higher	 ratios	 tilt	 the	 balance	 towards	 impaired	 DC	proliferation	until	nearly	abolishing	organoid	growth	(Figure	6.1,	in	vitro).		
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Figure	6.1	Conclusions	of	the	in	vivo	and	in	vitro	cross-talk	between	SCA1+	Msc	cells	and	DC.		In	the	liver	lobule,	SCA1+	Msc	cells	reside	in	very	close	proximity	to	the	ductal	cell	(DC)	epithelium.	Hepatotoxic	damage	through	a	DDC	diet	 induces	expansion	of	both	DC	and	SCA1+	Msc	cells,	so	 that	 the	ratio	between	these	two	populations	(SCA1+	Msc	:	DC)	changes	from	0.3:1	at	DDC	d0,	to	0.1:1	at	DDC	d4	(preliminary)	and	to	0.5:1	at	DDC	d12.	SCA1+	Msc	cells	express	pro-regenerative	growth	factors	like	Rspo1/3,	Hgf	and	Fgf,	and	in	vitro	co-culturing	of	DC	with	SCA1+	Msc	in	the	absence	of	cell-cell	contact	enhances	DC	proliferation	and	thus	organoid	formation.	The	proliferating	DC	in	turn	support	SCA1+	Msc	growth.	However,	when	SCA1+	Msc	and	DC	are	in	physical	proximity,	only	a	mesenchymal-to-epithelial	 ratio	of	0.1:1	 supports	DC	proliferation,	whilst	higher	ratios	arrest	it.		
By	merging	our	in	vitro	and	in	vivo	data,	we	can	conceive	a	working	model	as	follows	(Figure	6.2):	 in	 the	homeostatic	 liver,	DC	and	SCA1+	Msc	physically	contact	each	other	in	a	ratio	(0.3:1)	where	the	cytostatic	factors	of	the	mesenchyme	limit	DC	proliferation,	 yet	 still	 allow	 DC	 to	 remain	 responsive	 to	 pro-proliferative	 inputs;	damage	 and	 inflammation	 may	 provide	 such	 stimuli	 in	 the	 early	 phases	 of	 the	regenerative	cascade,	so	that	DC	begin	to	expand	with	respect	to	the	SCA1+	Msc	cells	until	 reaching	a	0.1:1	 ratio	where	 the	mitogens	of	 the	mesenchymal	 cells	override	their	contact-dependent	block	of	proliferation.	Given	that	the	proliferating	DC	secrete	mitogenic	 and/or	 pro-survival	 factors	 that	 help	 the	 SCA1+	 Msc	 cells	 expand,	 the	process	of	regeneration	may	be	self-limiting,	as	the	increased	numbers	of	SCA1+	Msc	cells	 will	 re-instate	 a	 higher	 SCA1+	 Msc	 :	 DC	 ratio	 (0.5:1)	 that	 will	 consequently	
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terminate	proliferation	through	cell-cell	contact	interactions.	To	prove	this	model,	a	careful	 temporal	 regulation	of	 the	 SCA1+	Msc	numbers	will	 be	 required,	 either	 via	
iDTR-based	 strategies	 or	 conversely,	 via	 transplantation.	 In	 the	meantime,	we	will	make	 use	 of	 our	 in	 vitro	 tools	 to	 dissect	 the	 molecular	 mechanisms	 of	 the	mesenchymal-to-epithelial	 interplay,	 particularly	 with	 respect	 to	 the	 SCA1+	 Msc-derived	cytostatic	factor.	In	conclusion,	our	study	has	shown	that	periportal	SCA1+	Msc	cells	behave	as	a	niche	population	for	DC	with	antagonistic	properties:	mitogenic	vs	cytostatic;	a	duality	that	may	 be	 extremely	 pertinent	 for	 the	 activation	 and	 termination	 phases	 of	 liver	regeneration,	respectively.	
	
Figure	 6.2	 Working	 model	 of	 the	 role	 of	 SCA1+	 Msc	 cell	 in	 regulating	 ductal-driven	 liver	
regeneration.We	propose	 that	 in	homeostasis,	 SCA1+	Msc	and	DC	exist	at	a	0.3:1	 ratio	 that	predominantly	limits	DC	proliferation	through	contact-dependent	cytostatic	signals	from	the	mesenchyme.	Damage	stimuli,	still-to-be	characterised,	induce	DC	proliferation	and	change	the	SCA1+	Msc	:	DC	ratio	towards	0.1:1,	which	in	turn	exacerbates	DC	expansion	due	to	fewer	DC	being	physically	contacted	by	the	mesenchyme	yet	receiving	the	mesenchyme-secreted	growth	factors.	In	the	later	phases	of	regeneration,	the	proliferating	DC	secrete	a	mitogen	that	promotes	SCA1+	Msc	expansion,	which	establishes	a	new	ratio	of	0.5:1	whereby	increased	contact	with	the	mesenchyme	shuts	down	DC	proliferation.		
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Abbreviations	
a	SMA	 	a	Smooth	muscle	actin		
2-AAF	 	2-acetylaminofluorene		
4-OHT	 	4-hydroxytamoxifen		
A1AT	 	a1-antitrypsin		
AAV	 	Adeno-associated	virus	
AFP	 	a-Fetoprotein	
APC	 	Allophycocyanin	
BD	 	Biliary	duct	
BDL	 	Bile	duct	ligation		
BM-MSC	 	Bone	marrow	mesenchymal	stem	cells		
BMP	 	Bone	morphogenetic	protein	
BMP2	 	Bone	morphogenetic	protein	2	
BMP4	 	Bone	morphogenetic	protein	4	
BSA	 	Bovine	serum	albumin	
CCl3*	 	Trichloromethyl	radical	
CCl4	 	Carbon	tetrachloride	
CDE	 	Choline-deficient	ethionine-supplemented	
CM	 	Conditioned	medium	
CPT	 	Camptothecin		
CTGF	 	Connective	tissue	growth	factor	
CV	 	Central	vein	
CYP2E1	 	Cytochrome	P450	2E1		
DC	 	Ductal	cell	
DDC	 	Diethoxycarbonyl-1,4-dihydrocollidine	
DT	 	Diphtheria	toxin		
ECM	 	Extracellular	matrix	
EdU	 	Ethynyldeoxyuridine	
EGF	 	Epidermal	growth	factor	
EM	 	Organoid	expansion	medium	
EMT	 	Epithelial-to-mesenchymal	transition	
ESC	 	Embryonic	stem	cell	
FACS	 	Fluorescent	activated	cell	sorting	
Fah	 	Fumarylacetoacetate	hydrolase	
FAP	 	Fibro-adipogenic	progenitors		
FBS	 	Foetal	bovine	serum	
FFD	 	Flow	focusing	device		
FGF	 	Fibroblast	growth	factor	
FGF7	 	Fibroblast	growth	factor	7	
FITC	 	Fluorescein	isothiocyanate	
Foxf1	 	Forkhead	box	f1		
Foxl1	 	Forkhead	box	L1		
GFAP	 	Glial	fibrillary	acidic	protein	
GM-CSF	 	Granulocyte-macrophage	colony	stimulating	factor		
GPI-AP	 	Glycosyl	phosphatidylinositol-anchored	cell	surface	protein		
H/E	 	Hematopoietic/endothelial		
HA	 	Hepatic	artery	
HC	 	Hepatocyte	
Hes1	 	Hes	family	bhlh	transcription	factor	1	
HGF	 	Hepatocyte	growth	factor	
Hlx	 	H2.0-like	homeobox	
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hMSCs	 	Human	mesenchymal	stem	cells		
hMSCs	 	Human	mesenchymal	stem	cells		
HNF-6	 	Hepatocyte	nuclear	factor-6		
Hnf4a	 	Hepatocyte	nuclear	factor	4-alpha	
HSC	 	Hepatic	stellate	cell	
HUVECs	 	Human	umbilical	cord	endothelial	cells	
HUVECs	 	Human	umbilical	cord	endothelial	cells		
iPSC	 	Induced	pluripotent	stem	cell	
IL-6	 	Interleukin-6	
Itgb1	 	Integrin	β1		
Krt19	 	Keratin	19	
LDL	 	Low-density	lipoprotein		
Lgr5	 	Leucine	rich	repeat	containing	G	protein	coupled	receptor	5			
LPM	 	Lateral	plate	mesoderm	
Lrat	 	Lecithin-retinol	acyltransferase	
LSECs	 	Liver	sinusoidal	endothelial	cells	
LV	 	Lentiviral	vector	
M-CSF	 	Macrophage	colony	stimulating	factor		
Mdm2	 	Transformed	mouse	3T3	cell	double	minute	2	
MEFs	 	Mouse	embryonic	fibroblasts	
MF	 	Myofibroblasts		
mGFP	 	Nuclear-localised	green	fluorescent	protein	
MMPs	 	Matrix	metalloproteinases		
MP	 	Myogenic	progenitors		
Msc	 	Mesenchymal	
mtdTomato	 	Membrane-localised	tdtomato	protein	
nGFP	 	Nuclear-localised	green	fluorescent	protein	
NK	 	Natural	killer	cell	
NPC	 	Non-parenchymal	cell		
ntdTomato	 	Nuclear-localised	tdtomato	protein	
OC-2	 	One-cut-2		
OPN	 	Osteopontin		
OSM	 	Oncostatin	m		
PBS	 	Phosphate	buffer	saline	
PCK	 	Pancytokeratin		
PCR	 	Polymerase	chain	reaction		
PDGF	 	Platelet-derived	growth	factor		
PDGFR	 	Platelet-derived	growth	factor	receptor	
PDGFRa	 	Platelet	derived	growth	factor	a	
PDGFRb	 	Platelet	derived	growth	factor	b	
PE	 	Phycoerythrin	
PFA	 	Paraformaldehyde	
PHx	 	Partial	hepatectomy		
PV	 	Portal	vein	
RPKM	 	Reads	Per	Kilobase	of	transcript	per	Million	mapped	reads	
Ri	 	ROCK	kinase	inhibitor		
Rspo1	 	Rspondin	1	
Rspo3	 	Rspondin	3	
S.I.	 	Small	intestine	
SCA1	 	Stem	cell	antigen	1		
Sfrp5	 	Secreted	frizzled-related	protein	5	
Sox9	 	SRY-related	HMG	box	transcription	factor	9	
STM	 	Septum	transversum	mesenchyme	
Tert	 	Telomerase	reverse	transcriptase	
TGFb	 	Transforming	growth	factor	b	
Thy1	 	Thymus	cell	antigen	1		
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TIMP1	 	Tissue	inhibitor	of	metalloproteinase-1		
TNFa	 	Tumour	necrosis	factor	a		
Ttr	 	Transthyretin	
uPA	 	Urokinase-type	plasminogen	activator	
VEGFR2	 	Vascular	endothelial	growth	factor	receptor	2		
VEGFR3	 	Vascular	endothelial	growth	factor	receptor	3			
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